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Com a chegada da chamada era genómica tornou-se importante focar os 
estudos de fenómenos biológicas num ponto de vista de “sistema”. Isto deve-
se ao facto de ser fundamental compreender como é que as funções celulares 
emergem da interacção e integração dos muitos componentes celulares. Para 
tornar isto possível, muitos dos recentes desenvolvimentos tecnológicos têm 
sido focados na colecção de um grande números de dados sobre grande parte 
dos componentes celulares. A necessidade de desenvolver novos métodos 
computacionais, capazes de integrar e relacionar esta informação tornou-se 
por isso num imperativo. Estes novos métodos de análise devem permitir a 
criacao de modelos que consigam extender o conhecimento actual de forma a 
prever dados não conhecidos.  
O trabalho apresentado nesta tese tem como foco o desenvolvimento de 
métodos computacionais para o estudo de interacções entre proteínas. Em 
particular, foi desenvolvido um método para prever a especificidade de 
interacção de domínios de proteínas que ligam péptidos utilizando informação 
estrutural. Para demonstrar este método, foram escolhidos domínios SH3 de 
S. cerevisiae e domínios SH2 de H. sapiens. O trabalho aqui apresentado 
mostra que, conhecendo a especificidade de interacção, é possível usar 
genómica comparativa e o conhecimento da estrutura secondária das 
proteínas para prever quais os alvos de interacção destas proteínas no 
proteoma com mais de 75% de exactidão. Foi observado que a exactidão 
destas previsões aumenta quando se restringe a procura de locais de 
interacção a zonas do proteoma previstos como desordenados, sugerindo que 
os locais de interacção de domínios que se associam a péptidos tendem a 
residir nestas zonas.  
A análise dos actuais mapas de interacção de proteínas de várias espécies 
revelou que estas interacções apresentam considerável plasticidade evolutiva. 
O ritmo a que estas interacções mudam durante o processo evolutivo depende 
tanto da especificidade da interacção como dos processo biológico em que 
participam as proteínas. Como exemplo, o estudo do proteoma humano 
revelou que proteínas que participam na resposta imune, em funções de 
transporte e no estabelecimento de localização mostram sinais de selecção 
positiva para mudarem de interacções.  
Em resumo, são apresentados nesta tese novos métodos para prever 
interacções entre proteínas assim como novas hipóteses sobre o processo 
evolutivo destas interacções. 
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abstract 
 
With the developments of the so called Genomic era there has been an 
increasing awareness of the necessity to study biological phenomena from a 
systems view point. This is due to the importance of understanding how the 
interplay between the many cellular components brings about cellular functions. 
To this effect many of the most recent technological efforts in biology have 
been directed at collecting data that encompass most cellular components. 
Integration of these different experimental approaches and better 
comprehension of the vast data available, urged for the development of 
computational methods in biological research. These computational tools 
should be able to search for patterns that can extend current knowledge by 
providing predictive models of biological events.  
The work presented in this thesis focuses on computational methodologies to 
study protein-protein interactions. In particular, the results presented show that 
binding specificity of peptide binding domains can be obtained from protein 
structure. SH3 domains from S. cerevisiae and human SH2 domains were used 
to demonstrate this method. Also, this work demonstrates that, by knowing the 
binding specificity, it is possible to use comparative genomics and protein 
secondary structure information to accurately (>75% accuracy) predict the 
binding partners of a protein in the proteome. It was observed that restricting 
predictions to unstructured elements of the proteome increases the accuracy of 
the prediction. 
The analysis of current protein interaction information of many different species 
has revealed that protein interactions are quite plastic in evolution and are 
determined both by binding specificity and biological function. It was observed, 
for example, that human proteins related with immune response, transport and 
establishment of localization, show signs of positive selection for change of 
interactions. 
In summary, the work reported here, explores new methods to computationally 
predict protein interactions shedding light into the possible evolution of these 
interactions.   
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1 - Introduction  
 
Cellular functions and complexity emerges from the interaction of cellular 
components. To understand cellular complexity, scientists need to continue the efforts 
to map and comprehend these cellular interactions. In the past decade several 
technological developments have created tools that allowed us to explore these 
interactions at a much larger pace than in the early days of molecular biology. The need 
to deal with larger amounts of information has triggered a boom in the use of computers 
in biological research. This PhD was done in this context, of an increase need to 
establish computational methods that are able to take the incoming information and to 
extend it into predictive models. I have focused my research in the computational study 
of protein-protein interactions, in particular on methods to predict these interactions and 
to study their evolutionary dynamics. 
  
1.1 - Experimental methods to determine proteins interactions 
I will briefly review here some of the most commonly used experimental 
methods to determine protein-protein interactions. Most of information on protein-
protein interactions that I have used in my studies has been obtained with one of these 
methods.  
 
1.1.1 - Yeast-two hybrid and protein complementation methods 
In vivo detection of protein interactions on a large scale was made possible with 
the development of the yeast-two-hybrid (Y2H) method [1]. This method was inspired 
on the modular nature of some transcription factors that contain a separate DNA binding 
domain (DBD domain) and a transcription activation domain (TAD domain). The 
protein of interest (called “bait” protein) is fused to a DBD domain and the potential 
target proteins (called “prey” proteins) are fused to TAD domains. If a bait interacts 
with a prey the DBD and TAD domains will act together to drive the expression of a 
reporter gene.  
The Y2H method is one of the most popular methods for detection of protein 
interactions and it has been used is several attempts to map large parts of the possible 
interactome (all protein interactions) in several species [2-7]. 
Chapter 1 
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The success of the Y2H method has guided other scientist to explore similar 
strategies of domain complementation. Instead of the DBD and TAD domains, other 
domains (or domain fragments) are used. Upon interaction of prey and bait proteins, the 
domains or domain fragments that were fused complement each other signaling a 
positive interaction. Examples of this include the split ubiquitin, split lactamase, split 
galactosidase, split YFP and split luciferase methods (see review [8]). These methods 
overcome one the biggest caveats of the Y2H, that the interaction can only be detected 
in the nucleus. The Y2H method is also not very appropriate to study the impact of post-
translational modification (PTMs) on the interaction being studied.  
 
1.1.2 - Microscopy detection methods 
Protein-protein interactions can also be studied in vivo by microscopy with the 
use of spectroscopy methods (for review see [9]). The most widely used is Florescence 
Resonance Energy Transfer (FRET) that can measure the interaction of two 
chromophores if they are closer than 80 angstroms and in an appropriate orientation. 
The protein and its binding partner are tagged with two different chromophores with 
overlapping emission/absorption spectra and the interaction can be observed in the 
living cell with millisecond time resolution. Commonly the chromophores used are 
fluorescent protein domains as the green fluorescent protein (GFP) or other color 
variants that are fused to the proteins of interest. Given the limited emission/absorption 
spectra of these proteins and the relatively large size there has been a lot of interest in 
developing chemical chromophores to be used in microscopy [10].  
Another related powerful technique to detect protein interactions is fluorescence 
cross-correlation spectroscopy (FCCS). This sensitive method focuses on a very small 
volume of the cell (ca. 1um
3) and tries to determine if the protein and it’s putative 
target, both labeled with two different chromophores, have simultaneous occurring 
fluctuations in the fluorescence intensity. This correlated change signals that the 
proteins are likely traveling together trough the small volume studied.  
 
1.1.3 - TAP-tag pull down, protein arrays and solid-phase detection 
In contrast to the above mentioned methods, there are several techniques that detect 
interactions outside of the cell (in vitro). One commonly used approach is to tag the bait 
protein, express it in the cell and to purify it from a cell extract trying to enrich the 
purification with binding targets. The isolated targets are then identified with the use of 
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mass spectrometry (for a review see [9]). Several different tags have been developed 
[11] for this propose and currently the most commonly used tag for large scale mapping 
of protein complexes is the TAP tag [12]. TAP stands for Tandem Affinity Purification 
and it allows for a two step purification of protein complexes. Recent examples of large 
scale usage of TAP-tag pull down include the mapping of protein complexes in S. 
cerevisiae [13-15]. Some would argue that a pull-down experiment is probing 
interactions that occur inside the cell and therefore should be described as an in vivo 
method but given that the detection is made outside the cell I have grouped it with other 
in vitro methods.  
A promising technology to determine protein binding in a high-throughput 
manner is protein-arrays.  In this approach purified proteins or peptides are fixed in an 
array format and the whole array is probed for potential interactions (for review see 
[16]). One of the advantages of this approach is that it also gives information on relative 
binding affinities of the probed interaction with all the spotted proteins or peptides in 
the array.  Some interesting examples of this technology include the detection of SH2 
and PTB domain interactions with phosphopeptides derived from the ErbB receptors 
[17], SH3 domain interactions with spotted peptides [18] and the detection of MAP 
kinase substrates within a set of spotted Arabidopsis proteins [19]. 
Knowing that proteins might interact is informative but it does not say much 
about properties of the interaction observed like the kinetics and affinity of binding. 
More detailed studies are possible with the use of surface plasmon resonance (SRP) 
where one of the interaction partners is immobilized and binding of a flowing putative 
target is detected in real-time. The interaction is detected as a change of mass in the 
layer of medium near to the sensor surface. This approach can be used to detect protein-
protein interactions but it can also be used to detect other type of interactions (for 
review see [20]). 
 
1.1.4 - Molecular display methods 
A group of methods, collectively referred to as molecular display, aim to define 
specificity or improve the binding affinity of a protein to a ligand. These approaches are 
based on the presentation of a large library of variants of the protein ligand to the 
binding protein/domain. The variants are displayed to the binding protein in a form that 
is always linked to the coding genotype allowing for easy identification of the selected 
ligand. The oldest and most commonly used form of molecular display developed is the 
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Phage display [21, 22]. In this method, the protein variants are displayed in the phage 
coat. The best ligands are recovered by probing against the immobilized binding protein 
and amplified by bacterial infection.  More recently, other display vectors like bacteria, 
yeast and  ribosomes have also been tried (see Review [23]). Most commonly, 
molecular displayed is used to evolve proteins with redesigned binding specificities [24] 
or binding affinities [25] but it can also be used to study the binding specificity of a 
binding domain [26]. For example, phage display has been used to study the binding 
specificity of most S. cerevisiae SH3 domains to proline rich peptides [27]. For each 
domain a motif was defined according to the peptides that were enriched in the selection 
procedure. These motifs establish, for each position of the binding ligand, the preferred 
residues that determine binding to the SH3 domain.  Although phage display allows the 
exploration of many different peptides it is still unlikely that all possible amino acid 
combinations of even a small binding ligand can be adequately sampled. For this reason 
the libraries are usually biased using previous knowledge of the binding specificity of 
these binding domains. For these reasons it is possible to miss some of the binding 
determinants using this approach.  Also, characterizing the binding specificity of a 
domain will only tells us what in the cell is likely to bind to the domain but more 
information is required (i.e availability of the binding determinants, protein 
concentration and localization) to define the binding partners in the cell.  
 
 
1.2 - Computational methods to predict protein-protein interactions 
The wealth of information regarding protein interactions should be studied for 
extraction of rules and models that may be used in a predictive manner. The search for 
these predictive patterns is a main goal of current computational biology. I have tried to 
review here most of the approaches for computational prediction of protein-protein 
interactions developed so far, trying to highlight some of the known advantages and 
drawbacks. I have also collected some of the attempts to unify the different methods 
into a common integrative predictive model. 
 
1.2.1 - Sequence based methods  
The large scale genome sequencing was arguably the start of the “-omics” boom, 
by which vast amounts of data are produced in some automated fashion. Comparative 
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studies of genome sequences (comparative genomics) were one of the initial tasks of 
bioinformatics, along with all of the data management problems associated with large 
amounts of information. Some of the early attempts to predict protein-protein 
association came from these comparative genomics analysis. For example, it was 
observed that conserved proximity of two open reading frames correlates with increase 
in likelihood of protein interaction between the coded proteins [28]. More precisely, the 
approach identifies functional association between proteins and it is particularly useful 
for bacterial species that tend to code functional units in operons.  
In similar fashion, it was shown that phylogenetic association of protein pairs 
also signals functional linkage. That is, if two proteins are always present or absent 
together (not necessarily in close vicinity in the genome) in many different species then 
the two proteins are likely part of the same complex/pathway [29]. Another sequence 
based method relies on the determination of protein fusion events. In 1999, Marcotte 
and colleagues [30] showed that if two proteins are sometimes seen in some species 
fused into one contiguous protein, then these are very likely to be related in function 
and therefore also more likely to interact.  
These methods have the advantage that only require the simple analysis of a 
large number of genomes but they do not predict directly protein interactions but instead 
functional association. Another disadvantage is that these methods are not very effective 
in eukaryotic species, given that they have a more complex genome structure and fewer 
of these genomes are available to study.  
A different method to predict protein interaction from sequence information was 
developed by Pazos and colleagues [31, 32]. Analyzing alignments of interacting 
proteins the authors showed that correlated mutations, between the two proteins, are 
identifiable signals for protein-protein interaction. This method not only identifies 
directly protein-protein association but it also determines the protein binding regions. 
Unfortunately the approach requires that the interaction be conserved in many other 
species, a problem that I have also faced and discuss further in manuscripts 1 and 4.   
Another analysis that can be done, knowing only the sequence of the proteins, is 
to study the domain composition of each protein of interest. From the analysis of the 
different interaction networks experimentally determined one can extract the likelihood 
that any two given protein domains might interact [33] and extend this to any protein 
pair under analysis. Although this is a relative week predictor it can be used in 
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conjunction with many other methods to increase the overall accuracy of most 
approaches.  
 
1.2.2 - Graph theory methods 
One of the first approaches to study the large cellular interaction maps was to 
simplify the information into a graph form. Each component was symbolized as a node 
and each interaction as an edge in the graph [34]. This graph abstraction is in many 
respects too large of a simplification from what we already know of proteins and 
cellular functions but it allowed for a vast number of studies regarding interactions 
networks [34-37]. One interesting observation coming from these graph studies is that 
protein interactions, or edges, can be predicted just by analyzing the graph structure of 
current incomplete interactomes [38, 39]. In my opinion some of the most interesting 
recent advances in protein-protein interaction prediction have come from trying to do 
comparative graph analysis between the interactomes of different species [40, 41]. This 
type of approach can be though as the analogy to comparative genomics mentioned 
above and I will cover this in more detail when I review some of the studies of protein 
network evolution.  
 
1.2.3 - Structural based methods  
Instead of simplifying information about protein interactions one could look in 
even more detail, into how the protein’s structure might give us some insight into its 
interactions. Trying to understand and predict how two proteins interact in a complex 
has been the challenge of structural computational biology for more than two decades 
now. The initial attempt to understand protein-interaction from computational analysis 
of structural data (what is known today as docking) was published by Wodak and Janin 
in 1978 [42]. In this seminal study, the authors established a computational procedure to 
reconstitute a protein complex from simplified models of the two interacting proteins. In 
the twenty-years that have followed the complexity and accuracy of docking methods 
has steadily increased but still faces difficult hurdles (see reviews [43, 44]).  Docking 
methods start from the knowledge that two proteins interact and aim at predicting the 
most likely binding interfaces and conformation of these proteins in a 3D model of the 
complex. Ultimately, docking approaches might one day also predict new interactions 
for a protein by exhaustively docking all other proteins in the proteome of the species, 
but at the moment this is still not feasible.  
  
 11 
It should still be possible to use the 3D structures of protein complexes to 
understand at least particular interactions types. In a recent study, Russel and Aloy have 
shown that it is possible to transfer structural information on protein-protein interactions 
by homology to other proteins with identical sequences [45]. In this approach the 
homologous proteins are aligned to the sequences of the proteins in the 3D structure. 
The changes in the new sequences are evaluated with an empirical potential to 
determine the likelihood of binding. A similar approach was described soon after by Lu 
and colleagues [46] and both have been applied on large scale genomic studies [47, 48]. 
As any other functional annotation by homology this method is limited by how much 
the target proteins have diverged from the templates. Alloy and Rusell estimated that 
interaction modeling is reliable above 30% sequence identity [49].  
This method also depends on the structural coverage of interactions types that is 
currently very low. It was however recently postulated that there is a limited number of 
possible interactions types, used in the cell, so structural genomics initiatives targeting 
uncharacterized interaction types will greatly increase our ability to predict new 
interactions in this way [50].  
Instead of determining binding by looking at aligned proteins and evaluating 
changes with statistical potentials as described by Alloy and Russel a more 
sophisticated approach requires homology modeling of the aligned sequences on the 
structural template of the complex followed by accurate energy evaluation. This was 
first done by Kiel and colleagues [51] with the use of FoldX [52] a protein design 
algorithm developed in the lab I have done my PhD in.  
All of these studies focused on trying to predict domain-domain interactions and 
ignore domain-peptide interactions. That is, the interaction is assumed to be between 
two folded structures with relatively large binding interfaces instead of interactions with 
linear peptides has is the case of several protein domains (ex SH2, SH2, WW domains). 
To my knowledge the first attempt to predict domain-peptide interaction with the aid of 
some structural information was developed by Brinkworth and colleagues in 2003 [53]. 
In this work, the authors analyzed the structures of several protein kinases, for which 
they had experimental information on binding specificity, in complex with substrates. 
The authors then determined the kinase residues important for binding and observed a 
set of rules correlating observed residues at important positions with the known binding 
specificity. With these rules it is possible to take any protein kinase domain, with 
similar enough sequence, and match key residues with predicted binding specificity. 
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This approach depends on very detailed human structural analysis and it is therefore not 
very easily extendable. As described by Kiel and colleagues [51] and in this thesis in 
manuscripts 2 and 3 it is possible to take any domain-domain or domain-peptide 
structure and an empirical force field to predict the specificity of interactions by 
automatic in silico mutagenesis. Even in the cases where no structure is available it is 
possible to use predicted domain-peptide complex from homology modeling to 
determine the binding specificity of SH3 domains (see Manuscript 2 and [51]).  
In 2006 one other group has used a similar in silico mutagenesis strategy to 
predict the binding specificity and binding targets of the Abl SH3 domain [54].  
 
 
1.3 - Large scale data integration methods  
The proliferation of experimental and computational methods to study protein-
protein interactions has prompted comparative studies of the different approaches [55]. 
These analyses have shown that the different experimental and computational 
approaches are not overlapping and all suffer from low accuracy and low coverage 
when benchmarked against a trusted data-set. Also, it was demonstrated that 
interactions that were observed in more than one of the analysis was more likely to be a 
true interaction. From these first efforts to compare the different methods came then the 
idea that more reliable information can be obtained from the combination of different 
experimental and computational observations. One year after the comparative analysis 
from von Mearing and colleagues [55], two different groups provided the first examples 
of a statistical combination of the different approaches with a Bayesian framework [56, 
57]. This strategy was used in 2005 to integrate different information sources to predict 
human protein interactions with considerable success (10 000 predictions with a 20% 
false positive rate) [58]. Given the interdependences that occur between the different 
datasets used there is a limit to the benefit obtained from this type of integration [59]. 
Nevertheless, an effort should be made by the community to establish prediction servers 
that are constantly updated to integrate meaningful datasets and computation methods. 
A very good example of this type of server is the STRING database [60] that integrates 
datasets and computational methods to predict functional association between proteins.  
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1.4 - Modular protein domains  
Most of my efforts, in predicting protein-protein interactions, have been directed 
at domain-peptide interactions. These peptide interacting domains are part of a large 
family of what are called modular protein domains. These are parts of proteins that form 
independently folding units that can be studied and viewed as autonomous units inside 
the proteins [61]. This modular nature of proteins was first observed in studies of 
oncogenes like v-Fps in the lab of Tony Pawson [62]. In 1986 Sadowski and colleagues 
in Pawson’s lab observed that by inserting a dipeptide into different parts of the v-Fps 
tyrosine kinase they could impair different functions of the protein separately. From this 
and from looking at the sequence of different tyrosine kinases they postulated that these 
proteins were composed of independent folding units with separate functions. One of 
these domains that they identified by insertion and homology with other sequences was 
the Src homology domain 2 normally referred today as SH2 domain. At that time the 
kinase domain was the only other known Src domain but latter, with increase in the 
number of sequenced proteins [63, 64] they identified a common domain that was also 
present in Src that was called the Src homology domain 3 (still called today the SH3 
domain). Since then many other domains have been identified and studied in detail. 
Many of these domains either modify residues of other proteins by inserting or 
removing post-translational modification (phosphorylation, ubiquitination, sumoylation, 
etc) or are able to recognize other proteins and their modification states [65].  
Given the historical perspective outlined above it is not surprising that those 
initially discovered protein domains like the SH2, SH3 are among the most well 
characterized domains to date. The large amount of structural and binding information 
available for these domains allows us to more readily develop computational methods 
that can be tested. This is why I have chosen SH2 and SH3 domains as the focus for my 
computational prediction efforts in manuscripts 1, 2 and 3. 
 
1.4.1 - SH3 domains 
The first two structures of SH3 domains were both reported in 1992 by two 
separate groups, one by X-ray crystallography in the lab of Serraste [66] and the other 
by NMR in the lab of Schreiber [67]. These domains are relatively small, around 60 
amino-acids long, and their secondary structure is composed of five antiparallel beta 
strands with three connecting loops: the RT-loop connecting strands 1 and 2; the N-Src 
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loop connecting strands 2 and 3; and the distal loop connecting strands 3 and 4. Strands 
4 and 5 are separated by a 3(10) helix (see Figure 1).  
 
Figure 1 – A visual representation of an SH3 domain in complex with a ligand. 
Ligand, RT and N-Src loops are highlighted. The 3D representation was prepared with 
the Yasara package.  
 
The SH3 domain participates in protein-protein interactions by binding to 
proline rich peptides trough a relatively flat interface with three shallow binding pockets 
defined by a series of conserved aromatic residues (see Figure 2). The interaction with 
proline rich regions was first observed in studies with a GST-tagged SH3 domain from 
Abl in 1992 [68] and further characterized in 1994 with the aid of randomized 
sequences either bound to beads [69] or in screens of phage display libraries [70, 71]. 
These studies of randomized peptides were instrumental in describing the binding 
specificity of SH3 domains. They uncovered a motif of PxxP (were x is any amino-acid) 
common to all binding peptides. Further structural studies revealed a more complex 
picture of SH3 binding specificity with at least two well established binding modes: 
class 1 consensus peptides ([+]xxPxxP) that is bound with a basic residue N-terminal to 
the PxxP core and a class 2 motif (PxxPx[+]) where the basic residue is C-terminal in 
respect to central PxxP [70, 71]. In both cases, the peptide adopts an extended 
polyproline-2 helix (also know as PPII helix) with thee residues per turn and left-
handed. The PPII helix interaction with the SH3 domain can be visualized as a 
triangular prism with a base sitting on the SH3 interface (see Figure 2).  
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A detail study of most of S. cerevisiae SH3 domains using phage display has 
shown that although most SH3 domains conform to the previously defined rules, they 
also have individual motifs that are more specific than the general binding pattern [27]. 
That is, each SH3 domain of S. cerevisiae binds a set of proline rich regions in the 
proteome and these regions overlap but not completely. The same study then showed 
that it is possible to use the specificity patterns derived from phage display in 
combination with yeast-two-hybrid studies to derive a set of high confidence SH3-target 
interactions. I will show in Manuscript 1 that to make the most of these binding motifs 
we should use secondary structure information and comparative genomics to search for 
conserved putative targets that are accessible for binding. Also, in Manuscript 2 I will 
show that there is indeed a large structural variability in peptide binding conformation 
and possible changes in loop length and loop conformation in the SH3 domains. This 
structural variability observed is important in binding specificity and should be taken 
into account when trying to predict protein-interactions from structural information.  
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 Figure 2 – Typical binding modes of SH3 domains. Crystal structures of two SH3 
domains in complex with peptides are displayed to exemplify the two most common 
modes of binding of SH3 domains. In the figure, to the left, are shown the peptide 
motifs most typically associated with those binding modes (X corresponds to any amino 
acid) and the peptide orientation. The structures were visualized using the Yasara 
package.  
 
 
1.4.2 - SH2 domains 
SH2 domain, are small modular domains constituted by around 100 amino acids. 
Like the SH3 domains, these also bind short peptide sequences. However they 
specifically recognize phosphorylated tyrosine residues and don’t usually bind to the 
un-phosphorylated form of the same peptide [72, 73]. The SH2 domain can then serve 
as a sensor for the cell reporting on the phosphorylated state of proteins. The prototypic 
example of this sensing mechanism occurs in the initial steps of a signal transduction 
cascade: the cell is exposed to a ligand molecule; 2) interaction of the ligand with the 
membrane receptor leads to phosphorylation of the cytoplasmatic part of the receptor; 3) 
phosphorylated tyrosine residues are recognized by SH2 domains leading to the 
recruitment of more signaling molecules.  
Randomized peptide studies have shown that individual SH2 domain further 
restrict their binding by accepting different residues at positions +1 and +3 C-terminal 
to the phosphorylated tyrosine residue (pTyr) [74, 75]. Structural analysis of the SH2 
domain showed that it general consists of two a-helices surrounding a large b-sheet 
containing four strands (see Figure 3). The structure contains two separate binding sites, 
one to each side of the beta-sheet (see Figure 3). The pTyr residue binds the more 
conserved of the two binding pockets contacting several positively charged residues. 
The second binding pocket is more divergent and contributes more for the 
discrimination between different phospho-peptides.  
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Figure 3 - The SH2 domain and its typical binding characteristics. A structure of an 
SH2 domain in complex with a phosphorylated peptide is shown. To the right the 
binding pockets are shown in more detail. The structure was visualized using the Yasara 
package. 
 
Given the ability to discriminate between different phosphorylation states, these 
domains participate in many of the cellular pathways involved in response to extra-
cellular signals and in the control of cellular states. To understand these processes it is 
therefore important to study and to comprehend the underlying rules that determine SH2 
specificity. In manuscript 3 I show that structural information can also be used to 
predict the specificity of binding of different SH2 domains.  
 
1.5 - Evolution of cellular networks  
The development of some of the experimental methods described above 
increased the amount of information on protein-protein interactions available for several 
different model organisms [2-7, 13-15]. It is tempting to try to compare these 
interactomes very much like one would compare genomes (referred to as comparative 
genomics), trying to look for similarities and differences that might tell us something 
about the cellular function and evolution. The attempt at what could be called 
comparative interactomics was first tried by Cesareni [76] with very limited success. 
The main conclusion from this analysis was that the current coverage of these maps is 
so low that it is pre-mature to embark on these comparative efforts. A more recent 
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attempt to compare the interaction networks of different species also suggested that very 
little could be concluded from the small overlap observed [77]. Both these studies have 
however ignored the large evolutionary distance between the species studied. Given that 
little is nown about the evolutionary rate of protein interaction one other possible 
explanation for the small overlap could be evolutionary divergence. In fact, Andreas 
Wagner proposed in 2001 that in S. cerevisiae around 50 new interactions might be 
formed every million years [37]. This would also explain the apparent limited success in 
extrapolating interactions across different species, attempted by Lisa R. Matthews and 
colleagues in Vidal’s lab [78]. Functional constraints should lead to conservation of 
complexes and pathways but not necessarily of the exact binary interactions or 
individual proteins involved. Therefore, a more promising direction in comparative 
interactomics is to look for conservation of network structures and not conservation of 
exact binary interactions. This approach was developed in the Ideker lab in the form of 
the PATHBLAST tool [40, 41] and recently also by Flannick and colleagues [79]. 
In Manuscript 4 I have tried to study the evolutionary rate of protein interaction 
networks as well as the protein’s characteristics that shape the rate of change in their 
interactions.  
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2.1 –Abstract  
 
Protein interaction networks are an important part of the post-genomic effort to 
integrate a part-list view of the cell into system-level understanding. Using a set of 
eleven yeast genomes we show that combining comparative genomics and secondary 
structure information greatly increased consensus based prediction of SH3 targets. 
Benchmarking of our method against positive and negative standards gave 83% 
accuracy with 26% coverage. The concept of an optimal divergence time for effective 
comparative genomics studies was analysed, proving that genomes of species that 
diverged very recently from S. cerevisiae (S. mikatae, S. bayanus and S. paradoxus), or 
a long time ago (N.crassa and S. pombe) contain less information for accurate 
prediction of SH3 targets than species within the optimal divergence time proposed. It 
was shown here that intrinsically disordered SH3 domain targets are more probable sites 
of interaction than equivalent sites within ordered regions. Our findings highlight 
several novel S. cerevisiae SH3 protein-interactions, the value of selection of optimal 
divergence times in comparative genomics studies and importance of intrinsic disorder 
for protein interactions. Based on our results we propose novel roles for the S. 
cerevisiae proteins Abp1p in endocytosis and Hse1p in endosome protein sorting. 
Chapter 2 
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2.2 – Non-technical summary 
 
How can we tackle the complexity of a living cell? It is commonly said that 
living organism are complex and display “emergent” properties.  Emergence is 
perceived in this context as the process of deriving behaviours at the system level that 
are not observable at the level of the system’s components. In the cell this would be 
equivalent to saying that the cellular complexity could be understood if we could 
understand the interplay between the cellular components. Not only describe the “parts” 
that make up a cell but understand how they interact with each other to perform the 
necessary tasks. A big step on the road of understanding cellular complexity will be a 
complete list of all relevant interactions between the cellular components. Although a 
lot of progress as been made in this direction, we are often dependent on experimental 
methods that are costly and time consuming. Computational Biology has here a big 
challenge to process the current available knowledge and to propose new ways of 
predicting the interactions between cellular components.  
We have studied, in this work, protein interactions that are mediated by small 
linear peptide motifs. An example of this type of interactions is the one between an SH3 
domain and its targets, usually small peptide stretches containing a PXXP motif (where 
X is any amino acid). The results showed that the putative target motifs that are 
conserved in ortholog proteins and are within regions that do not have a defined 
secondary structure are more likely to be relevant binding sites.  
Besides proposing a way to combine secondary structure information with 
comparative genomics to predict protein-protein interactions, we have highlighted a 
possible role of intrinsically disordered proteins in SH3 protein interactions. The results 
also showed that when looking for conservation of these motifs it is important to 
carefully select the species to use in the study. Some species will be more informative 
than others and our work proves that there is an optimal divergence time for the species 
to include.  
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2.3 – Introduction 
Important advances have been made on mining the ever growing quantity of 
experimental results with computational methods in order to derive predictions of 
protein-protein interactions. For such interactions there are methods that explore 
sequence and structure analysis, like gene fusion [30, 80], gene order [28], phylogenetic 
profiling [29, 81-83], correlated mutations [31, 84] and multimeric threading [46, 48]. It 
as also been shown that it is possible to combine different experimental and functional 
data to predict protein interactions, especially when weighted using Bayesian networks 
[56]. The accumulation of validated interactions can also be mined by interolog 
mapping in order to transfer protein interaction annotations across species [2, 85]. 
The work described here deals with the prediction of protein interactions 
mediated by recognition modules that target small linear motifs [86, 87] and more 
specifically to SH3 domains. This type of asymmetric binding between globular 
domains and linear peptides was first reported in the work on Src kinase [62, 64, 68, 88] 
and many other domains have now been shown to have similar properties [86, 87]. In a 
previous study [89], knowledge from phage display experiments was used to derive a 
position specific scoring matrix (PSSM) for a particular SH3 domain which was then 
used to predict putative target ligands.  Later, Tong et al, devised a strategy where two-
hybrid and PSSM were combined to derive a high confidence network [27]. It was 
reasoned that an interaction identified by two-hybrid was more likely to be biologically 
relevant if the target protein had a high scoring linear peptide according to the PSSM of 
the bait SH3 domain.  
In this work we set out to obtain a high-confidence, biologically relevant, 
protein interaction network, starting from the consensus information and using 
computational methods. The study showed that it is possible to greatly increase the 
accuracy of consensus based predictions of protein-linear sequence interactions by 
considering that biological relevant target ligands of SH3 domains were more likely to 
be within disordered regions and conserved in orthologs. The method’s performance 
was improved by selection of species within “an optimal divergence time” from the 
species of interest.  
It has been proposed that intrinsic disorder may play a role in protein 
interactions [90-93] and there are documented cases where binding is coupled to folding 
[94, 95] (reviewed in [96]). It is also been observed that small linear motifs tend to 
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accumulate in protein regions predicted to be intrinsically disordered [97] and that 
proline rich regions are usually devoid of secondary structure [98]. In most structures 
that we are aware of, the SH3 domain is in complex only with short target peptides, and 
not with full proteins. In all cases the ligands adopted a non-regular secondary structure 
but there is little information one can take from these, in respect to the order/disorder of 
target sites in the context of the whole target protein. Although there is currently no 
experimental evidence to support that the SH3 domains preferentially bind to 
intrinsically disordered regions the results presented here showed that binding motifs 
within disordered protein regions are more likely to be biologically relevant binding 
sites than equivalent sites within ordered regions.  
We used the method developed to suggest novel SH3 interactions for S. 
cerevisiae with information of the binding sites within the target proteins.  
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2.4 – Results & Discussion 
 
2.4.1 – Identification and conservation of SH3 domains and selection of genomes. 
Using profile hidden Markov models (see methods and Table 1), all putative SH3 
domains, and their key binding positions (see methods) were determined in S. cerevisiae 
and in a set of thirteen yeast species: C. glabrata, D. hansenii, K. lactis, Y. lipolytica 
[99], C.albicans [100], S. paradoxos, S. bayanus, S. mikatae [101], S. castellii, S. 
kudriavzevii, S. kluyveri [102], N. crassa [103] and S. pombe [104].  
In S. castellii, S. kluyveri and S. kudriavzevi no orthologs for the majority of the S. 
cerevisiae SH3 domains could be identified (results not shown). However, these 
genomes  had only been sequenced with a two to three fold coverage [102] which may 
have led to some genomic regions being poorly sequenced. . As a result of this, these 
three genomes were not included in our work. 
The ortholog SH3 domains were split into three groups:  “conserved domain”, 
“possibly divergent” (if the putative ortholog SH3 domain is in the same branch of the 
phylogenetic tree and has more than two conservative changes in the binding positions - 
see methods) or “divergent domain” (if the putative ortholog SH3 domain was not in the 
same branch of the phylogenetic tree) (Table 1).  As expected the percentage of 
“conserved” domains was higher in genomes of species that diverged recently from S. 
cerevisiae.  
Intuitively we can think that there should be an optimal divergence time, for the 
species to be used in a particular comparative genomic study. In recently divergent 
species most protein sequence is conserved and the statistical power for comparative 
genomics of biological features is therefore smaller. Inter-species conservation becomes 
less meaningful in a background of low evolutionary divergence. On the other hand, 
finding a conserved consensus in a very divergent genome might be more significant 
but only if there was no major change in the specificity of the domain. This change will 
be more probable the more divergent the specie is from the specie of interest.  
To test the improvement of consensus based predictions with a comparative 
genomics approach an initial set of genomes was chosen based on the conservation 
analysis of the SH3 domains across the different yeast species (Table I). N. crassa and 
S. pombe were excluded because the SH3 domains in these two species might be too 
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divergent to observe conservation of the S. cerevisiae motifs. Very close relatives (S. 
paradoxus, S. bayanus and S. mikatae) were excluded as these species would have 
lower statistical power. Therefore the first group analysed consisted of five yeast 
genomes that broadly covered the hemiascomycete phylum, containing the four recently 
reported genomes of C. glabrata, D. hansenii, K. lactis and Y. lipolytica that we 
grouped with the C.albicans’ genome.  
 
2.4.2 – Evaluation of the “conservation” approach.  
To evaluate the predictive power of our method two positive datasets, containing 
experimentally verified SH3-linear peptide interactions, and one negative dataset, 
containing non interacting protein pairs were defined (see methods). The binding motifs 
of the SH3 domains of S. cerevisiae included in the two sets of positive standards (15 
SH3 domains in the gold set and 10 in the platinum set) were taken from the data 
published in Tong et al [27]. Table II shows the consensus used in the study and also, 
for each SH3 domain, the total number of peptides found with these consensus in the S. 
cerevisiae proteome. From this a measure of accuracy and coverage (see methods) 
based on the positive and negative datasets was calculated. For simple pattern matching 
of consensus the accuracy (defined as TP/(TP+FP), where TP means True Positives and 
FP, False Positives) for predicting protein interaction was 12% and the coverage 
(defined as TP/P) was 92% when using the gold positives set (see fig 1a).   
Using T-Coffee [105], an alignment of all putative orthologs (obtained using the 
BLAST reciprocal best hit method [106]) of S. cerevisiae proteins containing sequences 
matching a consensus for an SH3 domain was carried out. This alignment was then used 
to determine the level of conservation of putative target ligand sites by searching for 
sequences matching the same consensus in the orthologs. We did not search for 
conservation of putative target motifs in genomes without an ortholog for the domain in 
study. If there is no ortholog SH3 domain in the comparing specie then the conservation 
of the motif, in the ortholog of the putative target, is not biological relevant and should 
not be counted to increase our confidence in the putative interaction. Having said this it 
should be noted that there could be several technical reasons why the ortholog of an 
SH3 domain could be missed in a genome. There might be errors for example in the 
genome assembly, genome annotations, domain annotation and ortholog assignment. 
For all these reasons we also tried to calculate conservation scores without disregarding 
genomes with no ortholog for the domain in study. While this did not change 
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significantly the results (data not shown) we felt that the first approach was more 
stringent. 
In the orthologs, the search was restricted to a window surrounding the putative 
target ligand in the S. cerevisiae sequence and we called this the probing region.  In 
Figure 1, accuracy versus coverage for increasing probing regions are plotted and it can 
be seen that by searching in a wider region of the alignment both coverage and accuracy 
are increased, especially for higher conservation scores (the complete analysis with the 
number of hits and false and true positives for each positive set is given in 
supplementary table 1). Optimal results were obtained when using a probing region of 
210 alignment positions. It is important to emphasize that these were not necessarily 
amino acids, but 100 gaps or amino-acids on each side of a motif of 10 amino acids.  
This result could be due to poor alignment of some proteins, especially those rich in Pro 
sequences. In fact most of the gain in coverage was due to interactions with proline rich 
proteins that were difficult to align and had multiple gaps (i.e. Las17p, App1p and 
Vrp1p).  Also, this data may suggest that these small target ligands may be easily 
moved in primary sequence space during evolution, due to compensatory mutations in 
proteins that are already proline rich in nature.  For both sets of positives a big 
improvement in accuracy was observed when we selected for consensus conserved in 
the 5 genomes used (3.8 fold with the “gold” positives and 3.3 fold with the “platinum” 
positives). There was, however, a similar fold reduction in the coverage, 3 fold for the 
gold and 4.3 fold for the platinum set. 
Since most known target proteins in the SH3 interaction network are proline rich 
and a large probing window was used, it is possible that the hits found in orthologs were 
due to chance and lacked biological meaning. To eliminate this possibility two “decoy” 
proline rich patterns were analysed: PxxxPxxxP and ExxPxxP (where x is any amino-
acid), different from the consensus sequences.  Both patterns were found with high 
frequency (>400 hits) on S. cerevisiae proteins.  Using these two patterns a loss in 
accuracy and coverage was observed (an average of 1.4 times less accuracy and 1.2 
times less coverage for the PxxxPxxxP motif and an average of 3.4 times less accuracy 
and 2.5 times less coverage for the ExxPxxP motif).  Thus we can eliminate that the 
results were generated by chance and confirm that the observed phenomenon was the 
conservation of specific SH3 binding motifs and not of Pro-rich tracks. 
However, the accuracy obtained with conservation alone was still poor (using the 
gold set: accuracy 46%; coverage 31% and the platinum set: accuracy 30%; coverage 
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16%). A hyper-geometric test allowed us to say that that the improvement in both 
positive sets and for all conservation scores was significant (p<0.05) and not due to 
random sampling. 
 
2.4.3 – Combining comparative genomics and disorder prediction  
Since SH3 domains generally bind linear amino acid stretches we tried to improve 
the accuracy of our consensus based method by extracting secondary structure 
information about the sequences containing the target motifs. It has been argued that 
there might be biological advantages in presenting binding sites within unstructured 
regions [90-93]. It has also been observed that small linear motifs tend to accumulate in 
protein regions predicted to be intrinsically disordered [97] and that proline rich regions 
are usually devoid of secondary structure [98]. To our knowledge there is no clear 
experimental evidence to support that SH3 domain target sites are generally 
unstructured before binding, but since SH3 domains bind small linear peptide motifs 
that are proline rich we hypothesised that SH3 domain targets might be mainly found in 
unstructured regions of the polypeptide chain.  Therefore we used GlobPlot [97] in 
combination with coil-region predictions [107] to identify and study all consensuses 
found within disordered protein regions.  
Combining disorder prediction with comparative genomics resulted in a 
significant (p<0.01, using a hyper-geometric test) increase in the accuracy of protein 
target prediction (there was a 2 fold average increase in both sets) (Figure 2). The 
decrease in coverage was 1.4 for the gold and 1.1 fold for the platinum set. For 
consensus conserved in five or more genomes we obtained 94% accuracy with 28% 
coverage for the gold set.  For consensus conserved in four or more genomes 83% 
accuracy with 26% recovery for the platinum set were obtained. These results argue that 
intrinsic disorder plays an important role in SH3 protein-interactions, however further 
experimental work is needed to verify this observation.  
Since the platinum positive set was independent (see methods) the values obtained 
with this set may be used as a score for the performance of our method compared to 
others. Higher values of coverage and accuracy with the golden positive set were 
observed when using our method, but it should be noted that this could be due to a 
possible bias (see methods). A detailed table with the number of hits, false and true 
positives for each conservation level in both positive sets can be found in supplementary 
table 2.  
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Using the methods described in this work, we show proof of concept on how to 
integrate secondary structure prediction with comparative genomics to increase the 
accuracy of consensus based prediction of peptide recognition modules. However, the 
method employed involves a clear trade-off between accuracy and coverage.  
Of the 59 interactions in the final high confidence interaction presented in the Tong et 
al. paper the method was able to predict 20 interactions when restricting for consensus 
within disorder and found in 4 of the 5 genomes used. We then tried to look for 
distinguishing features within these 20 interactions, when compared to the remaining 39 
that the method does not predict. There were no statistical differences in the average 
size of protein targets (p=0.32 with a T-Test), average proline content of protein targets 
(p=0.12 with a T-Test), usage of Class II motif (p=0.21 with a Hypergeometric 
distribution test) and conservation of SH3 domain (p=0.82 with a T-Test). There was a 
statistically significant difference in the average conservation of the target proteins 
(p=0.03 with a T-Test). The protein targets the method was able to predict were on 
average conserved in 8.7 of the 10 species, while the targets not recovered were 
conserved in 7.6 species. This small but significant difference highlights the bias this 
method has for conserved interactions. A higher level of confidence can be placed in 
any putative target motif found conserved in most yeast species analysed, but this level 
of conservation will only happen for essential interactions. It is important to note that 
for this reason this method will always miss species-specific protein interactions. By 
requiring high conservation we also lower our coverage and probably bias our 
predictions to essential interactions. However adding more genomes of species within 
an appropriate divergence time should alleviate this problem, a concept discussed in 
more detail below.  
Another possible cause of loss in coverage could come from interactions that are 
mediated by currently uncharacterized motifs or through non-canonical SH3 binding 
(i.e. through globular regions of the target protein). 
As shown by other authors (reviewed in [108]), it should be possible to further 
improve the reliably of a protein interaction network and therefore our method, by 
adding information from other sources of data (i.e. RNA expression, essentiality and 
function information). This is especially true if the information is efficiently combined, 
for example employing a Bayesian network [56]. It was our intention to develop a 
method that could be used in species where these sources of information were not 
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available, but in the future we will try to develop weighting schemes to include such 
sources for prediction of interactions mediated by small linear motifs.    
 
 
2.4.4 – Determining an optimal divergence time for the genomes used when 
searching for conservation of target ligands of SH3 domains 
Included in our initial hypothesis, was the notion that there might be an optimal 
time of divergence to efficiently use the comparative genomics approach. To test this, 
phylogenetic data [99, 109, 110] with approximate values for the divergence times of 
the yeast species from S. cerevisiae (see Methods),  was used  to create seven groups of 
four genomes with increasing average divergence time. Using the gold positives, the 
highest accuracy obtained for a small range of coverage values was determined for each 
of these groups. For different coverage ranges the highest accuracy was generally 
obtained with groups of genomes that diverged from S. cerevisiae on average around 
400My to 950My (Fig. 3).  
To explore this issue further we tried to find out which genomes might be more or 
less informative to our consensus based predictions. For each possible combination of 
two or more genomes we calculated the highest accuracy obtained for eleven small 
windows of coverage (with intervals of 5% of coverage from 15% to 70%). Figure 4 
shows the average of the individual genome representation in all possible groups, in the 
groups scoring in the highest 20% accuracies and in the groups scoring within the 
lowest 20% accuracies, over all the coverage windows studied. For each species, a t-test 
determination was carried out to see if the average frequencies within the highest and 
lowest combinations were significantly different from the frequency in all possible 
combinations. From the analysis of the results the more informative genomes are: C. 
albicans, D. hansenii, C. glabrata, K. lactis and Y. lypolitica. We can also see that N. 
crassa and S.pombe are not over represented in highest scoring groups, suggesting that 
they have less informative genomes. More importantly it is clear that including the 
genomes of S. bayanus, S. mikatae or S. paradoxus leads to a decrease in the accuracy 
of predictions. These observations correlate well with the degree of divergence observed 
for the SH3 domains (Table 1) and with our proposed range for optimal divergence 
time.  
In a very recent report [111] Sean R. Eddy used a theoretical model to study the 
statistical power of comparative genome sequence analysis. The model showed that, at 
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close evolutionary distances, the number of comparative genomes needed to obtain the 
same statistical power increases. The model also suggests that the decline in statistical 
power for divergence times above optimal is smaller than for divergence times below 
optimal. In general our results support some of the proposals made by this model. 
According to the model it should be possible to obtain a high accuracy with closely 
divergent species but it would be necessary to use considerably more genomes at that 
distance. The author suggests that, for example, for human/baboon distances it would be 
necessary to use about 7 times more genomes than at human/mouse distance, to obtain 
the same statistical strength. For future work, we are therefore considering extending 
our method to include a weighing scheme based on the evolutionary distance between 
the comparing species and the target species. We think this could be achieved using an 
adaptation of the theoretical model proposed by Sean R. Eddy [111]. 
It would be also interesting to study how many genomes would suffice to 
accurately predict an SH3 target interaction. Since the decrease in statistical power for 
S. pombe and N. crassa is small when compared to closely related species, we 
calculated the accuracy and coverage after addition of one or two of these species for 
different conservation scores. In general an increase in coverage with a small or no 
decrease in accuracy was observed (see supplementary table IV). Addition of any of the 
closely related species resulted in a large loss of accuracy with moderate gain in 
coverage (results not shown). We believe that the improvement by addition of species 
within the optimal divergence time would be better than that observed with N. crassa 
and S. pombe. This result generated with the latter two species only suggests that the 
“sufficient number” of genomes required was not reached, since addition of more 
genomes still improved our scores. However, at present there are not enough genomes 
available to empirically tackle this question of a “sufficient number” of genomes for 
SH3 target prediction.  
We believe the main factor determining the optimum divergence time observed is 
the conservation level of the biological feature. A biological feature that has higher 
conservation will require genomes of more divergent species to be accurately identified. 
We think that interaction types that are equally conserved would be accurately predicted 
with genomes of species at the same divergence times. This might mean that the same 
genomes could be used to predict interactions for other protein domains that bind small 
linear peptides (i.e. PDZ, WW, SH2, 14-3-3). Other interaction types that are mediated 
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by larger interaction surfaces are probably more conserved and therefore might require 
genomes from more divergent species.  
Although some results [101, 102] have shown the importance of having genomes 
of recently divergent species available to use in the study of DNA regulatory regions, 
recent findings [112] have shown that regulatory systems can be conserved over 
hundreds of millions of years. We argue that the concept of optimal divergence time 
presented should also be taken into consideration for protein-DNA interactions. 
In this paper we show that for the study of SH3 protein interactions the genomes 
with more relevant information are from species that diverged around 400My to 950My 
from the species of interest. As was suggested by Sean R. Eddy [111], this optimum 
might be specific for the particular interaction type being analysed. Nevertheless, we 
believe that our results should be taken into consideration when identifying other 
biological features using comparative genome sequence analysis.    
 
2.4.5 – Predictions of novel SH3 - linear peptide interactions  
We used the method described above and the genomes of C. glabrata, K. lactis, C. 
albicans, D. hansenii, Y. lipolytica, N. crassa and S. pombe to predicted a set of 69 
interactions, when considering consensus conserved in four of the seven genomes used 
(see Figure 5 and Supplementary Table III for a complete list of the predicted 
interactions).Genomes of species that were over-represented in groups of genomes 
scoring within the 20% highest accuracies or under-represented in groups of genomes 
scoring within the 20% lowest accuracies were used. Some experimental evidence was 
found to support 37 of these interactions, all of which occurred between proteins 
labelled as belonging to the same compartments. Of the 32 remaining predictions, 8 
might not be possible since the putative interaction partners are annotated as having 
different cellular compartments, although in some cases a link between the two 
compartments could be possible (see below for some examples).  Benchmarking with 
the gold positive and negative sets resulted in an accuracy of 73% and coverage of 37%. 
This level of conservation was chosen to allow for higher coverage but it is important to 
note that higher accuracy for particular interactions can be attributed depending on the 
degree of conservation observed. We have included this information in the 
supplementary table III. 
As expected we obtained a highly interconnected network with a very significant 
over-representation of proteins participating in processes typically associated with SH3 
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domains in S. cerevisiae. GO Term-Finder [113] was used to find significantly shared 
GO terms within the list of targets of the predictions. Amongst the most significant 
process associations found were cytoskeleton organization and biogenesis (p= 3.67E-
15), morphogenesis (p= 7.62E-12), establishment of cell polarity (p=1.19E-11), actin 
cortical patch assembly (p=5.09E-9) and bud site selection (p=1.28E-8).  
Some of the proposed interactions were further explored, taking into account 
which S. cerevisiae biological processes these proteins are involved in. An interesting 
example is the proposed interaction between the Abp1 protein with the P-type ATPases 
Dnf1p and Dnf2p. These proteins are required for phospholipid translocation and they 
mainly localize to the plasma membrane and intercellular compartments. The regulation 
of the lipid bilayer arrangement by Dnf1p and Dnf2p was demonstrated to be critical for 
budding endocytic vesicles [114]. It is also known that Abp1p is one of the activators of 
the Arp2/3 complex and is important in coupling the actin and membrane dynamics 
during endocytosis [115]. Following from the proposed interaction seen using our 
method, we suggest that Abp1p might target Dnf1p and Dnf2p to sites of endocytosis to 
play a role in endocytic vesicle formation or maintenance.  
In order to calculate accuracy and coverage scores, we initially considered 
“negative” interactions between proteins that did not share the same cellular 
compartment. After having obtained our list of predicted interactions we decided to 
investigate them without disregarding these “negative” interactions. This decision was 
taken as the negative set is based in part on high throughput measurements that do not 
take into account the dynamics of cellular localization. Two proteins might not share a 
compartment, in a given cellular condition, but this might change in different cellular 
states (examples in S. cerevisiae include cell-cycle, pheromone response and 
filamentous growth). This reasoning actually leads us to think that the localization data 
on proteins is under-evaluated and if anything will result in an under-estimation of our 
accuracy scores.  
Within our set of final predictions, Hse1p mediated interactions are examples of 
those occurring between proteins marked as belonging to different compartments. 
According to our results the SH3 domain of Hse1p has a high probability of binding to 
proline rich regions of Ste20p, Bck1p and Las17p. The Hse1p protein was recently 
reported to be part of a complex that binds ubiquitin and is important in sorting proteins 
in the endosome [116, 117]. Knowing that both Ste20p and Bck1p are involved in the 
response to mating and that Hse1p is involved in the trafficking/sorting of the alpha-
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factor pheromone receptor, these SH3 domain interactions might be part of the sorting 
mechanism of the alpha receptor in the multi-vesicular bodies. Activated alpha-factor 
pheromone receptors recruit Ste20p by the dissociation of Gβγ subunits (reviewed in 
[118]). There is some evidence that Ste20p activation can lead to the phosphorylation of 
Bck1p in the mating response [119]. Activated mating receptors are internalized after 
phosphorylation and ubiquitination of their carboxy-terminal tails and targeted for the 
vacuole for degradation [120]. We propose that these internalized vesicles are decorated 
with complexes containing Ste20p, Bck1p and Las17p and that the interaction of the 
SH3 domains of Hse1p with these proteins might be important in the sorting of 
internalized mating receptors. 
 
2.5 – Summary 
We present here a method to predict biologically relevant protein interactions 
mediated by peptide recognition modules. Conservation of target linear peptides and 
analysis of protein disorder can be effectively combined to screen for biologically 
relevant interactions that are predicted from binding matrixes obtained from 
experimental data. However, the method has a small coverage and still relies on 
experimental determination of the SH3 target consensus. In the future it should be 
possible to predict the target motifs using available structural data and homology 
modelling [51, 121].  
This study provides some evidence for the importance of intrinsic disorder in the 
context of protein interactions. Specifically, binding motifs within disordered protein 
regions are more likely to be biologically relevant binding sites than equivalent sites 
within ordered regions. To our knowledge there is no experimental evidence currently 
available to support the idea that in general SH3 domains bind within unstructured 
regions, therefore particular cases should be investigated carefully. Nevertheless, we 
hope our observations will contribute to discussion of the role of intrinsically disordered 
protein regions.   
The analysis carried out demonstrated that there is an optimal divergence time for the 
species to be included in comparative genomics when looking for the conservation of 
binding sites of peptide recognition modules. For SH3 domains in yeast this interval is 
between 400My to 950My and although these divergence times may be specific to SH3 
domains and to yeast evolution, the concept should be taken into consideration for 
future comparative studies.   
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Finally we have used this method to predict novel SH3-linear peptide interactions for 
S. cerevisiae. The interaction map obtained contains information on the binding regions 
of both interaction partners and should allow experimentalist to devise effective and 
precise system perturbations by targeting a particular interaction. 
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2.7 – Methods 
 
2.7.1 – SH3 domain conservation 
We created a phylogenetic tree (see supplementary material) produced by the 
neighbour-joining method from a ClustalW alignment [122] of the SH3 domains of the 
thirteen yeast species in our set. The SH3 domains were identified using SMART [123]. 
Putative orthologs for all S. cerevisiae proteins were determined by the BLAST 
reciprocal best hit method [106]. We considered that a putative ortholog of a S. 
cerevisiae SH3 domain was not conserved if the two domains were not in the same 
branch of the phylogenetic tree.  
After eliminating these “divergent” domains we did multiple sequence alignments 
of the groups of orthologous domains. To determine the binding positions we included 
in the alignments the SH3 domain of Fyn. From visual inspection of crystal structures of 
complexes of SH3 domains with ligands we decided to analyse the positions Tyr91, 
Tyr93, Arg96, Thr97, Asp99, Asp100, Asp118, Trp119, Tyr132, Pro134 and Tyr137 of 
Fyn that we consider might influence binding specificity. By manual inspection of the 
alignments we extracted the positions of all domains corresponding to the positions of 
the Fyn SH3 domain that are important for binding specificity and determined their 
conservation. Any substitution that scored a non-negative value in the blosum62 matrix 
that would not result in a reversal of charge was considered to be conserved. 
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2.7.2 – Positive and negative datasets 
We considered a positive set of interactions that we called “gold set” of 59 
interactions (containing 15 different SH3 domains from 15 different proteins) defined 
by Tong and colleagues [27]. The authors obtained the final set of interactions by the 
overlap of two sets of interactions obtained with two different methods. The authors 
used phage display data to create a position specific scoring matrix (PSSM) and used it 
to scan the S. cerevisiae proteome. Using a threshold on the PSSM they selected the 
first set of interactions, then they created a second interaction network by yeast two-
hybrid and obtained the final network (our gold set) by the overlap of the two. 
We considered a second positive standard, that we called “platinum set”, of higher 
confidence, with 19 interactions (containing 10 different SH3 domains from 10 different 
proteins), derived from the overlap of the two-hybrid assays, obtained from Tong et al 
[27], with the MIPS complexes dataset [124].  
The two positive data sets overlap only partially (10 interactions from the platinum 
set are also in the gold set).  
To build our negative data set we considered that two proteins that do not share the 
same sub-cellular compartment according to MIPS localization data [124], cannot 
interact and we compiled a list of all S. cerevisiae proteins pairs that do not share at 
least one sub-cellular compartment.   
Since we also used the phage display data from Tong et al [27] to derive the 
consensus sequences recognized by the yeast SH3s used in this study we might be 
biased towards the gold positive dataset. We would like to stress that we did not use a 
PSSM as in the Tong et al paper and therefore even our initial motif based predictions 
without any filtering is not the same as the network obtained by Tong and colleagues 
with the phage display data. 
We did not merge the two positive datasets to keep the platinum one as a truly 
independent positive dataset. We decided to also use the gold set because although we 
should not use the absolute performance value to compare the method with others it still 
served as a check for the relative performance of different filters. 
 
2.7.2 – Accuracy and Coverage determination 
The ratio between true positives (TP) and the sum of true plus false positives (FP) 
was used as a measure of accuracy. True positives were the number of predicted 
interactions within a positive set. False positives were the number of predicted 
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interactions found within the negative set. To measure the coverage of the methods we 
tracked the ratio TP/P, where P is the total number of positives in the positive set.   
 
2.7.3 – Estimated divergence time from S. cerevisiae 
The divergence times from S. cerevisiae for the species C. glabrata, D. hansenii, K. 
lactis, Y. lipolytica, C.albicans, S. paradoxus, S. bayanus, S. mikatae, N. crassa  and S. 
pombe were estimated to be 300 My, 800 My, 400 My, 900 My, 800 My, 50 My, 50 
My, 50 My, 1000 and 1100 respectively. These values were based on phylogenetic 
studies found in the literature [99, 109, 110].  
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2.8 – Tables and Figures 
 
Table 1 – Conservation study of the SH3 domains of S. cerevisiae in 10 other yeast 
genomes. NO (No ortholog)– No ortholog found for SH3 containing protein in a 
particular genome; DD (“divergent domain”) – SH3 containing protein has an ortholog 
in this genome but the domain is not on the same branch of the phylogenetic tree; PD 
(“possibly divergent”) – SH3 containing protein had an ortholog in this genome but the 
ortholog SH3 domain had at least one non conservative change in the binding positions 
or more than two conservative changes in the binding positions; CD (“conserved 
domain”) – The SH3 containing protein had an ortholog and the ortholog SH3 domain 
is possibly conserved (less than 3 conservative changes and no non conservative change 
in the binding positions).    
 
SH3 domain 
S. 
paradoxus 
S. 
bayanus 
S. 
mikatae 
C. 
glabrata 
K. 
lactis 
C. 
albicans 
D. 
hansenii 
Y. 
lipolytica 
N. 
crassa 
S. 
pombe 
YBL007C 1st CD CD CD CD CD CD CD PD PD PD 
YBL007C 2nd CD CD CD PD CD CD PD PD PD PD 
YBL007C 3rd CD CD CD CD CD PD PD PD PD CD 
YAR014C  CD CD NO PD PD PD PD PD PD PD 
YCR088W  CD NO NO CD CD PD PD PD CD PD 
YDR162C  CD NO CD CD CD CD CD CD CD PD 
YKL129C  CD CD CD CD CD PD CD PD PD PD 
YMR109W  CD CD CD CD CD PD CD PD PD PD 
YER118C  CD PD CD CD CD PD PD PD PD NO 
YHR114W 1st CD CD CD CD CD PD PD PD PD PD 
YHR114W 2nd CD CD CD CD CD CD CD PD PD PD 
YFR024C-A CD PD CD CD CD CD CD CD PD CD 
YHR016C  CD PD CD CD CD CD CD CD PD CD 
YER114C  CD CD CD CD CD PD PD PD NO DD 
YBL085W  CD CD CD CD CD PD PD PD NO DD 
YDL117W  CD CD CD PD PD PD PD PD PD PD 
YLR310C  CD CD NO PD PD PD PD PD PD NO 
YPR154W  CD CD CD CD CD PD PD PD NO NO 
YGR136W  CD CD CD CD CD CD PD PD NO NO 
YDR388W  CD CD CD CD PD PD PD PD PD PD 
YJL020C  CD CD CD CD CD CD CD CD PD PD 
YMR032W  CD CD CD PD PD NO NO DD DD DD 
YCL027W  CD NO NO PD PD PD PD PD NO NO 
YHL002W  NO NO CD CD CD PD PD PD PD PD 
YBR200W 1st CD NO CD PD NO PD PD PD PD PD 
YBR200W 2nd CD NO CD CD PD CD CD CD CD CD 
YLR191W  CD CD NO CD CD PD PD PD PD PD 
 
 
Table 2 – SH3’s consensus information. From the SH3 domains study published by 
Tong et al [27] the consensus from the phage display data were obtained and the 
number of pattern matches found in S. cerevisiae proteins with at least one putative 
ortholog in the other 10 yeast genomes considered in our study was counted.  
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ORF Name Gene Name Consensus of target peptides derived from 
phage display 
Pattern matches 
YMR109W MYO5 PXXXPPXXPX 57 
YKL129C MYO3 PXXXPPXXPX 57 
YBL085W BOI1 RXXPXXPXXX 
XPRXPXRXXX 
255 
YCL027W FUS1 XXXXR[ST][ST][ST]LX 51 
YCR088W ABP1 XXXPXXPX[RK]P 71 
YDR388W RVS167 RX[LV]PX[PL]PXXX 
XXPP[VLRIPAM]PXRXX 
XXPX[VLRIPAM]PPRXX 
56 
YER118C SHO1 XX[RK]XLPXXPX 76 
YBL007C SLA1 XXRXXPXPP 31 
YGR136W LSB1 XXRXR[YFLP]X[LP]PX 
XXPX[IVLP]PXRXX 
117 
YHR114W BZZ1 XKXXPPPXXX 
XKXXPPXPXX 
X[RKH][RKH][VILMP]P[LVP]PXXX 
72 
YHL002W HSE1 XXRX[VLRIPAM]PX[VLRIPAM]PX 77 
YFR024C LSB3 XRX[IVLM]PXXPXX 
XXPX[ML]PXRXX 
128 
YHR016C YSC84 XXRX[ML]PX[VLRIPAM]PX 
XPX[ML]PXRXXX 
68 
YJL020C BBC1 XX[KR][KR]XPXXPX 
PX[VLRIPAM]PXRPXXX 
107 
YPR154W PIN3 [YF]XRPXX[AKDP]XPX 
XPP[VLRIPAM]PXRXXX 
XPX[VLRIPAM]PXRPXX 
51 
 
 
 
Figure 1 – Size of probing window when looking for conservation of the consensus 
in orthologs of the putative target protein.   We defined the conservation score as 
simply the number of species where the consensus is conserved.  With this information 
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the accuracy and coverage was calculated, with the gold (1A) and platinum (1B) 
positive sets, for consensus conserved in a different numbers of species and for different 
sizes of the probing region 
 
 
 
Figure 2 – Combining conservation and secondary structure prediction. We 
calculated, with the gold (1A) and platinum (1B) positive sets, the accuracy and 
coverage for target prediction when including or excluding secondary structure 
information. We used in this analysis a probing region of 210 alignment positions.  
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Figure 3 – Optimal divergence time to search for conservation of target motif of 
SH3 domains. We designated seven groups of species with an increasing average 
divergence time from S. cerevisiae and calculated for each group the highest accuracy 
obtained for restricted windows of coverage. We used the gold positive and the negative 
set to calculate the accuracy and coverage (see methods). The seven groups of species 
are the fallowing: 1) S. bayanus, S. paradoxus, S. mikatae, C. glabrata (average 
divergence of 112.5 My from S. cerevisiae); 2) S. paradoxus, S. mikatae, C. glabrata, 
K. lactis (average divergence of 200 My from S. cerevisiae); 3) S. mikatae, C. glabrata, 
K. lactis, C. albicans (average divergence of 387.5 My from S. cerevisiae); 4) C. 
glabrata, K. lactis, C. albicans, D. hansenii (average divergence of 575 My from S. 
cerevisiae); 5) K. lactis, C. albicans, D. hansenii, Y. lipolytica (average divergence of 
725 My from S. cerevisiae); 6) C. albicans, D. hansenii, Y. lipolytica, N. crassa 
(average divergence of 875 My from S. cerevisiae); 7) D. hansenii, Y. lipolytica, N. 
crassa, S. pombe (average divergence of 950 My from S. cerevisiae); The individual 
values for the divergence time from S. cerevisiae were taken from the literature has 
described in the methods section.  Although we tried to create groups that would not 
have genomes of species with very different separation dates from S. cerevisiae it 
should be noted that, due to the small number of available genomes, the groups are not 
homogenous. Also the values of the divergence time of each species were not always 
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obtained with the same method. Therefore this range of values should be taken 
critically.   
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Figure 4 – Most informative genomes in the search for conservation of target motif 
of SH3 domains. We created all possible combinations of two or more genomes of our 
set of ten genomes. For each combination we calculated the highest accuracy obtained 
for eleven windows of coverage from 15% to 70% with intervals of 5%. We then 
calculated the average frequency, over all coverage windows, of each individual species 
in all groups of genomes, in the combinations of genomes scoring within the 20% 
highest accuracy values and in the combinations scoring in the lowest 20% values of 
accuracy. We then used a t-test to determine, for each species, if the average frequencies 
within the highest and lowest combinations are significantly different from the 
frequency in all possible combinations. Bars marked with “*” show a significant 
difference (p<0.05) and bars marked with “**” show a very significant difference 
(p<0.001). 
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Figure 5 - Predictions of S. cerevisiae SH3’s interactions. We considered that a 
potential target consensus, found by pattern matching, in an S. cerevisiae protein would 
be biologically relevant if it was within an unstructured region of the S. cerevisiae 
protein and also conserved in four of the seven genomes used. (C. glabrata, K.lactis, C. 
albicans, D. hansenii, Y. lipolytica, N. crassa and S. pombe). In red are the interactions 
for which we found some experimental evidence in protein interaction databases [125-
127]. In thin lines are interactions between proteins that are labelled as locating to 
different compartments and in black are interactions for which we found no evidence.  
There were two S. cerevisiae SH3 domains for which we could not predict any 
interaction due to the stringency applied. A complete list of the interactions with 
function, localization and binding positions is given in the supplementary materials. 
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2.9 – Supplementary Results  
 
Supplementary Table 1 – Detailed analysis of the conservation of target consensus 
on putative targets of S. cerevisiae SH3 domains. We used the SH3 domain binding 
motifs, extracted from Tong et al. to scan the S. cerevisiae proteome for predicted 
binding sites. We then determined how many of these sites are conserved in ortholog 
proteins using different sizes for the probing region. It is important to mention that the 
size of the probing region includes gaps and amino acids and therefore the found hits 
could be much closer to the region of the ortholog protein aligned with the S. cerevisiae 
target. We calculated also the accuracy (TP/(TP+FP)) and coverage (TP/P) with both 
positive datasets.  
 
Size of probing region 
Conservation of target motifs of S. cerevisiae SH3 domains 
Calculated with Gold Positives (Total Positives =59) Calculated with Platinum Positives (Total Positives =19) 
30 
Cons. Score Total TP FP TP/(TP+FP) TP/P Total TP FP TP/(TP+FP) TP/P 
0 1148 54 390 0.1216216 0.9152542 476 13 131 0.0902778 0.6842105 
1 490 48 158 0.2330097 0.8135593 210 11 58 0.1594203 0.5789474 
2 309 33 91 0.266129 0.559322 136 7 32 0.1794872 0.3684211 
3 194 23 55 0.2948718 0.3898305 88 7 17 0.2916667 0.3684211 
4 136 18 37 0.3272727 0.3050847 66 5 12 0.2941176 0.2631579 
5 67 9 21 0.3 0.1525424 37 3 7 0.3 0.1578947 
70 
Cons. Score Total TP FP TP/(TP+FP) TP/P Total TP FP TP/(TP+FP) TP/P 
0 1148 54 390 0.1216216 0.9152542 476 13 131 0.0902778 0.6842105 
1 502 48 159 0.2318841 0.8135593 213 11 58 0.1594203 0.5789474 
2 318 38 93 0.2900763 0.6440678 141 7 34 0.1707317 0.3684211 
3 202 27 55 0.3292683 0.4576271 92 7 17 0.2916667 0.3684211 
4 140 20 37 0.3508772 0.3389831 69 5 12 0.2941176 0.2631579 
5 68 9 21 0.3 0.1525424 37 3 7 0.3 0.1578947 
110 
Cons. Score Total TP FP TP/(TP+FP) TP/P Total TP FP TP/(TP+FP) TP/P 
0 1148 54 390 0.1216216 0.9152542 476 13 131 0.0902778 0.6842105 
1 515 49 164 0.2300469 0.8305085 216 12 58 0.1714286 0.6315789 
2 327 40 96 0.2941176 0.6779661 144 9 34 0.2093023 0.4736842 
3 207 27 57 0.3214286 0.4576271 94 7 18 0.28 0.3684211 
4 142 22 37 0.3728814 0.3728814 70 6 12 0.3333333 0.3157895 
5 75 15 21 0.4166667 0.2542373 42 3 7 0.3 0.1578947 
210 
Cons. Score Total TP FP TP/(TP+FP) TP/P Total TP FP TP/(TP+FP) TP/P 
0 1148 54 390 0.1216216 0.9152542 476 13 131 0.0902778 0.6842105 
1 533 49 170 0.2237443 0.8305085 220 12 60 0.1666667 0.6315789 
2 349 43 101 0.2986111 0.7288136 154 11 35 0.2391304 0.5789474 
3 214 27 59 0.3139535 0.4576271 97 8 20 0.2857143 0.4210526 
4 149 23 40 0.3650794 0.3898305 73 6 13 0.3157895 0.3157895 
5 80 18 21 0.4615385 0.3050847 44 3 7 0.3 0.1578947 
410 
Cons. Score Total TP FP TP/(TP+FP) TP/P Total TP FP TP/(TP+FP) TP/P 
0 1148 54 390 0.1216216 0.9152542 476 13 131 0.0902778 0.6842105 
1 556 50 175 0.2222222 0.8474576 230 12 61 0.1643836 0.6315789 
2 363 44 104 0.2972973 0.7457627 156 11 35 0.2391304 0.5789474 
3 230 31 62 0.3333333 0.5254237 106 8 21 0.2758621 0.4210526 
4 153 26 42 0.3823529 0.440678 75 6 14 0.3 0.3157895 
5 89 20 24 0.4545455 0.3389831 46 3 7 0.3 0.1578947 
610 
Cons. Score Total TP FP TP/(TP+FP) TP/P Total TP FP TP/(TP+FP) TP/P 
0 1148 54 390 0.1216216 0.9152542 476 13 131 0.0902778 0.6842105 
1 569 50 181 0.2164502 0.8474576 232 12 62 0.1621622 0.6315789 
2 373 44 107 0.2913907 0.7457627 158 11 35 0.2391304 0.5789474 
3 237 31 63 0.3297872 0.5254237 108 8 21 0.2758621 0.4210526 
4 159 27 43 0.3857143 0.4576271 77 7 14 0.3333333 0.3684211 
5 93 21 26 0.4468085 0.3559322 47 3 7 0.3 0.1578947 
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Supplementary Table 2 – Detailed analysis of the conservation of target consensus 
on putative targets of S. cerevisiae SH3 domains, within unstructured regions of 
proteins. We used the SH3 domain binding motifs, extracted from Tong et al. [27]. to 
scan the S. cerevisiae proteome for predicted binding sites that were within unstructured 
parts of proteins of the putative targets. We then determined how many of these sites are 
conserved in ortholog proteins using different sizes for the probing region. It is 
important to mention that the size of the probing region includes gaps and amino acids 
and therefore the found hits could be much closer to the region of the ortholog protein 
aligned with the S. cerevisiae target. We calculated also the accuracy (TP/(TP+FP)) and 
coverage (TP/P) with both positive datasets.  
 
Size of probing region 
Conservation of target motifs of S. cerevisiae SH3 domains 
Calculated with Gold Positives (Total Positives =59) Calculated with Platinum Positives (Total Positives =19) 
30 
Cons. Score Total TP FP TP/(TP+FP) TP/P Total TP FP TP/(TP+FP) TP/P 
0 395 39 117 0.25 0.6610169 221 11 63 0.1486486 0.5789474 
1 180 36 48 0.4285714 0.6101695 105 10 29 0.2564103 0.5263158 
2 111 25 24 0.5102041 0.4237288 69 6 14 0.3 0.3157895 
3 73 20 11 0.6451613 0.3389831 46 6 5 0.5454545 0.3157895 
4 50 16 5 0.7619048 0.2711864 31 4 1 0.8 0.2105263 
5 18 9 1 0.9 0.1525424 12 3 0 1 0.1578947 
70 
Cons. Score Total TP FP TP/(TP+FP) TP/P Total TP FP TP/(TP+FP) TP/P 
0 395 39 117 0.25 0.6610169 221 11 63 0.1486486 0.5789474 
1 188 37 49 0.4302326 0.6271186 107 10 29 0.2564103 0.5263158 
2 119 29 27 0.5178571 0.4915254 75 6 17 0.2608696 0.3157895 
3 78 21 11 0.65625 0.3559322 48 6 5 0.5454545 0.3157895 
4 53 17 5 0.7727273 0.2881356 33 4 1 0.8 0.2105263 
5 19 9 1 0.9 0.1525424 12 3 0 1 0.1578947 
110 
Cons. Score Total TP FP TP/(TP+FP) TP/P Total TP FP TP/(TP+FP) TP/P 
0 395 39 117 0.25 0.6610169 221 11 63 0.1486486 0.5789474 
1 197 38 52 0.4222222 0.6440678 109 11 29 0.275 0.5789474 
2 123 30 27 0.5263158 0.5084746 78 8 17 0.32 0.4210526 
3 80 21 12 0.6363636 0.3559322 50 6 6 0.5 0.3157895 
4 55 19 5 0.7916667 0.3220339 34 5 1 0.8333333 0.2631579 
5 23 13 1 0.9285714 0.220339 15 3 0 1 0.1578947 
210 
Cons. Score Total TP FP TP/(TP+FP) TP/P Total TP FP TP/(TP+FP) TP/P 
0 395 39 117 0.25 0.6610169 221 11 63 0.1486486 0.5789474 
1 208 38 55 0.4086022 0.6440678 110 11 30 0.2682927 0.5789474 
2 136 33 30 0.5238095 0.559322 82 10 18 0.3571429 0.5263158 
3 86 21 13 0.6176471 0.3559322 52 7 7 0.5 0.3684211 
4 61 20 6 0.7692308 0.3389831 38 5 1 0.8333333 0.2631579 
5 30 17 1 0.9444444 0.2881356 20 3 0 1 0.1578947 
410 
Cons. Score Total TP FP TP/(TP+FP) TP/P Total TP FP TP/(TP+FP) TP/P 
0 395 39 117 0.25 0.6610169 221 11 63 0.1486486 0.5789474 
1 217 37 58 0.3894737 0.6271186 117 11 31 0.2619048 0.5789474 
2 144 32 32 0.5 0.5423729 85 10 18 0.3571429 0.5263158 
3 92 23 15 0.6052632 0.3898305 56 7 8 0.4666667 0.3684211 
4 64 22 8 0.7333333 0.3728814 40 5 2 0.7142857 0.2631579 
5 37 18 3 0.8571429 0.3050847 22 3 0 1 0.1578947 
610 
Cons. Score Total TP FP TP/(TP+FP) TP/P Total TP FP TP/(TP+FP) TP/P 
0 395 39 117 0.25 0.6610169 221 11 63 0.1486486 0.5789474 
1 219 37 59 0.3854167 0.6271186 118 11 32 0.255814 0.5789474 
2 146 32 33 0.4923077 0.5423729 85 10 18 0.3571429 0.5263158 
3 99 23 16 0.5897436 0.3898305 58 7 8 0.4666667 0.3684211 
4 70 23 9 0.71875 0.3898305 42 6 2 0.75 0.3157895 
5 40 19 4 0.826087 0.3220339 23 3 0 1 0.1578947 
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Supplementary table 3 - Effect of addition of more informative genomes on accuracy 
and coverage scores. We calculated the accuracy and coverage after addition of N. 
crassa and S. pombe genomes, for different conservation scores. The analysis is only for 
putative target motifs within predicted unstructured protein regions in the S. cerevisiae 
proteome  and for a probing region of 210.  
 
 
Calculated with Gold Positives (Total 
Positives =59) 
Calculated with Platinum Positives (Total 
Positives =19) 
Total TP FP 
TP/(TP
+FP) 
TP/P Total TP FP 
TP/(TP
+FP) 
TP/P 
Conserved in 1 of 5 
genomes 
208 38 55 0.41 0.64 110 11 30 0.27 0.58 
Conserved in 1 of 6 
genomes 
215 38 58 0.40 0.64 115 11 31 0.26 0.58 
Conserved in 1 of 7 
genomes 
216 38 58 0.40 0.64 115 11 31 0.26 0.58 
Conserved in 2 of 5 
genomes 
136 33 30 0.52 0.56 82 10 18 0.36 0.53 
Conserved in 2 of 6 
genomes 
140 34 31 0.52 0.58 85 11 18 0.38 0.58 
Conserved in 2 of 7 
genomes 
145 34 34 0.50 0.58 87 11 20 0.35 0.58 
Conserved in 3 of 5 
genomes 
86 21 13 0.62 0.36 52 7 7 0.50 0.37 
Conserved in 3 of 6 
genomes 
89 23 13 0.64 0.39 54 8 7 0.53 0.42 
Conserved in 3 of 7 
genomes 
92 24 13 0.65 0.41 56 9 7 0.56 0.47 
Conserved in 4 of 5 
genomes 
61 20 6 0.77 0.34 38 5 2 0.71 0.26 
Conserved in 4 of 6 
genomes 
67 21 8 0.72 0.36 43 6 3 0.67 0.32 
Conserved in 4 of 7 
genomes 
69 22 8 0.73 0.37 43 6 3 0.67 0.32 
Conserved in 5 of 5 
genomes 
30 17 1 0.94 0.29 20 3 0 1 0.16 
Conserved in 5 of 6 
genomes 
40 20 3 0.87 0.34 28 5 0 1 0.26 
Conserved in 5 of 7 
genomes 
45 20 4 0.83 0.34 30 5 0 1 0.26 
 
 
 
Supplementary table 4 – List of predicted interactions. We considered that a potential 
target consensus, found by pattern matching, in an S. cerevisiae protein would be 
biologically relevant if it was within an unstructured region of the S. cerevisiae protein 
and also conserved in four of the six genomes used. We used the genomes of C. 
glabrata, K.lactis, C. albicans, D. hansenii, Y. lipolytica and N. crassa because these 
species diverged from S. cerevisiae at a time that falls within the optimal range 
proposed in our analysis. We retrieved function and localization information from MIPS 
[124] and SGD databases (www.yeastgenome.org). 
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SH3 
protein 
Localization Function 
Target 
protein 
Localization Function 
Target 
binding 
positions 
Accura
cy % 
LSB1 
cytoplasm 
nucleus 
biological_process 
unknown;intracellular signalling; 
ABP1 
cytoplasm actin 
cytoskeleton 
cytoskeleton organization and 
biogenesis;assembly of protein 
complexes;protein binding;cell 
growth ;actin cytoskeleton;budding; 
446-456 83% 
LSB1 
cytoplasm 
nucleus 
biological_process 
unknown;intracellular signalling; 
APP1 
cytoplasm actin 
cytoskeleton 
nucleus 
cytoskeleton organization and 
biogenesis;cell growth ;actin 
cytoskeleton;budding; 
505-515 
 
83% 
LSB1 
cytoplasm 
nucleus 
biological_process 
unknown;intracellular signalling; 
YBP2 cytoplasm - 537-547  
LSB1 
cytoplasm 
nucleus 
biological_process 
unknown;intracellular signalling; 
LAS17 
cytoplasm actin 
cytoskeleton 
cytokinesis; ;assembly of protein 
complexes;protein 
binding;endocytosis;osmotic and salt 
stress response;cell growth ;actin 
cytoskeleton;budding; 
311-321 
323-333 
352-362 
384-394 
83% 
LSB1 
cytoplasm 
nucleus 
biological_process 
unknown;intracellular signalling; 
CUE5 cytoplasm - 337-347 73% 
LSB1 
cytoplasm 
nucleus 
biological_process 
unknown;intracellular signalling; 
GYP5 
bud neck   cell 
periphery 
cytoplasm 
vesicle-mediated transport;GTPase 
activator ;vacuolar transport; 
279-289 
293-303 
83% 
LSB1 
cytoplasm 
nucleus 
biological_process 
unknown;intracellular signalling; 
APP2 
bud neck   
cytoplasm 
mitochondria 
cytoskeleton organization and 
biogenesis;actin cytoskeleton; 
200-210 83% 
LSB1 
cytoplasm 
nucleus 
biological_process 
unknown;intracellular signalling; 
GTS1 
cytoplasm actin 
cytoskeleton 
nucleus 
morphogenesis;mitotic cell cycle 
and cell cycle control;transcriptional 
activator;drug transport;stress 
response;rhythm ;cell growth ;cell 
aging;budding;development of asco; 
247-257 73% 
LSB1 
cytoplasm 
nucleus 
biological_process 
unknown;intracellular signalling; 
YIL108W cytoplasm - 577-587 73% 
LSB1 
cytoplasm 
nucleus 
biological_process 
unknown;intracellular signalling; 
YDL146W 
bud neck   cell 
periphery 
cytoplasm 
nucleus 
- 477-487 73% 
MYO5 
actin 
cytoskeleton 
cell wall organization and 
biogenesis;conversion to kinetic 
energy 
;cytoskeleton;exocytosis;endocyto
sis;osmotic and salt stress 
response;osmosensing;cell 
wall;budding; 
SRV2 
cell periphery 
actin 
cytoskeleton 
cytoskeleton organization and 
biogenesis;metabolism of cyclic and 
unusual nucleotides;protein 
binding;small GTPase mediated 
signal transduction;cell growth 
;cytoskeleton;budding; 
276-286 83% 
MYO5 
actin 
cytoskeleton 
cell wall organization and 
biogenesis;conversion to kinetic 
energy 
;cytoskeleton;exocytosis;endocyto
sis;osmotic and salt stress 
response;osmosensing;cell 
wall;budding; 
FAR11 ambiguous 
cell cycle;conjugation;cell cycle 
arrest;pheromone response; 
520-530 73% 
MYO5 
actin 
cytoskeleton 
cell wall organization and 
biogenesis;conversion to kinetic 
energy 
;cytoskeleton;exocytosis;endocyto
sis;osmotic and salt stress 
response;osmosensing;cell 
wall;budding; 
BNI1 
neck   neck   
cytoplasm 
cytoskeleton 
response to stress;cytokinesis 
;spindle pole body;protein 
binding;structural protein;RNA 
transport;small GTPase mediated 
signal transduction;osmotic and salt 
stress response;pheromone 
response;cell growth ;actin 
cytoskeleton;budding; 
1238-1248 
1277-1287 
83% 
MYO5 
actin 
cytoskeleton 
cell wall organization and 
biogenesis;conversion to kinetic 
energy 
;cytoskeleton;exocytosis;endocyto
sis;osmotic and salt stress 
response;osmosensing;cell 
wall;budding; 
VRP1 
cytoplasm actin 
cytoskeleton 
vesicle-mediated transport;response 
to stress;budding;protein 
binding;endocytosis;osmotic and salt 
stress response;cell growth ;actin 
cytoskeleton; 
4-14 
234-244 
395-405 
83% 
MYO5 
actin 
cytoskeleton 
cell wall organization and 
biogenesis;conversion to kinetic 
energy 
;cytoskeleton;exocytosis;endocyto
sis;osmotic and salt stress 
response;osmosensing;cell 
wall;budding; 
BNR1 
neck   cell 
periphery actin 
cytoskeleton 
response to stress;budding;protein 
binding;osmotic and salt stress 
response;cell growth ;actin 
cytoskeleton; 
765-775 
819-829 
83% 
YSC84 cytoplasm vesicle-mediated ABP1 cytoplasm actin cytoskeleton organization and 447-457 83% 
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cytoskeleton transport;endocytosis;cell growth 
;actin cytoskeleton;budding; 
cytoskeleton biogenesis;assembly of protein 
complexes;protein binding;cell 
growth ;actin cytoskeleton;budding; 
YSC84 
cytoplasm 
cytoskeleton 
vesicle-mediated 
transport;endocytosis;cell growth 
;actin cytoskeleton;budding; 
APP1 
cytoplasm actin 
cytoskeleton 
nucleus 
cytoskeleton organization and 
biogenesis;cell growth ;actin 
cytoskeleton;budding; 
506-516 83% 
YSC84 
cytoplasm 
cytoskeleton 
vesicle-mediated 
transport;endocytosis;cell growth 
;actin cytoskeleton;budding; 
CDC14 
nucleus 
nucleolus 
phosphate utilization;DNA synthesis 
and replication;mitotic cell cycle and 
cell cycle control;modification by 
phosphorylation; 
121-131 73% 
YSC84 
cytoplasm 
cytoskeleton 
vesicle-mediated 
transport;endocytosis;cell growth 
;actin cytoskeleton;budding; 
GTS1 
cytoplasm actin 
cytoskeleton 
nucleus 
morphogenesis;mitotic cell cycle 
and cell cycle control;transcriptional 
activator;drug transport;stress 
response;rhythm ;cell growth ;cell 
aging;budding;development of asco; 
248-258 73% 
YSC84 
cytoplasm 
cytoskeleton 
vesicle-mediated 
transport;endocytosis;cell growth 
;actin cytoskeleton;budding; 
CUE5 cytoplasm - 338-348 83% 
YSC84 
cytoplasm 
cytoskeleton 
vesicle-mediated 
transport;endocytosis;cell growth 
;actin cytoskeleton;budding; 
GYP5 
bud neck   cell 
periphery 
cytoplasm 
vesicle-mediated transport;GTPase 
activator ;vacuolar transport; 
280-290 
294-304 
83% 
HSE1 endosome 
transport;protein targeting;protein 
binding;vacuolar transport; 
BCK1 cytoplasm 
phosphate utilization;mitotic cell 
cycle and cell cycle 
control;modification by 
phosphorylation;MAPKKK 
cascade;stress response;perception 
of nutrients and nutritional 
adaptation;directional cell growth 
;budding; 
803-813 83% 
HSE1 endosome 
transport;protein targeting;protein 
binding;vacuolar transport; 
LAS17 
cytoplasm actin 
cytoskeleton 
cytokinesis;assembly of protein 
complexes;protein 
binding;endocytosis;osmotic and salt 
stress response;cell growth ;actin 
cytoskeleton;budding; 
308-318 
319-329 
83% 
HSE1 endosome 
transport;protein targeting;protein 
binding;vacuolar transport; 
STE20 bud cytoplasm 
pseudohyphal growth;phosphate 
utilization;modification by 
phosphorylation;transmembrane 
signal transduction;pheromone 
response;cell growth 
;cytoskeleton;budding; 
471-481 83% 
ABP1 
cytoplasm actin 
cytoskeleton 
cytoskeleton organization and 
biogenesis;assembly of protein 
complexes;protein binding;cell 
growth ;actin 
cytoskeleton;budding; 
SRV2 
cell periphery 
actin 
cytoskeleton 
cytoskeleton organization and 
biogenesis;metabolism of cyclic and 
unusual nucleotides;protein 
binding;small GTPase mediated 
signal transduction;cell growth 
;budding; 
351-361 83% 
ABP1 
cytoplasm actin 
cytoskeleton 
cytoskeleton organization and 
biogenesis;assembly of protein 
complexes;protein binding;cell 
growth ;actin 
cytoskeleton;budding; 
DNF2 
bud 
cell periphery 
plasma 
membrane 
peptide transport;protein 
transport;lipid transport;transport 
ATPases; 
1468-1478 73% 
ABP1 
cytoplasm actin 
cytoskeleton 
cytoskeleton organization and 
biogenesis;assembly of protein 
complexes;protein binding;cell 
growth ;actin 
cytoskeleton;budding; 
PRK1 
cytoplasm actin 
cytoskeleton 
cytokinesis;phosphate 
utilization;mitotic cell cycle and cell 
cycle control;modification by 
phosphorylation;assembly of protein 
complexes;endocytosis;actin 
cytoskeleton;budding; 
746-756 73% 
ABP1 
cytoplasm actin 
cytoskeleton 
cytoskeleton organization and 
biogenesis;assembly of protein 
complexes;protein binding;cell 
growth ;actin 
cytoskeleton;budding; 
HUA1 
cytoplasm 
nucleus 
cytoskeleton organization and 
biogenesis;assembly of protein 
complexes;cell growth ;actin 
cytoskeleton;budding; 
70-80 83% 
ABP1 
cytoplasm actin 
cytoskeleton 
cytoskeleton organization and 
biogenesis;assembly of protein 
complexes;protein binding;cell 
growth ;actin 
cytoskeleton;budding; 
YIR003W 
cytoplasm actin 
cytoskeleton 
- 
3-13 
386-396 
73% 
ABP1 
cytoplasm actin 
cytoskeleton 
cytoskeleton organization and 
biogenesis;assembly of protein 
complexes;protein binding;cell 
growth ;actin 
cytoskeleton;budding; 
ARK1 
cytoplasm actin 
cytoskeleton 
cytokinesis;phosphate 
utilization;modification by 
phosphorylation;assembly of protein 
complexes;endocytosis;actin 
cytoskeleton;budding; 
605-615 
616-626 
83% 
ABP1 
cytoplasm actin 
cytoskeleton 
cytoskeleton organization and 
biogenesis;assembly of protein 
complexes;protein binding;cell 
DNF1 
plasma 
membrane 
cytoplasm golgi 
peptide transport;protein 
transport;lipid transport;transport 
ATPases; 
1425-1435 73% 
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growth ;actin 
cytoskeleton;budding; 
mitochondria 
ABP1 
cytoplasm actin 
cytoskeleton 
cytoskeleton organization and 
biogenesis;assembly of protein 
complexes;protein binding;cell 
growth ;actin 
cytoskeleton;budding; 
SLA1 
cytoplasm actin 
cytoskeleton 
nucleus 
cell wall organization and 
biogenesis;assembly of protein 
complexes;protein 
binding;endocytosis;cell growth ;cell 
wall;actin cytoskeleton;budding; 
191-201 83% 
BBC1 cytoplasm 
cytoskeleton organization and 
biogenesis;protein binding;actin 
cytoskeleton; 
HUA1 
cytoplasm 
nucleus 
cytoskeleton organization and 
biogenesis;assembly of protein 
complexes;cell growth ;actin 
cytoskeleton;budding; 
73-83 73% 
BBC1 cytoplasm 
cytoskeleton organization and 
biogenesis;protein binding;actin 
cytoskeleton; 
RPO21 
nucleus nucleus 
mitochondria 
transcription;general transcription 
activities;DNA binding; 
241-251 83% 
BBC1 cytoplasm 
cytoskeleton organization and 
biogenesis;protein binding;actin 
cytoskeleton; 
LAS17 
cytoplasm actin 
cytoskeleton 
cytokinesis;assembly of protein 
complexes;protein 
binding;endocytosis;osmotic and salt 
stress response;cell growth ;actin 
cytoskeleton;budding; 
346-356 
379-389 
73% 
LSB3 
neck   cell 
periphery 
cytoplasm 
cytoskeleton 
mitochondria 
cytoskeleton organization and 
biogenesis;actin cytoskeleton; 
ABP1 
cytoplasm actin 
cytoskeleton 
cytoskeleton organization and 
biogenesis;assembly of protein 
complexes;protein binding;cell 
growth ;actin cytoskeleton;budding; 
446-456 83% 
LSB3 
neck   cell 
periphery 
cytoplasm 
cytoskeleton 
mitochondria 
cytoskeleton organization and 
biogenesis;actin cytoskeleton; 
APP1 
cytoplasm actin 
cytoskeleton 
nucleus 
cytoskeleton organization and 
biogenesis;cell growth ;actin 
cytoskeleton;budding; 
505-515 83% 
LSB3 
neck   cell 
periphery 
cytoplasm 
cytoskeleton 
mitochondria 
cytoskeleton organization and 
biogenesis;actin cytoskeleton; 
LAS17 
cytoplasm actin 
cytoskeleton 
cytokinesis;assembly of protein 
complexes;protein 
binding;endocytosis;osmotic and salt 
stress response;cell growth ;actin 
cytoskeleton;budding; 
311-321 83% 
LSB3 
neck   cell 
periphery 
cytoplasm 
cytoskeleton 
mitochondria 
cytoskeleton organization and 
biogenesis;actin cytoskeleton; 
CUE5 cytoplasm - 337-347 83% 
LSB3 
neck   cell 
periphery 
cytoplasm 
cytoskeleton 
mitochondria 
cytoskeleton organization and 
biogenesis;actin cytoskeleton; 
GYP5 
bud neck   cell 
periphery 
cytoplasm 
vesicle-mediated transport;GTPase 
activator ;vacuolar transport; 
293-303 83% 
LSB3 
neck   cell 
periphery 
cytoplasm 
cytoskeleton 
mitochondria 
cytoskeleton organization and 
biogenesis;actin cytoskeleton; 
APP2 
bud neck   
cytoplasm 
mitochondria 
cytoskeleton organization and 
biogenesis;actin cytoskeleton; 
200-210 83% 
LSB3 
neck   cell 
periphery 
cytoplasm 
cytoskeleton 
mitochondria 
cytoskeleton organization and 
biogenesis;actin cytoskeleton; 
CDC14 
nucleus 
nucleolus 
phosphate utilization;DNA synthesis 
and replication;mitotic cell cycle and 
cell cycle control;modification by 
phosphorylation; 
120-130 73% 
LSB3 
neck   cell 
periphery 
cytoplasm 
cytoskeleton 
mitochondria 
cytoskeleton organization and 
biogenesis;actin cytoskeleton; 
GTS1 
cytoplasm actin 
cytoskeleton 
nucleus 
morphogenesis;mitotic cell cycle 
and cell cycle control;transcriptional 
activator;drug transport;stress 
response;rhythm ;cell growth ;cell 
aging;budding;development of asco; 
247-257 73% 
LSB3 
neck   cell 
periphery 
cytoplasm 
cytoskeleton 
mitochondria 
cytoskeleton organization and 
biogenesis;actin cytoskeleton; 
SLA1 
cytoplasm actin 
cytoskeleton 
nucleus 
cell wall organization and 
biogenesis;assembly of protein 
complexes;protein 
binding;endocytosis;cell growth ;cell 
wall;actin cytoskeleton;budding; 
192-202 83% 
BZZ1 
cytoplasm actin 
cytoskeleton 
response to stress;osmotic and salt 
stress response;osmosensing;actin 
cytoskeleton; 
MYO5 
actin 
cytoskeleton 
cell wall organization and 
biogenesis;conversion to kinetic 
energy 
;cytoskeleton;exocytosis;endocytosis
;osmotic and salt stress 
response;osmosensing;budding; 
1008-1018 83% 
BZZ1 
cytoplasm actin 
cytoskeleton 
response to stress;osmotic and salt 
stress response;osmosensing;actin 
cytoskeleton; 
BCK1 cytoplasm 
mitotic cell cycle and cell cycle 
control;modification by 
phosphorylation;MAPKKK 
cascade;stress response;perception 
of nutrients and nutritional 
1394-1404 83% 
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adaptation;directional cell growth 
;budding; 
BZZ1 
cytoplasm actin 
cytoskeleton 
response to stress;osmotic and salt 
stress response;osmosensing;actin 
cytoskeleton; 
ARK1 
cytoplasm actin 
cytoskeleton 
cytokinesis;phosphate 
utilization;modification by 
phosphorylation;assembly of protein 
complexes;endocytosis;actin 
cytoskeleton;budding; 
606-616 73% 
BZZ1 
cytoplasm actin 
cytoskeleton 
response to stress;osmotic and salt 
stress response;osmosensing;actin 
cytoskeleton; 
LAS17 
cytoplasm actin 
cytoskeleton 
cytokinesis;assembly of protein 
complexes;protein 
binding;endocytosis;osmotic and salt 
stress response;cell growth ;actin 
cytoskeleton;budding; 
181-191 83% 
BOI1 
bud neck   cell 
periphery 
cytoplasm 
signal transduction;lipid 
binding;small GTPase mediated 
signal transduction;cell growth 
;cytoskeleton;budding; 
BCK1 cytoplasm 
mitotic cell cycle and cell cycle 
control;modification by 
phosphorylation;MAPKKK 
cascade;stress response;perception 
of nutrients and nutritional 
adaptation;directional cell growth 
;budding; 
805-815 83% 
BOI1 
bud neck   cell 
periphery 
cytoplasm 
signal transduction;lipid 
binding;small GTPase mediated 
signal transduction;cell growth 
;cytoskeleton;budding; 
CDC54 
cytoplasm 
nucleus 
DNA metabolism;DNA topology;ori 
recognition and priming complex 
formation;mitotic cell cycle and cell 
cycle control;ATP binding; 
680-690 83% 
BOI1 
bud neck   cell 
periphery 
cytoplasm 
signal transduction;lipid 
binding;small GTPase mediated 
signal transduction;cell growth 
;cytoskeleton;budding; 
RPO41 
mitochondria 
mitochondria 
organelle organization and 
biogenesis;transcription;DNA 
synthesis and replication;general 
transcription activities;DNA 
binding;mitochondrion; 
828-838 73% 
BOI1 
bud neck   cell 
periphery 
cytoplasm 
signal transduction;lipid 
binding;small GTPase mediated 
signal transduction;cell growth 
;cytoskeleton;budding; 
LAS17 
cytoplasm actin 
cytoskeleton 
cytokinesis;assembly of protein 
complexes;protein 
binding;endocytosis;osmotic and salt 
stress response;cell growth ;actin 
cytoskeleton;budding; 
310-320 
321-331 
348-358 
381-391 
83% 
BOI1 
bud neck   cell 
periphery 
cytoplasm 
signal transduction;lipid 
binding;small GTPase mediated 
signal transduction;cell growth 
;cytoskeleton;budding; 
STE20 bud cytoplasm 
pseudohyphal growth;modification 
by phosphorylation;transmembrane 
signal transduction;pheromone 
response;cell growth 
;cytoskeleton;budding; 
473-483 83% 
BOI1 
bud neck   cell 
periphery 
cytoplasm 
signal transduction;lipid 
binding;small GTPase mediated 
signal transduction;cell growth 
;cytoskeleton;budding; 
BOI2 
bud neck   cell 
periphery 
cytoplasm 
signal transduction;lipid 
binding;small GTPase mediated 
signal transduction;cell growth 
;cytoskeleton;budding; 
439-449 73% 
RVS16
7 
actin 
cytoskeleton 
vesicle-mediated 
transport;response to 
stress;budding;protein 
binding;endocytosis;osmotic and 
salt stress response;cell growth 
;cytoskeleton;budding; 
ABP1 
cytoplasm actin 
cytoskeleton 
cytoskeleton organization and 
biogenesis;assembly of protein 
complexes;protein binding;cell 
growth ;actin cytoskeleton;budding; 
515-525 73% 
RVS16
7 
actin 
cytoskeleton 
vesicle-mediated 
transport;response to 
stress;budding;protein 
binding;endocytosis;osmotic and 
salt stress response;cell growth 
;cytoskeleton;budding; 
APP1 
cytoplasm actin 
cytoskeleton 
nucleus 
cytoskeleton organization and 
biogenesis;cell growth ;actin 
cytoskeleton;budding; 
505-515 83% 
RVS16
7 
actin 
cytoskeleton 
vesicle-mediated 
transport;response to 
stress;budding;protein 
binding;endocytosis;osmotic and 
salt stress response;cell growth 
;cytoskeleton;budding; 
LAS17 
cytoplasm actin 
cytoskeleton 
cytokinesis;assembly of protein 
complexes;protein 
binding;endocytosis;osmotic and salt 
stress response;cell growth ;actin 
cytoskeleton;budding; 
341-351 
384-394 
384-394 
83% 
RVS16
7 
actin 
cytoskeleton 
vesicle-mediated 
transport;response to 
stress;budding;protein 
binding;endocytosis;osmotic and 
salt stress response;cell growth 
;cytoskeleton;budding; 
YDL146W 
bud neck   cell 
periphery 
cytoplasm 
nucleus 
- 477-487 73% 
MYO3 
cytoplasm actin 
cytoskeleton 
cell wall organization and 
biogenesis;conversion to kinetic 
energy 
;cytoskeleton;exocytosis;endocyto
sis;osmotic and salt stress 
response;cell wall;budding; 
SRV2 
cell periphery 
actin 
cytoskeleton 
cytoskeleton organization and 
biogenesis;metabolism of cyclic and 
unusual nucleotides;protein 
binding;small GTPase mediated 
signal transduction;cell 
growth;budding; 
276-286 83% 
MYO3 
cytoplasm actin 
cytoskeleton 
cell wall organization and 
biogenesis;conversion to kinetic 
energy 
FAR11 ambiguous 
cell cycle;conjugation;pheromone 
response; 
520-530 73% 
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;cytoskeleton;exocytosis;endocyto
sis;osmotic and salt stress 
response;cell wall;budding; 
MYO3 
cytoplasm actin 
cytoskeleton 
cell wall organization and 
biogenesis;conversion to kinetic 
energy 
;cytoskeleton;exocytosis;endocyto
sis;osmotic and salt stress 
response;cell wall;budding; 
BNI1 
neck   neck   
cytoplasm 
cytoskeleton 
response to 
stress;budding;cytokinesis ;spindle 
pole body;protein binding;structural 
protein;RNA transport;small GTPase 
mediated signal 
transduction;osmotic and salt stress 
response;pheromone response;cell 
growth ;actin cytoskeleton; 
1238-1248 
1277-1287 
83% 
MYO3 
cytoplasm actin 
cytoskeleton 
cell wall organization and 
biogenesis;conversion to kinetic 
energy 
;cytoskeleton;exocytosis;endocyto
sis;osmotic and salt stress 
response;cell wall;budding; 
VRP1 
cytoplasm actin 
cytoskeleton 
vesicle-mediated transport;response 
to stress;budding;protein 
binding;endocytosis;osmotic and salt 
stress response;cell growth ;actin 
cytoskeleton; 
4-14 
234-244 
395-405 
83% 
MYO3 
cytoplasm actin 
cytoskeleton 
cell wall organization and 
biogenesis;conversion to kinetic 
energy 
;cytoskeleton;exocytosis;endocyto
sis;osmotic and salt stress 
response;cell wall;budding; 
BNR1 
neck   cell 
periphery actin 
cytoskeleton 
response to stress;budding;protein 
binding;osmotic and salt stress 
response;cell growth ;actin 
cytoskeleton; 
765-775 
819-829 
83% 
PIN3 
cytoplasm 
nucleus 
cytoskeleton organization and 
biogenesis;actin cytoskeleton; 
APP1 
cytoplasm actin 
cytoskeleton 
nucleus 
cytoskeleton organization and 
biogenesis;cell growth ;actin 
cytoskeleton;budding; 
506-516 83% 
PIN3 
cytoplasm 
nucleus 
cytoskeleton organization and 
biogenesis;actin cytoskeleton; 
LAS17 
cytoplasm actin 
cytoskeleton 
cytokinesis;assembly of protein 
complexes;protein 
binding;endocytosis;osmotic and salt 
stress response;cell growth ;actin 
cytoskeleton;budding; 
324-334 
342-352 
353-363 
385-395 
83% 
PIN3 
cytoplasm 
nucleus 
cytoskeleton organization and 
biogenesis;actin cytoskeleton; 
GTS1 
cytoplasm actin 
cytoskeleton 
nucleus 
cell cycle;morphogenesis;mitotic 
cell cycle and cell cycle 
control;transcriptional activator;drug 
transport;stress response;rhythm 
;cell growth ;cell 
aging;budding;development of asco; 
248-258 73% 
PIN3 
cytoplasm 
nucleus 
cytoskeleton organization and 
biogenesis;actin cytoskeleton; 
YDL146W 
bud neck   cell 
periphery 
cytoplasm 
nucleus 
- 478-488 73% 
SLA1 
cytoplasm actin 
cytoskeleton 
nucleus 
cell wall organization and 
biogenesis;assembly of protein 
complexes;protein 
binding;endocytosis;cell growth 
;cell wall;actin 
cytoskeleton;budding; 
LAS17 
cytoplasm actin 
cytoskeleton 
cytokinesis;assembly of protein 
complexes;protein 
binding;endocytosis;osmotic and salt 
stress response;cell growth ;actin 
cytoskeleton;budding; 
319-328 
346-355 
379-388 
83% 
SLA1 
cytoplasm actin 
cytoskeleton 
nucleus 
cell wall organization and 
biogenesis;assembly of protein 
complexes;protein 
binding;endocytosis;cell growth 
;cell wall;actin 
cytoskeleton;budding; 
STE20 bud cytoplasm 
pseudohyphal growth;phosphate 
utilization;modification by 
phosphorylation;transmembrane 
signal transduction;pheromone 
response;cell growth 
;cytoskeleton;budding; 
471-480 83% 
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3.1 –Abstract  
 
A great challenge in the post-genomic era is to predict protein structure and 
function from sequence, including the identification of biological partners.  With all 
currently available genomes it would be important to be able to determine the network 
of interactions of a domain family from its sequence.  We show here that by homology 
modelling we can structurally resolve most of the yeast SH3 domains.  We built 
position specific binding matrices based on the superimposition of 29 canonical (and 
non-canonical) ligands on the models and on the X-Ray structures followed by in silico 
mutagenesis screening. These matrices were validated on a set of sequences known to 
bind these domains and were used to scan the proteome of S. cereivisae. The resulting 
putative interaction network was benchmarked at 72% accuracy, containing many 
known SH3 targets and also putative novel interactions.  Our work also allows us to 
identify key residues that determine loop conformation in SH3 domains, which could be 
used to model human SH3 domains and do target prediction.  The success of this 
methodology opens the way for sequence based, genome-wide prediction of protein-
protein interactions. 
 
 
 
 
 
 
Chapter 3 
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3.2 – Introduction 
 
Identification of interaction sites of proteins and knowing which proteins interact 
with which others are crucial for understanding the basis of many biological processes.  
Several experimental approaches have been developed to do this and one of the more 
popular is yeast 2-hybrid which has been used on a genome-wide scale [2-5, 7, 128].  
All the methods developed so far have some weaknesses and strengths with the main 
problem being the biological validation of the interactions found [55].  In parallel to this 
massive screening of protein-protein interactions there are large initiatives aimed at 
determining the structure of all proteins of an organism as well as all stable complexes 
(http://www.3drepertoire.org/).  Although significant progress has been made in this 
direction we are still far from achieving this goal.  However, the progress so far allows 
us in many cases to have structures covering major branches of a protein family. 
Computational analysis of many protein complexes have shown that proteins of the 
same family tend to interact in a similar way, that is with the same surface [45, 49].  
This has prompted some groups to develop simple potentials that, when applied to 
multiple sequence alignments of members of the families of two interacting proteins, 
predict putative interactions [46, 47].  A more sophisticated approach requires 
homology modelling of the aligned sequences on the structural template of the complex 
followed by accurate energy evaluation [51].  This method has been successfully 
employed with the interactions between Ras and Rbd/Ra domains [51]. 
There are 13 SH3 domains from S. cerevisiae of the total 28 SH3 domains with 
available crystal structures. Also there are 183 SH3 structures determined from other 
organisms of which 51 have been determined with a ligand.  For this reason, the SH3 
domain is probably one of the families best covered from a structural view-point.  In 
parallel phage-display, peptide-display and 2-hybrid analysis have been done on a large 
subset of all yeast S. cerevisiae SH3 domains [18, 27].  We use here the yeast SH3 
domain family as an example to demonstrate the possibilities of homology modelling 
and use of structural information in predicting protein-protein interactions. 
 
3.3 – Results and Discussion 
The methodology developed here requires first to do a multiple structural 
sequence alignment of all yeast SH3 domains and of the sequences of all SH3 structures 
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available.  Previous studies of SH3 domains provided a set of important positions to be 
taken into account for alignment: nine core residues, two very well conserved Gly and a 
triad in the binding positions can be distinguished [129]. Once the sequences were 
aligned we clustered them first by looking at the length of the 2 loops involved in 
binding (RT and src-loop) (figure 1).  Other features like the identity of the residue that 
could determine the orientation of one of the Trp involved in binding [130], were also 
examined.  Structural superimposition of the available structures after sequence 
alignment showed the importance of 2 motifs in the RT loop for its conformation. One 
is the aromatic motif [YF]-X-[YF] (figure 2), were the second aromatic residue points 
to the interior of the RT loop and packs close to the consensus Trp residue forming a 
second surface groove where poly-Pro sequences fit. The presence of a Phe instead 
allows the RT loop to move closer to the Trp residue (figure 2AB).  The second 
identified motif in the RT loop we denominate the “charged motif” (figure 2A). It is 
formed usually by a negatively charged group (Glu, Asp, but also Thr), although in few 
occasions this position can hold hydrophobic residues. Following this position a core 
forming hydrophobic residue (mainly Leu, but also Ile or Val) is found, followed by a 
small polar residue (mainly Ser and Thr, but also Pro, Gly, Ala), and another 
hydrophobic core forming residue, showing the general motif pattern: [DET] – [ ] – 
[STPGA] – [ ] (figure 2A).  The charged motif is involved in supporting the RT loop: 
i) the hydrophobic residues anchor the loop basement to the core, ii) the charged/polar 
groups fix usually the upper part of the RT backbone through hydrogen bonds; and 
eventually iii) the charged group hydrogen bond to the Tyr (if present) from the 
aromatic motif (see figure 2B).   
This motif information was used in a second step to cluster the sequences around 
the different structural templates (table 1). In many cases it was clear that one or more 
structural templates had the same loop length and shared the same motifs with some of 
the yeast sequences thus allowing for homology modelling.  In other cases we could 
find very good partial matches with two different structures and for these we built a 
chimera (see table 5). 
Once the yeast sequences were clustered with different structural templates we 
homology modelled the sequences using the algorithm FoldX [52]. For all SH3 domains 
we obtained models for the domain in complex with 29 selected ligands that would 
cover the structural variability observed (see figure 2CD, Methods and table 5). 
  
 53 
To determine the binding specificity of each domain we used FoldX to explore by 
in silico mutagenesis all 20 aa at each ligand position (see Methods). The final result for 
each yeast SH3 domain was a series of positional matrices, were the effect of all amino 
acids at each position on ligand binding were annotated.   
One advantage of using S. cerevisiae SH3 domains to develop a method for 
structural based prediction of protein domains biding properties is that we can explore 
the wealth of data available [18, 27] to score the methods developed. The predicted 
binding energies calculated with the matrices derived above should: a) allow us to 
discriminate between random peptides and peptides known to bind to the SH3 domains; 
b) correlate with available thermodynamic data; and c) allow us to predict the targets of 
the SH3 domains studied in the S. cerevisiae proteome.  
To test the first assumption we took from Tong and colleagues [27] the binding 
motifs determined by phage display for several of S. cerevisiae SH3 domains. The 
matrices developed were then used to compare the binding energy of peptides matching 
the known consensi with the binding energy of random peptides (see table 1). For all the 
SH3 domains evaluated the predicted average binding energy of peptides matching a 
known consensus is lower than the average binding energy of random peptides. We 
calculated the number of standard deviations that separate the two averages (see table 
1). For 13 of the 19 domains evaluated there is at least one motif with a z-score equal or 
lower than -1.6 that is equivalent to a lower tail p value of less than 0.05. There is a 
clear difference in the method’s performance for the different binding modes. The 
matrices generated could discriminate between random and peptides matching type I 
binding in 7 out of 17 motifs evaluated. The performance for type II binding is higher 
with 9 out 11 motifs confidently discriminated from random peptides. This difference in 
performance is most likely due to the method’s dependence on the availability of 
structures of SH3 complexes covering the conformational space of the different binding 
modes of SH3 domains to the target peptides. We have for example no model for type I 
binding of the pex13p and boi1p SH3 domains and for the other domains there is 1 to 4 
ligands selected for type I binding. This is in contrast to an average of 12 ligand 
conformations modeled for type 2 binding. 
For some of the yeast SH3 domains evaluated there are also approximate values for 
in vitro binding affinity to peptides probed with SPOT synthesis [18]. We have used 
these values to evaluate the capability of the binding matrices to discriminate between 
strong binding peptides and random peptides (table 2) and between strong and weak 
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binding peptides (table 3 and methods). In all cases evaluated strong binding peptides 
score z-scores lower than -2 (see table 2) when compared to random peptides. We can 
therefore state that the binding matrices created confidently describe the binding 
specificities of most of the SH3 domains analyzed. The method correctly describes the 
specificities of 13 out of 19 SH3 domains evaluated with the known consensus and all 
domains evaluated with in vitro binding data from SPOT assays. Moreover for all SH3 
domains evaluated the predicted average binding energy of strong binding peptides is 
lower than for the weak binding peptides (see table3). As expected the differences 
between the two predicted distributions is smaller than between the energies of random 
peptides and strong binders. The predicted average binding energies for both peptide 
populations differs between 0.4 to 2 kcal/mol, averaging at 1.4 kcal/mol, and due to the 
limitations of the SPOT method we cannot expect to see a larger separation in energy.  
To assay more directly for the ability of FoldX derived matrices to predict binding 
to peptides we computed the correlation between experimentally determined 
dissociation constants (taken from [18]) and predicted binding energy. The overall 
correlation obtained (r=0.41, N=45, p<0.005) is significant and similar to the reported 
correlation between the same dissociation constants and the BLU intensity values from 
the SPOT assay [18]. This computational approach has therefore similar quantitative 
power when assaying for in vitro binding when compared to the SPOT method. The 
correlations for the four domains with available data (Abp1, Rvs167, Lsb3, Ysc84) are 
respectively -0.04, 0.46, 0.44 and 0.54. The SH3 domain from the Abp1 protein was the 
only domain showing a particularly poor correlation. This could be due again to limited 
structural coverage, as discussed above, since most of the peptides tested for the Abp1 
SH3 domain were not standard type I or II peptides [18]. 
Lastly the binding matrices created were evaluated on their capability to predict 
known binding targets of SH3 domains in the proteome of S. cerevisiae.  We combined 
the binding energy with comparative genomics and disorder prediction, as described 
previously [131], to make a set of predicted interactions. The accuracy and coverage of 
the predictions was calculated using known SH3 mediated interactions [27] that we 
considered as our set of positive interactions and a group of negative interactions that 
we inferred from localization data (any protein pair annotated to different cellular 
compartments). The putative targets were ranked according to binding energy and the 
performance of the method was evaluated for different selected thresholds (see table 4). 
Confident interactions (>65% accuracy) can be obtained by limiting the selection to 10 
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or less targets per SH3 domain. The tradeoff of using such a stringent method is the low 
coverage obtained (<23% coverage) that is likely due to the conservation requirement 
necessary to obtain high accuracy [131]. An accuracy 72% and coverage of 23% are 
obtained when we consider only the best 5 targets for each domain. The highest 
observed accuracy is 79% and it is obtained when selecting only the 3 best putative 
targets for each SH3 domain, resulting in coverage of 20%.  
Overall the results show that we can use the increasingly expanding protein 
structure repository to predict the binding properties of protein binding domains and 
therefore the binding targets of protein binding domains in the proteome of the species 
of interest.  
We used the described method to propose a set of high-confidence SH3 target 
prediction for S. cerevisiae based on the 5 highest scoring putative targets for each SH3 
domain. This network is enriched with several know targets and contains as well several 
unknown interactions. To this predicted network we can attribute an accuracy of 72% 
and a coverage of 23% based on our benchmark (table 4). The predictions are presented 
in figure 3.  
The main limitation of the methodology described is the availability of good 
templates for SH3 homology modelling as well as proper ligand conformations to build 
the complexes. Selection of the templates can not be done only by sequence identity and 
similarity after pair-wise sequence alignment. RT and n-Src loop lengths must be taken 
into account, since both are involved in ligand binding. The n-Src loops require special 
attention because more often they determine the binding selection to type I or type II 
ligands (figure 2C and D). Analysing RT and n-Src loop lengths in currently available 
structures (see table 5) it is noted that they cover only a narrow range of loop length 
combinations. The most populated are the (18,5) and (18,6) combinations [numbers 
refer to (RT,n-Src) lengths], while others are barely represented in the structural 
database. In addition to this, the RT loop can exhibit Y or F in the aromatic or EDT in 
the polar motifs, thus increasing the number of possible combinations of lengths and 
motifs, that again are not well represented in the available structures. 
For most of the standard yeast SH3 sequences we managed to construct good 
quality models (see table 1) using the information available in the PDB database. The 
complexes were able to discriminate correctly between binding and random peptides 
(see table 2). Other yeast SH3 sequences, however, didn’t fit with any available 
template, and the construction of the chimeras is an attempt to overcome, at least 
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partially, the lack of proper templates. The most representative example is the yeast 
RVS167 (figure 1D), that successfully discriminated between random and non-random 
peptides (table 2) after modelling with chimeras “fyn-ssh” and “fmk-ssh”. In contrast, 
some other chimeras (BZZ1_D1, BZZ1_D2, SLA1_D3, etc., see table 1 and 2) showed 
odd ability to correctly predict binders and non-binders. 
Finally, some SH3 domains from yeast couldn’t be correctly modelled at all 
because of the limitations in the structure database. The reasons behind these limitations 
are related to the motifs and loop lengths already mentioned: 1) BUD14 has a motif HC 
in the polar motif (RT loop basement), which is quite different from typical EL, DL or 
TL motifs. It has also an Ile instead Tyr in the well conserved triad in the binding 
pocket. 2) CDC25 is a very unusual domain with (23,5) loop lengths, and a 
hydrophobic residue in the polar motif (LL instead EL or DL). There are no available 
templates for this domain and the only possible chimera (“kjw-fyn”) was also not a 
successful model since it was based on a non-standard template (1KJW.PDB). 3) FUS1 
has a Cys instead Tyr in the binding triad. The models fulfil normal requirements, 
except for polar motif EI. This domain has also a very unusual long distal loop that 
might interact with n-Src and distort the binding pocket. 4) HOF1 has a (19,5) loop 
lengths, a non-aromatic residue in the aromatic motif (Leu instead Tyr or Phe), and a 
hydrophobic in the polar motif (LA instead EL, DL or TL). 5) SDC25 has a positive 
residue in the polar motif (KL instead EL, DL or TL). 6) SHO1 and 7) SLA1_D2 have 
unusual loop length combinations, (20,4) and (20,5) respectively, with no representation 
in the template set. Models made with RT loop of 18 residues and adding two additional 
residues at the tip of the loop were not possible. 
 
 
3.4 – Methods 
3.4.1 – Homology modelling  
All of yeast SH3 domains were clustered with available structural template 
according to important structural features defined by previous works[129] and extended 
by our analysis. The templates were then used for homology modelling. When different 
structural templates were available we chose those with better predicted energy after 
homology modelling.  All the final models are shown in table 5. In parallel we 
superimposed all SH3 domains whose structures were determined with a ligand. After 
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superimposition we carefully examined the ligands and selected 29 of them as 
canonicals that covered the structural variability observed. These ligands were then 
docked on our modelled SH3 structures after superimposition of the respective complex 
structures with the modelled domains (see table 5). At this point we had a total number 
of 61 modelled PDBs (15 of which are yeast structures), complexed with 29 ligands.  
The complexes were then evaluated with FoldX, and those showing backbone van der 
Waals’ clashes were discarded.  
The geometry of the complexes was optimized using the following protocol: 
First, each residue belonging to the complex interface is mutated to alanine and the 
side chain energies of the neighbor residues are annotated. Then, the alanine is 
mutated back to the wild type amino acid and the side chain energies are 
recalculated. For those with an unfavorable energy difference, the program looks for 
a more favorable rotamer. During this procedure, the side chains are rearranged to 
eliminate bad torsion angles, van der Waals clashes, or unfavorable total energies. 
This increases speed by decreasing the number of rotamer searches. Mutations were 
performed in the same way, except that the selected residue was first mutated to 
alanine and then to the selected mutant residue. Mutation in FoldX is done using a 
statistical rotamer library in which the probability of a dihedral angle χi of a 
sidechain is given according to the previous dihedral angle χi-1, the probability of 
the first dihedral angle χ1 depending on the backbone dihedrals phi and psi. The 
mutation engine selects the best rotamer at one position by evaluating the energy of a 
set of different sidechains generated according to these statistics.  
 
3.4.2 – Binding matrices and predicted binding energies 
In order to determine what sequences could bind to our modeled SH3 domains we 
first mutated all positions in our canonical ligands to Ala, and then we explored all 20 
aa at each ligand position. The binding energy for each residue at each position relative 
to alanine was then coded in a scoring matrix. For a given binding matrix, the binding 
energy of a sequence can be calculated by summing over all positions of the matrix, 
which are taken to be independent. For each SH3 domain several peptide conformations 
were modeled (see table 5) and analyzed in this way, resulting in multiple scoring 
matrices per domain. 
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To calculate the binding energy between an SH3 domain and a target peptide all 
binding matrices of that domain were used. The predicted binding energy is taken to be 
the lowest energy from any of the matrices. This should ensure that we pick the best 
ligand model for that particular peptide.  
For the SPOT information we defined as strong binding peptides the 100 peptides 
with the highest BLU intensity signals for each domain. We defined as weak binding 
peptides those having the 100 lowest BLU intensity signals for each domain. Different 
thresholds (50 and 150 cut-offs) give similar results (data not shown).  
 
3.5 – Tables and Figures  
 
A 
 
 
1fyn     TLFVALYDYEARTEDDLSFHKGEKFQILNSSEGDWWEARSLTTGETGYIPSNYVAPV 
 
B 
 
 
1gcp     -KMEVFQEYYGIPPPPGAFGPFLRLNPGDIVE-LTKAEAEHNWWEGRNTATNEVGWFPCNRVHPY 
1ruw     PKFEAAYDFPGS-----GSSSELPLKKGDIVF-ISRDEP-SGWSLAKLLDGSKEGWVPTAYMTPY 
1jo8     PWATAEYDYDAA------EDNELTFVENDKIINIEFVDD--DWWLGELEKDGSKGLFPSNYVSLG 
 
C 
 
 
1pht     YQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETT--------GERGDFPGTYVEYIG 
1bb9     FKVQAQHDYTATDTDELQLKAGDVVLVIPFQN----------PEEQDEGWLMGVKESDWNQHKELEKCRGVFPENFTERVQ 
1uhc     QVYFAVYTFKARNPNELSVSANQKLKILEFKD-----------VTGNTEWWLAEVNG----------KKGYVPSNYIRKTE 
1ycs     GVIYALWDYEPQNDDELPMKEGDCMTIIHRED------------EDEIEWWWARLND----------KEGYVPRNLLGLYP 
1oot     PKAVALYSFAGEESGDLPFRKGDVITILKKSD-------------SQNDWWTGRVNG----------REGIFPANYVELV- 
1abo     NLFVALYDFVASGDNTLSITKGEKLRVLGYNH--------------NGEWCEAQTKN----------GQGWVPSNYITPVN 
1fyn     TLFVALYDYEARTEDDLSFHKGEKFQILNSSE---------------GDWWEARSLTTG--------ETGYIPSNYVAPVD 
1qcf     IIVVALYDYEAIHHEDLSFQKGDQMVVLEES----------------GEWWKARSLATR--------KEGYIPSNYVARVD 
 
D 
 
rvs167   ETVTALYDYQAQAAGDLSFPAGAVIEIVQRTPDVNEWWTGR--YNGQQGVFPGNYVQLNK 
1fmk     TTFVALYDYESRTETDLSFKKGERLQIVNNT--EGDWWLAHSLSTGQTGYIPSNYVAPSD 
 
 
 
rvs167   ETVTALYDYQAQAAGDLSFPAGAVIEIVQRTPDVNEWWTGRYNGQQGVFPGNYVQLNK 
1ssh     PKAVALYSFAGEESGDLPFRKGDVITILKKSDSQNDWWTGRVNGREGIFPANYVELV- 
 
 
 
rvs167   ETVTALYDYQAQAAGDLSFPAGAVIEIVQRTPDVNEWWTGRYNGQQGVFPGNYVQLNK 
fmk-ssh  TTFVALYDYESRTETDLSFKKGDVITILKKSDSQNDWWTGRVNGREGIFPANYVELV- 
 
 
Figure 1 – SH3 sequence features. (A) Boundaries and main features of a typical SH3 
domain from Fyn Tyr kinase. Arrows mark RT. N-Src and distal loop extensions; 
conserved triad in the binding pocket is highlighted; conserved Gly are blue and core 
residues are underlined. The aromatic and polar motifs in the RT loop are in red. (B) 
RT n-Src 
RT n-Src distal 
RT n-Src 
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Variability of the RT loop length. Typical RT length is 18 residues. Only a few 
templates showed longer loops (i.e. 24 residues in 1gcp and 19 in 1ruw). (C) Variability 
of the n-Src loop. Typical length ranged from 4 to 6 residues, although there are 
representative templates with 7, 8, 9, 10 and even 20. (D) Chimera construction to 
increase the diversity of the templates for homology modelling. Yeast RVS167 protein 
was modelled with the chimera “fmk-ssh”, constructed with the N-terminal part of 
1FMK.PDB and C-terminal part of 1SSH.PDB templates to fulfil the n-Src loop length 
and the aromatics in the RT loops (both boxed) of RVS167. 
 
                       
 
 
 
 
Figure 2 – Aromatic and charged motifs in SH3 domains. (A) Superimposition of 
templates 1FMK and 1SSH (rmsd of 0.34 A) showed that the presence of Phe in the 
second position of the aromatic motif (arrow) allow a tighter packing of the upper part 
of the RT loop against the conserved triad in the binding pocket. If Tyr is present, the 
 
RT loop 
Aromatic motif 
Charged 
motif 
C 
A B 
D 
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loop moves away to avoid clashes and to hydrogen bond (dotted green) with polar motif 
in the basement of the loop (arrow). Panel B shows the arising clashes and 
incompatibilities when the sequence of the template 1FMK is modelled onto template 
1SSH, and vice versa. A Tyr modelled with a Phe-based template is extremely close to 
the conserved Trp and strongly clashes (dotted magenta). A Phe modelled with a Tyr-
based template is more permissive, but probably a small hole is created that could 
destabilize the molecule.  C)  nSrc loop movement. Same sequence 1ssh with ligand 
(blue) 1oot without ligand (green) D) nSrc loop movement. Same sequence 1fyn with 
ligand type I (blue) 1efn with ligand type II (green). 
 
Figure 3 – Predictions of S. cerevisiae SH3’s interactions. We derived a set of high 
confidence prediction (72% accuracy) taking the best 5 putative targets of SH3 
domains. All putative target sites are predicted to be within unstructured regions of the 
proteome and have a predicted binding energy that is at least 3.3 standard deviations 
lower than the average binding energy of a random peptide. We kept only predicted 
binding sites that were conserved in at least 5 of the 7 orthologs evaluated for each 
protein.  In color are the interactions for which we found some experimental evidence in 
protein interaction databases (red - physical interaction, orange - genetic interaction). In 
thin lines are interactions between proteins that are labeled as locating to different 
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compartments. At this level of stringency no targets were predicted for the SH3 
domains of bem1 (d1), lsb1, nbp2 and sla1 (d2). We did not attempt to predict 
interactions for SH3 domains that could not be confidently modeled (Bud14, Cdc25, 
Fus1, Hof1, Sdc25, Sho1 and Sla1d2).  
 
 
Table 1 – Structural templates used to model the Yeast SH3 domains and quality 
assessment of those. Loop length refers to the numbers of residues in RT and n-Src 
loops, taking Abl (1ABO.PDB) SH3 domain as the reference (RT= 18 and n-Src= 6 
residues long). Most yeast aromatic and polar motifs are standard, although three of 
them deviates (underlined). For the used templates, an asterisk marks the yeast SH3 
proteins with available structure in the PDB. These structures were also used as 
templates for homology modelling, ligand docking, matrix calculation, etc. When no 
templates were available, we used chimeras (underlined), that were built using the 
templates whose pdb codes form the name of the chimera. Computed ligands were 
selected by Foldx, avoiding backbone clashes between ligand and SH3 models.  
 
Yeast SH3 Loops 
length 
RT/n-Src 
YF-X-YF 
motif 
Polar 
motif 
Templates 
/structures* 
Quality 
ABP1 18 / 5 YDY ELTF 1jo8*, 
1ov3 
***** 
*** 
BBC1 18 / 5 FPY DLNF 1fyn 
2src 
1zuk* 
1tg0* 
** 
** 
***** 
***** 
BEM1_D1 18 / 4 YSY ELSF jo8-lck 
jo8-qcf 
*** 
*** 
BEM1_D2 18 / 5 YDF ELTT 1gcq 
1sem 
** 
** 
BOI1 18 / 8 NQY ELNM 1ycs ** 
BOI2 18 / 8 NEY ELDM 1ycs ** 
BUD14 18 / 5 YAF HCQL 1cka 
1ckb 
1gcq 
1sem 
- 
- 
- 
- 
BZZ1_D1 18 / 6 YAY EITI g2b-abo 
2a28 
1zuu* 
** 
** 
***** 
BZZ_D2 18 / 6 YAY EISI g2b-abo 
1zuu 
2a28* 
* 
* 
***** 
CDC25 23 / 5 YDF LLSV kjw-fyn - 
CYK3 18 / 4 YGW DLGF 1qcf * 
FUS1 18 / 5 QDY EIRI 1ov3 
1pwt 
1shf 
1fyn 
- 
- 
- 
- 
HOF1 19 / 5 YPL LANF 1r6s - 
HSE1 18 / 5 YDL ELSF 1gcq 
1sem 
1oeb 
* 
* 
* 
LSB1 18 / 5 YDF DLSL 1cka ** 
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1ckb ** 
LSB3 18 / 7 YSF DLPF 1oot* 
ckb-oot 
2a08 
1ssh* 
***** 
**** 
**** 
***** 
MYO3 19 / 5 YDF ELPL 1va7* 
1rs6 
***** 
**** 
MYO5 19 / 5 YDF ELPL 1rs6* 
1va7 
1zuy* 
***** 
**** 
***** 
NBP2 18 / 5 YDF ELRL 1gcq 
1sem 
1yn8* 
** 
** 
***** 
PEX13 19 / 10 YDF EVAL 1jqq 
1n5z* 
**** 
***** 
PIN3 18 / 5 YQF DLGL 1cka 
1ckb 
1zx6* 
** 
** 
***** 
RVS167 18 / 7 YDY DLSF fyn-ssh 
fmk-ssh 
*** 
*** 
SDC25 18 / 5 YQY KLSL 1ov32 
1jo8 
- 
- 
SHO1 20 / 4 YPY EISF 1qkx 
1qcf 
- 
- 
SLA1_D1 18 / 6 YAY ELAI 1zuu 
2a28 
* 
* 
SLA1_D2 20 / 5 YDY ELTF 1ov3 
1jo8 
- 
- 
SLA1_D3 18 / 6 YDF ELTI 1csk 
1k9a 
uj0-csk 
1z9z* 
* 
* 
** 
***** 
YSC84 18 / 6 YNF DLAF 1csk 
1oot 
2a08* 
*** 
*** 
***** 
 
 
Table 2 – The binding matrices accurately discriminate between random and 
binding peptides. For each SH3 domains, known binding motifs derived from phage 
display data were taken from the literature [27] and the binding energy of peptides 
matching these motifs was predicted with the binding matrices. We also predicted the 
binding energy for a set of peptides that are known to bind to some SH3 domains 
according to SPOT analysis data [18]. The distribution of the binding energies of 
binding peptides or peptides matching the binding motifs was compared with the 
distribution of the binding energy of random peptides. We show here the calculated z-
scores for class I motifs, class II motifs and unusual motifs generated from phage 
display data and the z-scores for strong binding peptides from the SPOT analysis (100 
top binding peptides for each domain). Highlighted in green are z-scores equal or below 
-1.6 that correspond to a lower tail probability of p<0.05.  
 
Class 1 motif 
Class 2 
motif 
Unusual 
motif 
Best 
Motif 
Strong 
binders (in 
vitro data) 
Model 
Quality 
ABP1 
 
-2.14 
 
-2.14 -2.099 **** 
BBC1 -1.24 -1.58 
 
-1.58 
 
** 
BEM1 D1 
  
-1.25 -1.25 
 
*** 
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BOI1 -1.17 -2.35 
 
-2.35 -2.564 ** 
BZZ1 D1 -1.96 
  
-1.96 
 
 
** 
 
 
-1.74 
   
BZZ1 D2 -1.69 
  
-1.69 
 
* 
FUS1 
  
-0.19 -0.19 
 
- 
HSE1 -1.15 
  
-1.15 
 
* 
LSB1 -0.84 -2.53 
 
-2.53 
 
** 
LSB3 -0.52 -3.07 
 
-3.07 -3.017 ***** 
MYO3 -2.07 
  
-2.07 
 
***** 
MYO5 -1.62 
  
-1.62 -2.887 ***** 
NBP2 -2.21 
  
-2.21 
 
** 
PEX13 -0.76 -2.82 
 
-2.82 
 
***** 
PIN3 -0.74 -2.29 
 
-2.29 
 
 
 
** 
 
  
-1.78 
 
RVS167 -1.72 
 
-1.59  
 
-2.01 
 
-2.387 
 
*** 
 
 
-2.01 
SHO1 -0.66 
  
-0.66 -2.284 - 
SLA1 D3 -1.20 
  
-1.20 
 
* 
YSC84 -1.00 -3.53 
 
-3.53 
 
***** 
 
 
Table 3 – The binding matrices can discriminate between strong and weak binding 
peptides. We tested if our method could discriminate between strong and weak binding 
peptides according to the BLU intensity signals taken from the literature [18]. For the 
two groups of peptides the distribution of the predicted binding energies was analyzed. 
In the table are shown the z-scores and difference in binding energy, in kcal/mol, 
between the average energies of strong and weak binding peptides. The binding 
matrices attribute an average lower binding energy to the strong binding peptides when 
compared to the weak binding peptides.  
SH3 
domain 
z-score 
∆G binding 
energy 
ABP1 -1.30769 2.00005 
BOI1 -0.82424 0.93345 
LSB3 -1.8633 2.17952 
MYO5 -1.62941 2.08232 
RVS167 -0.57332 0.91603 
SHO1 -0.4417 0.42183 
 
 
 
Table 4 - Combining predicted binding energy with comparative genomics and 
secondary structure information allows for accurate prediction of target peptides 
in the proteome of S. cerevisiae. All putative target sites are predicted to be within 
unstructured regions of the proteomes and have a predicted binding energy that is at 
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least 3.3 standard deviations lower than the average binding energy of a random 
peptide. We kept only predicted binding sites that were conserved in at least 5 of the 7 
orthologs evaluated for each protein.  TP – true positives; FP – false positives. 
Selected ligands 
per domain 
Predicted 
interactions 
TP FP Accuracy Coverage 
Fold enrichment of 
positives over random 
Best 10 ligands 41 13 7 65.0 23.2 430.3 
Best 5 ligands 33 13 5 72.2 23.2 534.6 
Best 3 ligands 25 11 3 78.6 19.6 597.1 
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Table 5 - Description of yeast SH3 domains: sequence-structure characteristics, templates used for homology modelling, and computed 
and selected ligands to construct the matrices. Most aromatic and polar motifs are standard, although three of them deviates (underlined). 
Loop length refers to the numbers of residues in loops, taking Abl SH3 domain as the reference (PDB code 1ABO.PDB) with RT and n-Src loop 
of 18 and 6 residues long, respectively. Conserved triad are underlined when deviates from the standard WPY. For the used templates, an 
asterisk marks the yeast SH3 proteins with available structure in the PDB. These structures were also used as templates for homology modelling, 
ligand docking, matrix calculation, etc. When no templates were available, we used chimeras (underlined), that were built using the templates 
whose pdb codes from the name of the chimera. Computed ligands were selected by Foldx, avoiding backbone clashes between ligand and SH3 
models. All computed ligands were reconstructed with the amino acids that had lowest energy at each position, in the in-silico mutational screen, 
and reconstructed ligands were discarded when the total binding energy was not lower than -4kcal/mol or the inter-chain clashes bigger than 
10kcal/mol.  
Yeast SH3 YF-X-YF 
motif 
Polar 
motif 
Loops 
length 
RT/n-Src 
Triad 
WPY 
Used 
templates 
/structures* 
Computed ligands Selected ligands 
ABP1 YDY ELTF 18-5 WPY 1jo8* 
1ov32 
1,3,5,7,8,9,11,12,13,14,15,16,17,18,19,20,21,23,26,27,28,29 
7,9,11,12,16,18,19,20,21,23,26,27,28,29 
1jo8t 
(1,3,5,7,8,9,11,12,13,14,15,16,17,18,19,20,21,23,2
6,27,28,29) 1ov32t 
(7,9,11,12,16,18,19,20,21,23,26,28,29) 
BBC1 FPY DLNF 18-5 WPF 1fyn 
2src 
1zuk* 
1tg0* 
1,2,4,5,7,8,9,13,16,18,19,20,21,25,26,27,28,29 
1,2,4,5,7,8,9,11,12,14,15,17,19,20,23,26,27,28,29 
1,2,4,5,7,8,9,11,12,13,14,15,16,17,18,19,20,21,23,26,27 
1,2,4,5,7,8,9,11,12,13,14,15,16,17,18,19,20,21,22,23,26,27 
1fynt (1,2,4,7,8,9,13,16,18,19,21) 2srct 
(2,4,7,8,11,14,17,20,23) 
BEM1_D1 YSY ELSF 18-4 WPY jo8-lck 
jo8-qcf 
1,2,4,5,7,8,9,11,12,13,14,15,17,19,20,21,22,23,25,26,27,28,29 
1,2,4,5,7,8,9,11,12,13,14,15,16,17,18,19,20,21,23,26,27,28,29 
jo8-qcf 
(1,2,4,7,8,9,11,12,13,14,15,16,17,18,20,21,23) 
jo8-lck (2,4,7,8,9,11,12,13,14,15,17,20,21,22,23) 
BEM1_D2 YDF ELTT 18-5 WPF 1gcq 
1sem 
4,5,7,9,11,12,14,15,16,17,18,19,20,21,23,25,26,27,28,29 
1,2,7,9,11,12,14,16,17,18,19,20,21,23,26,27,28,29 
1semt (2,7,9,11,12,14,16,17,18,19,20,21,23) 1gcqt 
(4,5,7,9,11,12,14,15,16,18,19,21,23) 
BOI1 NQY ELNM 18-8 WPF 1ycs 11,12,13,21,23,26,29 1ycst (11,13,21,23,26) 
BOI2 NEY ELDM 18-8 WPF jo8-ycs 
1yc 
26 
7,9,10,11,13,21,23,26 
1ycst (9,10,11,13,21,23) 
BUD14 YAF HCQL 18-5 WPI 1cka 
1ckb 
1gcq 
1sem 
1,2,4,7,8,9,11,12,13,14,15,17,19,20,21,23,25,26,27,28,29 
1,2,4,7,8,9,11,12,13,17,19,20,21,23,26,27,28,29 
1,2,4,5,7,9,11,12,14,15,16,18,19,20,21,23,26,27,28,29 
1,2,5,7,8,9,11,12,14,16,18,19,20,21,23,26,27,28,29 
1semt (1,2,5,7,8,9,11,12,14,16,18,19,21,23) 1gcqt 
(1,2,4,5,7,9,11,12,15,16,18,19,20,21,23) 1ckbt 
(1,2,7,8,9,11,12,13,17,20,21,23) 1ckat 
(1,2,4,7,8,9,11,12,13,14,15,17,19,20,21,23) 
BZZ1_D1 YAY EITI 18-6 WPY g2b-abo 
2a28 
1zuu* 
1,2,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,23,26,27,28,29 
1,2,4,5,7,8,9,11,12,13,14,15,16,17,18,19,20,21,23,26,27,29 
1,2,4,8,9,11,12,16,18,20,23,26 
g2b-abo 
(1,2,4,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21
,23,26,27) 2a28t 
(1,2,4,5,7,8,9,11,12,13,14,15,16,17,18,19,20,21,23
,26,27) 
BZZ1_D2 YAY EISI 18-6 WPY g2b-abo 1,2,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,23,26,27,28,29 1zuut (2,4,8,9,11,12,16,17,18,19,20,23) g2b-abo 
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1zuu 
2a28* 
1,2,4,8,9,11,12,16,17,18,19,20,23,26,29 
1,2,3,4,5,7,8,9,11,12,13,14,15,16,17,18,19,20,21,22,23,26,27 
(1,2,5,6,7,8,9,10,11,13,14,15,16,17,18,19,21,23,26
,27) 
CDC25 YDF LLSV 23-5 WPF kjw-fyn 1,2,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,23,25,26,27,28,29 kjw-fyn 
(1,2,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,
21,23,25,26,27) 
CYK3 YGW DLGF 18-4 WPF 1qcf 1,2,4,5,7,8,9,11,12,13,14,15,16,17,18,19,20,21,23,26,27,28,29 1qcft (1,2,5,7,8,9,11,12,14,15,18,19,20,23) 
FUS1 QDY EIRI 18-5 WPC 1ov32 
1pwt 
1shf 
1fyn 
1,2,4,7,8,9,11,12,13,14,15,17,20,21,23,25,26,27,28,29 
1,2,4,5,7,8,9,11,12,13,14,15,16,17,18,19,20,21,22,23,25,26,27,28,29 
1,2,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,23,26,29 
1,2,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,23,25,26,27,28,29 
1fyn 
(1,2,4,5,6,7,8,9,10,12,13,14,15,16,17,18,19,20,21,
23,25,26,27) 1shf 
(1,2,4,5,6,7,8,9,10,12,13,14,15,16,17,18,21,23,26) 
1pwtt 
(1,2,4,5,7,8,9,11,12,13,14,15,17,18,19,21,22,23) 
1ov32t (1,2,4,7,8,9,11,12,13,14,15,17,20,21,23) 
HOF1 YPL LANF 19-5 WPF 1r6s ¿?  
HSE1 YDL ELSF 18-5 WPY 1gcq 
1sem 
1oeb 
5,7,9,11,12,14,15,17,18,19,20,21,23,26,27,28,29 
1,2,4,5,7,9,11,12,14,15,16,17,18,19,20,21,23,26,27,28,29 
1,2,4,5,7,8,9,11,12,13,14,15,16,17,18,19,20,21,22,23,25,26,27,28,29 
1semt (1,5,7,9,11,12,14,15,16,17,18,19,20,21,23) 
1oeb 
(1,2,4,5,7,8,9,11,12,13,14,15,16,17,18,19,21,22,23
,25,26,27) 1gcqt (5,7,11,12,14,15,17,19,20,21,23) 
LSB1 YDF DLSL 18-5 WPY 1cka 
1ckb 
1,2,4,7,8,9,11,12,13,14,15,17,19,20,21,23,25,26,27,28,29 
1,2,4,7,8,9,11,12,13,14,15,17,19,20,21,23,26,27,28,29 
1ckbt (2,4,7,8,9,11,12,13,14,15,17,19,20,21,23) 
1ckat (2,4,7,8,9,11,12,13,14,17,19,20,21,23) 
LSB3 YSF DLPF 18-7 WPY 1oot* 
ckb-oot 
2a08 
1ssh* 
1,2,5,9,11,12,13,14,15,16,17,18,19,20,21,22,23,26,27,28,29 
1,2,5,9,11,12,13,14,15,16,17,18,19,20,21,22,23 
1,2,4,5,7,8,9,10,11,12,13,14,15,16,17,19,20,21,23,26,27,28,29 
1,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,25,26,27 
2a08t 
(1,2,4,5,7,8,9,10,11,12,13,14,15,16,17,21,23,26,27
) 1oott 
(1,2,5,9,11,12,13,14,15,16,17,18,19,20,21,22,23) 
ckb-oot (2,5,9,11,12,13,14,15,16,17,18,19,20,21) 
MYO3 YDF ELPL 19-5 WPY 1va7* 
1rs6 
1ruw*(?) 
1,2,4,11,12,13,17,19,20,21,23, 26,27,29 
1,2,3,4,11,12,13,17,19,20,21,23,26,27,29 
1va7t (1,2,3,4,11,12,13,17,19,20,21,23) 1r6st 
(1,2,4,11,12,13,17,20,21,23) 
MYO5 YDF ELPL 19-5 WPY 1rs6* 
1va7 
1zuy* 
1,2,4,11,12,13,17,19,20,21,23, 26,27,29 
1,2,4,11,12,13,17,19,20,21,23, 26,27,29 
1,2,4,5,8,9,11,12,13,16,17,19,20,21,23,26,27 
1va7t (1,2,4,11,12,13,17,19,20,21,23) 1r6st 
(1,2,4,11,12,13,17,19,20,21,23) 
NBP2 YDF ELRL 18-5 WPF 1gcq 
1sem 
1yn8* 
1,2,5,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,25,26,27,28,29 
1,2,4,5,7,8,9,10,11,12,13,14,16,18,19,20,21,23,25,26,27,28,29 
7,8,9,11,12,13,14,15,16,17,18,19,20,21,23,26 
1semt 
(1,2,4,5,7,8,9,10,11,12,13,14,16,18,19,20,21,23) 
1gcqt 
(1,2,5,7,8,9,10,11,12,13,14,15,16,17,18,21,22,23) 
PEX13 YDF EVAL 19-10 WPY 1jqq 
1n5z* 
7,8,9,11,12,13,14,15,16,17,18,19,20,21,23,26,27,28,29 
7,8,9,11,12,13,14,15,16,17,18,19,20,21,23,25,26,28,29 + 
1b,1c,1d,2b,4b 
1jqqt (7,8,9,11,12,13,14,15,16,18,19,20,21,23) 
1n5zt 
(1c,1b,2b,4b,7,8,9,11,12,13,14,15,16,17,18,20,21,
23) 
PIN3 YQF DLGL 18-5 WPY 1cka 
1ckb 
1zx6* 
1,2,4,7,8,9,11,12,13,14,15,17,19,20,21,23,25,26,28,29 
1,2,4,7,8,9,11,12,13,14,15,17,19,20,21,23,26,27,28,29 
1,2,5,7,9,11,12,14,15,16,17,18,19,20,21,22,23,26,27 
1ckbt (1,2,4,7,8,11,12,13,14,17,19,21,23) 1ckat 
(1,2,4,7,8,9,11,12,13,14,15,17,19,20,21,23) 
RVS167 YDY DLSF 18-7 WPY fyn-ssh 1,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,25,26,27,28,29 fyn-ssh 
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fmk-ssh 1,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,25,26,27,28,29 (1,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,2
2,23,25,26,27) fmk-ssh 
(1,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,2
2,23,25,26,27) 
SDC25 YQY KLSL 18-5 WPF 1ov32 
1jo8 
1,5,7,8,9,11,12,13,14,15,19,20,21,23,25,26,27,28,29 
1,5,14,15,16,17,18,19,20,25,28 
1jo8t (1,5,14,15,16,17,18,19,25) 1ov32t 
(1,5,7,8,9,11,12,13,14,15,19,20,21,23) 
SHO1 YPY EISF 20-4 WPY 1qkx 
1qcf 
1,7,8,9,11,12,13,14,15,17,19,20,21,22,23,26,27,28,29 
1,7,8,9,12,13,23,26,27 
1qkxt (7,8,9,11,12,13,14,19,20,21,22,23) 1qcf 
(1,7,8,12,13,23) 
SLA1_D1 YAY ELAI 18-6 WPY 1zuu 
2a28 
2,4,16,18,23 
2,4,12,14,15,16,17,18,19,20,21,23 
1zuut (2,4,16,18,23) 2a28t 
(2,4,12,14,15,16,17,18,19,20,21) 
SLA1_D2 YDY ELTF 20-5 WPY 1ov33 
1jo8 
1,2,4,5,9,11,12,13,15,16,17,18,20,21,23,26,27,29 
1,5,7,9,11,12,14,15,16,17,18,20,21,23,26,27,28,29 
1jo8 
(1,5,7,9,11,12,14,15,16,17,18,19,20,21,23,26,27) 
1ov33t (1,2,4,5,9,11,12,13,15,16,17,18,21,23) 
SLA1_D3 YDF ELTI 18-6 WPF 1csk 
1k9a 
uj0-csk 
1z9z* 
1,2,4,5,12,15,16,17,18,19,20,21,23,26,27,29 
2,4,9,11,12,15,16,17,18,19,20,21,23,26,27,29 
1,2,4,5,12,15,16,17,18,19,20,21,23,26,27,29 
1,2,4,5,7,8,9,11,12,14,15,16,17,18,19,20,21,23,26,27 
uj0-csk (1,2,4,5,15,16,17,18,19,20,21,23,26,27) 
1cskt (1,2,4,5,12,15,16,17,18,19,20,21,23,26,27) 
1ka9t (2,4,9,11,12,15,16,17,18,20,21,23,26,27) 
YSC84 YNF DLAF 18-6 WPY 1cs 
1oot 
2a08* 
12,16,17,18,19,20,21,23,26,27,29 
11,12,13,14,15,16,17,18,19,20,21,22,23,26,27,28,29 
1,2,4,5,7,8,9,11,12,13,14,15,17,19,20,21,23,26,27 
1oott 
(1,2,4,5,9,11,12,13,14,15,16,17,18,19,20,21,23) 
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4.1 – Abstract  
Phosphorylation is a ubiquitous post-translational modification that regulates 
many biological processes by controlling the formation of protein complexes. Here, we 
developed a method to predict interactions between SH2-mediated protein-protein 
interactions using the structure of an SH2-phosphopeptide complex and the FoldX 
algorithm. We calibrated FoldX using the effects of dephosphorylation on the stability 
of protein-phosphopeptide complexes and validated it by reproducing the effects of 
mutations in the environment of the phosphate group on the binding affinity. We use 
FoldX to compute the in vitro binding specificity of eight human SH2 domains. Our 
calculations are in agreement with consensus target sequences derived from peptide 
libraries and perform better than they in the prediction of in vitro SH2-phosphopeptide 
binding and in vivo SH2-mediated protein-protein interactions. FoldX can also locate the 
SH2 binding site for a known interaction with high confidence. We filter our predictions 
using information on secondary structure, phosphorylation state and conservation, in 
order to obtain a high confidence SH2 interaction network. We validated this network 
using information on co-expression, conservation of the interaction in other species, 
shared interaction partners and shared GO functions, integrated using a naïve Bayesian 
network. This supporting information provides a resource to anyone interested in 
exploring our predictions experimentally.  
Chapter 4 
  
 
  69 
 
4.2 – Introduction  
 
The cell's ability to respond to internal and external cues depends largely on 
reversible post-translational modifications of proteins, such as phosphorylation, 
ubiquitylation, methylation or acetylation. These modifications often occur on short 
unstructured stretches of proteins and are read by domains that recognize the modified 
form [65]. A prominent group of these interactions are mediated by phosphorylation of a 
serine, theronine or tyrosine residue in the linear motif. Binding of tyrosine-
phosphorylated motifs by SH2 domains plays an important role in signalling cascades 
[61]. However, our experimental knowledge of in vivo SH2-mediated interactions most 
likely covers only a small fraction of the full interaction network. A common way to 
predict new SH2-mediated interactions is to determine the in vitro binding specificity or 
the consensus target sequence of a given domain using peptide libraries [26, 74]. 
However useful, this approach is time-consuming and its application in a genome-wide 
basis seems impractical given the large number of human SH2-domains and the limited 
complexity of the peptide libraries available. Pairs of proteins of the same families tend 
to interact through complexes of similar structure, opening the door to homology-based 
modelling of protein interactions and binding specificity [45, 49]. Current computational 
methods for the prediction of SH2 domain specificity do not reach the necessary 
accuracy [132], use computer-expensive molecular dynamics simulations [133-135] or 
require additional information from experiments [136]. These limitations encouraged us 
to develop a new structure-based method to predict the specificity of SH2 domains. 
Our group has developed FoldX, an empirical force field for the prediction of 
protein energetics [52]. It can give accurate predictions for changes in protein stability 
upon mutation [52], water and metal binding [137] and interactions between globular 
domains [51]. The algorithm is fast enough to be used in genome-wide predictions and 
the modularity of its energy function makes the implementation of new capabilities 
straightforward. FoldX is available online at http://foldx.embl.de. We have implemented 
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protein phosphorylation into FoldX and used it to predict the binding specificity of eight 
human SH2 domains with known structure. Our calculations can reproduce 
experimental consensus target sequences and perform as well as they in the prediction of 
in vitro SH2-phosphopeptide binding. FoldX overperforms experimental consensus 
target sequences in the prediction of in vivo SH2-mediated protein-protein interactions. 
Together with information on secondary structure, phosphorylation state and 
conservation, FoldX can give accurate predictions of novel protein-protein interactions 
and identify the SH2 binding site for an already known interaction. Lastly, we predicted 
a high confidence SH2 interaction network and validated it using information on co-
expression, conservation of the interaction in other species, shared interaction partners 
and shared GO functions, integrated using a naïve Bayesian network. This supporting 
information provides a resource for future exploration of these putative interactions. 
 
4.3 – Results and discussion  
4.3.1 – Implementation of phosphorylated residues into FoldX  
We have implemented phosphorylation of tyrosine, serine and threonine residues 
into FoldX [52, 137]. Proteins are represented in FoldX as collections of residues and 
atoms with certain properties. The atomic and residue parameters in the original version 
of FoldX were calibrated using a large dataset of point mutations for which the change 
in stability was available from experiments [52, 137]. Unfortunately, no such large 
dataset is available for phosphorylated residues. We have chosen to combine available 
experimental information, empirical estimates and educated guesses in the 
parameterization of phosphorylated residues.  
The main chain entropy and the properties of atoms not belonging to the 
phosphate moiety in pSer, pThr and pTyr were set to the corresponding values of serine, 
threonine and tyrosine. Similarly, the parameters of atoms belonging to the phosphate 
moiety were set to be the same for pSer, pThr and pTyr. Side chain entropy values were 
calculated by adding R·ln(6) to the values for the unphosphorylated residues, where six 
is the additional number of states for the phosphate group [52, 138]. Atom radii and 
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volumes come, as previously, from crystal structures of small compounds and the 
Voronoi analysis of structures of protein-nucleic acid complexes [139]. Van der Waals 
energies in FoldX were derived from vapor-hexane-water transfer energies of 
aminoacids and shown to correlate well with atomic volume [52]. Since there are no 
data on vapor-hexane-water transfer energies for a phosphate group, we used the fitted 
value of -0.082 kcal/mol·Å3 [52].  
Atom charges in FoldX aim at reproducing the average behavior of residues 
under near-neutral, physiological, pH conditions. The pK-values for the phosphate 
hydrogens in pSer, pThr and pTyr are at around 2 and 5.9 [140]. The pK-value for the 
second ionization can be significantly lower when interactions with other molecules are 
present [141]. Therefore, around neutral pH the charge of the phosphate group should be 
close to -2. We chose a charge of -0.60 for the oxygen atom in the phosphate group. 
This corresponds to a total charge for the phosphate moiety of -1.80, in agreement with 
experiments and with previous theoretical estimates [134]. The average value of the 
solvation energy per unit of charge for charged atoms of Asp, Glu, Lys and Arg residues 
in FoldX  is 3.33 kcal/mol per unit of charge [52]. We used this value to estimate a 
solvation energy of 2 kcal/mol per oxygen atom.   
 
4.3.2 – Validation of phosphate group energetics  
We have validated our implementation of phosphorylated residues in FoldX in 
two ways. First, we predicted the change in the free energy of binding of 
phosphopeptides to proteins upon dephosphorylation. We extracted from the ADAN 
database (http://adan.embl.de, supplementary table 1) the data for nineteen complexes 
[142-153]. Nine of the complexes do not form at all or are severely destabilized (>5 
kcal/mol) if the peptide is not phosphorylated. The average predicted change in free 
energy for these complexes is 6.8±2.5 kcal/mol. For the other ten complexes, the 
average experimental change in the free energy of binding is 0.97±0.61 kcal/mol. The 
average predicted change in free energy for these complexes is 1.7±1.5 kcal/mol. Thus, 
FoldX can predict whether a protein-phosphopeptide complex will be disrupted or not 
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by dephosphorylation.  
Second, we have predicted the changes in the free energy of formation of 
protein-phosphopeptide complexes upon mutation of protein residues close to a 
phosphorylated residue. We extracted from the ADAN database (http://adan.embl.de, 
supplementary table 2) the data for twenty-one complexes [72, 146, 154-157]. The 
experimental changes in the free energy of binding range from -1.13 to 3.44 kcal/mol. 
Figure 1 shows the correlation between the experimental and calculated changes in free 
energy of binding upon mutation. A linear fit of the data gives a correlation R-value of 
0.72, a slope of 0.91 and a standard deviation of 0.95 kcal/mol. The quality of the 
predictions is comparable to that of changes in protein stability upon mutation [52], 
confirming that FoldX can be used to predict the energetics of phosphorylated residues.  
 
4.3.3 – FoldX predictions reproduce experimental consensus target sequences  
We have used the eight human SH2-phosphopeptide complexes of known three-
dimensional structure (table 1) to test the ability of FoldX to predict the binding 
specificity of phosphopeptide-binding domains. The binding specificity of SH2 domains 
is commonly determined using peptide libraries. In these in vitro experiments, an SH2 
domain is exposed to a synthetic phosphopeptide library in which several positions have 
been randomized. The pool of bound peptides is sequenced and the preferred residues at 
each randomized position are identified [74]. A consensus target sequence can be 
extracted by listing the preferred residues for all randomized positions. The consensus 
sequence patterns for seven of the eight SH2 domains considered here have been 
determined experimentally [74, 158-161] and are shown in table 1. All seven consensus 
peptides have been shown to bind the corresponding SH2 domain [74, 158-161], which 
strongly suggests that most sequences matching a consensus will bind the corresponding 
SH2 domain. On the other hand, the comparison of the experimental consensus 
sequence patterns and the crystallized sequences (table 1) clearly shows that there are 
sequences that do not match the consensus and yet bind the target SH2 domain. This is 
in agreement with the very heterogeneous pool of bound peptides found in most library 
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experiments with SH2 domains [74, 158-161].  
We have predicted the sequence specificity of all SH2 domains in table 1 and 
compared it with the experimental consensus target sequences. We have used scoring 
matrices calculated with FoldX to compute the binding energy of 50000 random 
sequences and 50000 sequences matching the experimental consensus (see methods). 
The average binding free energies for both classes of peptides and z-scores describing 
the separation between the averages are shown in table 1. In all cases, peptides matching 
the consensus pattern are predicted to bind better than peptides of random sequence. In 4 
out of the 7 there is a very good separation between the two populations with less than 
0.05 chance that a random peptide will score predicted binding energy lower than 
random. This indicates that the predictions from FoldX are in agreement with the 
experimental binding patterns of these seven SH2 domains.  
A variable fraction of random peptides is predicted to bind better than the 
average of peptides matching the consensus (table 1). These predictions may be due to 
the consensus target sequences not covering all possible binding sequences, to the 
crystallized sequence being a bad template for sequences matching the consensus or to 
modeling errors.  
 
4.3.4 – FoldX prediction of in vitro SH2 domain-phosphopeptide interactions  
In order to make a more direct comparison between experimental SH2 domain 
binding specificity and FoldX predictions, we have used the experimental binding 
affinities of SH2 domains with non-randomized peptides. MacBeath and coworkers used 
protein microarrays and fluorescent peptides to measure the binding constants of the 
eight SH2 domains in table 1 with 33 phosphopeptides [17]. Of the 264 putative protein-
phosphopeptide complexes, 31 showed a measurable affinity. We took these as positives 
and the other 233 as negatives. We have used the full optimization method (see 
methods) to compute the binding energy of each of the 264 putative complexes using 
FoldX. The binding energy of each putative complex was then compared to the binding 
energy of the crystallized sequence. Complexes having a binding energy better than the 
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reference plus a given amount of kcal/mol were considered as positives, and all other as 
negatives. This procedure allows us to use the information given by FoldX in a stringent 
manner, if candidates must have better energies than the crystal to be considered 
positives, or a permissive manner, if candidates with worse energies than the crystal can 
still be positive.  
The results are shown in figure 2A. For a very permissive cutoff (complex 
positive if binding energy is lower than the reference plus 6 kcal/mol), the coverage is 
90 % and the accuracy only 15 %. As the free energy threshold is made more stringent, 
towards the right part of the plot (in 1 kcal/mol steps), the coverage of the method 
decreases and the accuracy increases. If the free energy of the crystallized sequence is 
used as a cutoff, the coverage is 40 % and the accuracy 50 %. More stringent energy 
cutoffs decrease the coverage without increasing the accuracy. We have made a direct 
comparison of the performance of FoldX and experimental consensus target sequences 
in the detection of protein-phosphopeptide complexes for the seven domains for which a 
consensus sequence is available (Figure 2B). FoldX predictions were done as in figure 
2A. Predictions using experimental target sequences allowed zero (stringent setup, high 
accuracy point) and one mismatch (permissive setup, low accuracy point) with the 
consensus sequence. FoldX performs slightly better than experimental consensus 
sequences at both permissive and stringent setups. It may be argued that the extraction 
of a consensus target sequence discards part of the information obtained from a 
randomized peptide library. This information can be used by converting the data into a 
position-specific scoring matrix [162]. We tested this approach with the four available 
scoring matrices for human SH2 domains included in Scansite [162] (Grb2, P56-lck, 
PI3-kinase p85α and C-src) at both stringent and permissive setups. Figure 2C shows 
that FoldX performs as well as experimental position-specific scoring matrices. 
Altogether, we conclude that our structure-based calculations can predict in vitro 
protein-phosphopeptide binding specificity as well as experimental methods based on 
peptide libraries.  
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4.3.5 – FoldX prediction of in vivo SH2-mediated protein-protein interactions 
We showed so far that FoldX can give good predictions for which 
phosphopeptides will bind to an SH2 domain in vitro. Next, we used FoldX for the 
prediction of binding in vivo. We compiled a list of SH2-mediated protein-protein 
interactions in the following way: First, we extracted from the Human Protein Reference 
database[163] all interactions for the proteins containing the SH2 domains in table 1. 
We then hand curated the database to keep only interactions known to be mediated by 
the SH2 domains. The final list contains 85 interactions for the 7 proteins (see 
supplementary table 3). We have used these interactions as a positive set to compare the 
ability of FoldX and experimental consensus target sequences to identify these SH2-
mediated interactions in our list among all potential binding sites. We have used scoring 
matrices calculated with FoldX to compute the binding energy of each of the 443816 
(55477 tyrosines in the human genomes times 8 SH2 domains) putative complexes (see 
methods). Complexes having a binding energy lower than the average binding energy in 
the genome minus 1 (permissive setup) to 4 (restrictive setup) kcal/mol were taken as 
positives. As before, predictions using experimental target sequences allowed zero 
(stringent setup, high accuracy point) and one mismatch (permissive setup, low accuracy 
point) with the consensus sequence. Since there is no experimental information about 
which proteins do not interact via an SH2 domain and little information on the 
localization of human proteins (when compared to S. cerevisiae), we did not try to use a 
negative dataset to measure the accuracy of the predictions.  Instead of accuracy we 
calculate the fold enrichment of positive interactions when compared to random.  
The results of the predictions are shown in figure 3. The fold improvement 
values are low for both methods in all setups. In addition to errors in the predictions, 
there are two plausible causes for this low performance. First, the known in vivo protein-
protein interactions are most likely a small subset of the total. Second, high affinity 
between an SH2 domain and its binding site may not be sufficient to mediate binding in 
vivo due to co-expression, co-localization, phosphorylation and binding site availability 
requirements. The enrichment of positives of the FoldX predictions increases and the 
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coverage decreases as the energy and conservation cutoffs become more restrictive until 
a plateau is reached. More stringent setups decrease the coverage without increasing the 
enrichment in positive interactions. FoldX performs better than experimental consensus 
sequences with all setups in the prediction of SH2-mediated in vivo interactions.  
 
4.3.6 – Combining FoldX with information on phosphorylation state, secondary 
structure and conservation  
The final goal of our work is to make useful predictions of SH2-mediated 
protein-protein interactions. In order to increase the accuracy of the predictions from 
FoldX, we have filtered them using two kinds of empirical information. The first 
empirical filter is the conservation of the prediction, which was previously shown to 
improve the prediction of SH3-mediated interactions [131]. We have chosen a group of 
9 genomes of varying divergence from human (see methods). The points along each line 
in figure 4 are the results of the prediction using FoldX (energy cutoff is the average 
binding energy of a tyrosine in the human proteome minus 2 kcal/mol) and conservation 
of the prediction in 0 to 4 genomes. The conservation filter improves the positive 
enrichment of the predictions up to 1.4-fold. The second empirical filter is the 
phosphorylation and secondary structure state of the putative binding site. We required 
that a site is a known phosphorylation site [163-165] or is predicted by the disphos 
algorithm [166] to be phosphorylated and within a disordered region. The different lines 
in figure 4 correspond to predictions without secondary structure and phosphorylation 
information and predictions using cutoffs of 0.5 (permissive setup) to 1.0 (restrictive 
setup) for the disphos algorithm. The phosphorylation filter improves the positive 
enrichment of the predictions 32-fold. These results support the view that SH2 target 
sites are not only phosphorylated, but also within disordered regions of proteins[166]. 
Combination of the conservation and phosphorylation/secondary structure improves the 
enrichment of positives in the predictions 36-fold, supporting the combined use of the 
filters. The final predictions using both empirical filters are 56-fold better than random. 
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4.3.7 – FoldX prediction of in vivo SH2 binding sites 
Most experimental methods used to identify in vivo protein-protein interactions 
report the identities of the interacting proteins, but not the exact binding site. We have 
tested the ability of our prediction method to identify which tyrosine of the target protein 
is bound by the SH2 domain. First, we have taken the list of 85 interactions mediated by 
the SH2 domains in table 1 and searched in the literature for mapped binding sites. We 
found 35 experimentally verified in vivo binding sites in 27 target proteins (table S3). 
These proteins contain a total of 696 tyrosines, giving a 0.05 chance of correctly 
predicting a binding site by random choice. Information on secondary structure and 
phosphorylation state improves the prediction accuracy about 4-fold (lower-left point in 
figure 5). We have calculated the binding energy for all putative binding sites using 
FoldX (see above). Sites having a binding energy lower than the average binding energy 
in the genome minus 0 (permissive setup) to 4 (restrictive setup) kcal/mol were taken as 
positives. This procedure improves the accuracy of the predictions up to 3-fold (13-fold 
better than random), while keeping a reasonable coverage (figure 5). We conclude that 
our predictions can be used as a guide to identify SH2 binding sites in a target protein. 
 
4.3.8 – High-confidence predictions of SH2-mediated protein-protein interactions 
We have obtained a short list of highly accurate predicted interactions by 
running our method with the conservation and secondary structure/phosphorylation 
filters and selecting for each domain the ten targets with the lowest predicted binding 
energy (see figure 6, supplementary table 4 and methods). 16 of the 70 predicted 
interactions are known physical interactions (for the full proteins) included in the 
HPRD[163], representing an ~228 fold improvement over random (assuming a 
probability of ~0.001 that two random proteins interact as observed in HPRD). We 
assessed the quality of the predictions by integrating available information regarding co-
expression, number of shared interactions, shared GO-functions and conservation of the 
interaction at physical or genetic level in different species into a single likelihood score 
using a Naïve Bayesian approach (see methods). The width of a line in figure 6 is 
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proportional to the likelihood score, were thicker lines represent more reliable 
predictions. From the 70 predicted interactions, 28 (40%) have more than 50% odds of 
being a true in vivo interaction in the face of this additional evidence. We compared the 
predicted SH2 network with the network obtained in two recent yeast-two-hybrid 
interaction screens[5, 6]. Using the same scoring method, we found 5% of interactions 
with higher than 50% odds of being a true in vivo interaction in the combined yeast-
two-hybrid network. We should note that there is likely an experimental bias in current 
knowledge towards our set of SH2 domains, when compared to the proteins assayed in 
the yeast-two-hybrid studies. It is nevertheless clear that our predictions are enriched for 
interactions strongly supported by experimental evidence. It is important to state that the 
quality of the predictions does not appear to be homogeneous, with some domains faring 
better than others.  In particular we could not find supporting information for any of the 
predictions for the SH21A SH2 domain. This could be due the lack of information 
available for this protein and/or the poor performance of FoldX (table 1) for its 
unconventional mode of binding[156]. 
 
4.3.9 – Comparison with current structure-based prediction methods for 
phosphopeptide-mediated protein-protein interactions 
Several groups have developed structure-based methods to predict the in vitro 
binding specificity of SH2 domains [132, 133, 135]. Henriques and coworkers tested 
several solvent-accessible surface area-based energy functions for binding of 6 
phosphopeptides to the src SH2 domain, finding a poor correlation between their 
calculations and experiment [132]. Later algorithms using molecular dynamics [135] 
and comparative molecular field analysis [133]showed a good predictive power. Both 
studies focused on a small number of complexes (9 and 30, respectively) and on a single 
SH2 domain. The portability of these methods to other SH2 domains remains to be 
shown. Here, we have shown that FoldX can predict the in vitro binding 
thermodynamics of 264 protein-phosphopeptide complexes, including seven different 
SH2 domains, showing its applicability for genome-wide predictions. 
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The structure-based prediction of SH2-mediated in vivo protein-protein 
interactions has been attempted only once. McLaughlin and coworkers predicted the 
binding specificity of the Grb2 and SAP SH2 domains by combining information on 
known binding peptides plus structure-based predictions[136]. The resulting hidden 
Markov models gave predictions enriched in known in vivo interactions and binding 
sites [136]. The main advantage of our approach is that we derived the binding 
specificity using only structure-based calculations. Thus, our method is applicable to 
domains for which no binding experiments are available. We also benefit from the use 
of extra information on phosphorylation, conservation and secondary structure, which is 
readily calculated from sequence. 
 
4.4 – Conclusions and outlook  
We have successfully implemented phosphorylation into FoldX. The upgraded 
version of the software can use the structure of a protein-phosphopeptide complex to 
predict the in vitro binding specificity of an SH2 domain and the effect of 
dephosphorylation and of mutations in the environment of the peptide group. If an in 
vivo interaction between an SH2 domain and a protein has been experimentally 
determined, FoldX can be used to predict the most likely binding site or sites within the 
target protein. We have used FoldX to predict in vivo protein-protein interactions for 
seven SH2 domain-containing proteins and annotated the predicted interactions with 
supporting information, providing a resource for further experimental testing. 
Together with the prediction of binding specificity for different families of 
peptide binding domains and enzymes, we propose that FoldX can be used for the large 
scale prediction and study of protein-protein interaction networks and signaling 
cascades[167]. This method also opens the door for the design of drugs or mutant alleles 
that disrupt an interaction without affecting other functions of the protein. 
Our approach is limited by the small number of known structures of protein-
phosphopeptide complexes. Nevertheless, given the structure of an SH2 domain in 
isolation, the location of the phosphopeptide binding site and the structure of a given 
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SH2-phosphopeptide complex can be predicted computationally [134, 168, 169]. This, 
together with available methods for homology modelling of globular domains, may 
widen the applicability of FoldX considerably in the near future. 
 
 
4.5 – Methods  
4.5.1 – Calculation of binding energies  
The free energy for formation of protein-phosphopeptide complexes was 
calculated as the sum of the free energy of interaction between the protein and the 
phosphopeptide in the complex and the free energy for folding of the phosphopeptide. In 
the case of the full modelling method, the geometry of the complex was optimized for 
all modelled sequences before calculation of the binding energy. In the case of the 
matrix method, only the wild-type complex was optimized. After this, we mutated all 
positions in the phosphopeptide to alanine, and then we introduced all 20 residues at 
each phosphopeptide position. The binding energy for each residue at each position 
relative to alanine is stored in a scoring matrix. The binding energy of a given sequence 
was calculated by summing over all positions of the matrix, which are taken to be 
independent.  
The energy calculations and mutagenesis were done as previously documented (see 
Methods for chapter 3). For phosphorylated amino-acids, due to the few number of 
existing crystal structures, we assume that the sidechain dihedral angles were following 
the same distribution as their non-phosphorylated counterparts. The dihedral angles 
defined by the phosphate moiety were considered equiprobable. 
 
4.5.2 – Conservation and phosphorylation filters 
We have previously shown that it is possible to improve the prediction of 
protein-interactions by combining the in vitro binding specificity encoded in the form of 
linear motifs with additional information like conservation and secondary structure 
[131]. In this study we looked for the conservation of a putative binding site within a 
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human protein in predicted orthologs in 9 other species (Anopheles gambiae, Apis 
mellifera, Caenorhabditis elegans, Canis familiaris, Danio rerio, Fugu rubripes, Gallus 
gallus, Mus musculus and Pan troglodytes). These genomes were selected on basis of 
their availability and to cover a broad evolutionary time scale of divergence from 
human. The ortholog assignments were taken from the Inparanoid database [170]. We 
considered that a putative binding site was conserved in another species when the 
orthologous protein also contained a predicted binding site. 
Given that SH2 domains are known to bind to phosphorylated peptides we 
compiled information on known phosphorylated tyrosines in the human proteome from 
the Human Protein Reference Database, Phosida and Phospho.ELM [163-165]. To these 
experimentally determined phosphorylation sites we added phospho-tyrosines predicted 
using the disPhos algorithm[166]. 
 
4.5.3 – High-confidence SH2-mediated network  
For the 7 human SH2 domains with available complex structure we used FoldX 
to predict the 10 most likely targets in the human proteome that were conserved in at 
least 3 of the 9 genomes studied. We considered only tyrosines that have be shown to be 
phosphorylated experimentally or were predicted by disPhos (with a disPhos threshold 
of 1) to be phosphorylated. We considered that a putative site was conserved in one of 
the other species when the ortholog protein contained a putative target site with 
predicted energy below the average for a random peptide minus 2kal/mol. 
 
4.5.4 – Naïve Bayes predictor  
We have used a Naïve Bayes predictor previously described in Kiel et al (in 
preparation) and similar to the developed by Rhodes and colleagues [58] to integrate the 
different available supporting information into likelihood for the interactions of two 
proteins. Briefly, we have considered a group of 8235 in vivo protein interactions, found in 
the Human Protein Reference Database [163] (downloaded on 27/02/2006), as our positive 
standard. We considered that a protein defined in GO as belonging to the plasma membrane 
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is less likely to interact with proteins in the nucleus and defined a negative set from pairs of 
such proteins (2663352 negative interactions).  
Using the positive and negative dataset we determined for each evidence type (co-
expression, conservations of interaction, shared interacting partners and shared GO 
functions) how it impacts on the odds that a pair of proteins interact. Defining the prior odds 
(Oprior) as the odds that two random proteins interact, the posterior odds (Oposterior) are the 
odds that two proteins interact given new predictive evidences. The posterior odds can be 
calculated as:  
Oposterior = Oprior * L(f1…fn)  
Where L(f1…fn) is the likelihood ratio given by:  
L = P(f1…fn | pos) / P(f1…fn | neg)  
Where fi is the evidence found for a protein interaction in dataset i.  
Assuming that the datasets are conditionally independent L can be calculated as the product 
of individual likelihood ratios:  
LR = LRint_transfer × LRco-exp × LRGO × LRshared_int  
Where LRint_transfer is the likelihood ratio obtained from interaction transfer, LRco-exp is the 
likelihood ratio obtained from gene co-expression information, LRGO is the likelihood ratio 
obtained from Gene Ontology information and LRshared_int is the likelihood ratio obtained 
from the number of shared binding partners. The tables of likelihood ratios calculated for 
each evidence type as well as a more detailed description of the different evidences used can 
be found in Kiel et al (in preparation) and supplementary tables 5 to 9. 
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4.7 – Tables and Figures  
 
Figure 1 – Prediction of the changes in free energy for the formation of protein-
phosphopeptide complexes upon mutation of protein residues in the environment 
of the phosphate group. The fitted line has a correlation R-value of 0.72 and a slope of 
0.91.  
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Figure 2 –  Prediction of SH2 domain-phosphopeptide interactions using FoldX and 
experimental data from peptide library experiments. Coverage is the fraction of 
known positives that are detected. Accuracy is the fraction of correct positive 
predictions. (A) Predictions using FoldX and different energy cutoffs for the eight SH2 
domains in table 1. (B) Comparison between FoldX and experimental consensus target 
sequences for the seven SH2 domains in table 1 for which experimental data are 
available. Filled circles: FoldX predictions using different energy cutoffs. Empty circles: 
Predictions using consensus target sequences, allowing for zero (restrictive setup) and 
one mismatch (permissive setup). (C) Comparison between FoldX and experimental 
scoring matrices for the four domains in table 1 included in Scansite [162] (Grb2, P56-
lck, PI3-kinase p85α and C-src). Filled circles: FoldX predictions using different energy 
cutoffs. Empty circles: Predictions using Scansite and low and high stringency setups 
[162].  
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Figure 3 – Prediction of SH2-mediated protein-protein interactions using FoldX 
and experimental data from peptide library experiments. Coverage is the fraction of 
known positives that are detected. Accuracy is the fold enrichment of positives in the 
predicted sample when compared to all known protein-protein interactions. Filled 
circles: FoldX predictions using as energy cutoff the average binding energy of a 
tyrosine in the human genome minus 1 to 4 kcal/mol. Empty circles: Predictions using 
consensus target sequences, allowing for zero (restrictive setup) and one mismatch 
(permissive setup).  
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Figure 4 – Prediction of SH2-mediated protein-protein interactions using FoldX, 
conservation, secondary structure and phosphorylation information. Coverage is 
the fraction of known positives that are detected. Accuracy is the fold enrichment of 
positives in the predicted sample when compared to all known protein-protein 
interactions. All predictions use FoldX (energy cutoff is the average binding energy of a 
tyrosine in the human genome minus 2 kcal/mol) and conservation information. The 
points along each line correspond to conservation of the prediction in 0 to 4 genomes. 
The different lines correspond to prediction without secondary structure and 
phosphorylation information (triangles) and prediction using known phosphorylation 
sites and disphos with cutoffs of 0.7 (squares, permissive setup), 0.9 (inverted triangles) 
and 1.0 (diamonds, restrictive setup). The empty circle corresponds to prediction using 
the most restrictive setup, further restricted by taking for each domain only the 5 
peptides with the best predicted binding energies. 
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Figure 5 – Prediction of binding site for SH2-mediated protein-protein interactions 
using FoldX, secondary structure and phosphorylation information. Coverage is the 
fraction of known positives that are detected. Accuracy is the fold enrichment of 
positives in the predicted sample when compared to all known protein-protein 
interactions. The site with the lowest accuracy corresponds to predictions using only 
phosphorylation and secondary structure information. For the other points, a site was 
considered a positive if its binding energy was better than the binding energy of the 
crystallized sequence minus 0 (permissive setup) to 4 (restrictive setup) kcal/mol.  
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Figure 6 – High-confidence predictions of SH2-mediated protein-protein interactions.  For 7 SH2 domain containing proteins 
we used Fold-x, known and predicted phosphorylation information to predict a high confidence network of SH2 mediated 
interactions. Arrows depict the predicted interactions from SH2 containing proteins to their putative targets. Interactions confirmed 
by experimental evidence are highlighted in blue. The thickness of the line is proportional to the odds that the proteins interact in 
vivo as calculated by the Naive Bayes network. The exact odds score and the source of the supporting evidence found for each 
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particular interaction is detailed in supplementary table 4. 
Table 1 – Human SH2-phosphopeptide complexes with an available X-ray diffraction three-dimensional structure. Binding 
energies are relative to an all-alanine peptide and in kcal/mol units.  
SH2 domain Structure Crystallized sequence Consensus target sequence 
<∆Gbinding(Con
sensus)> 
<∆Gbinding(
Random)> 
P (Random 
better than 
Consensus) 
Z-score 
P56-lck 1lcj EGQpYQPQPA pYEEI [158] 0.02 ± 0.87 6.37 ± 4.80 0.038 -7.3 
PI3-kinase p85α 1h9o pYVPML pY[MLI]XM [74] -0.86 ± 0.64 3.16 ± 2.64 0.009 -6.3 
Grb2 1bmb KFPpYVNVEF pY[QY]NY [158] 1.86 ± 0.92 8.49 ± 6.00 0.041 -7.7 
C-src 1shd pYEEI pYE[ENY][IML] [74] 2.10 ± 1.38 6.53 ± 5.91 0.064 -3.2 
Syk (C-terminal) 1a81 
PDpYEPIRKGQR
D 
pY[QTE][QTE]L [161] 3.11 ± 1.48 5.12 ± 2.38 0.20 
-1.4 
Sap 1d4w SLTIpYQVQK TXpYXX[IV] [159] 3.11 ± 4.20 8.71 ± 9.11 0.34 -1.3 
Stat1 1yvl pYDKPH pYERQH [160] 0.99 1.67 ± 1.78 0.37 -0.38 
Syk (N-terminal) 1a81 DLpYSGLN - - - -  
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4.8 – Supplementary material 
Supplementary table 1 – Experimental and calculated changes in free energy for protein-phosphopeptide complex formation 
upon dephosphorylation. 
Protein Peptide Structure Resolution (Å) Mutation 
Gdephosphorylation (kcal/mol) 
Experimental Calculated 
Pin1 full length YpSPTpSPS 1f8a 1.84 pS1 → S 0.64 [142] 1.63 
Pin1 full length YpSPTpSPS 1f8a 1.84 pS2 → S 1.06 [142] 3.86 
Pin1 WW domain YpSPTpSPS 1f8a 1.84 pS1 → S 0.00 [142] 1.66 
Pin1 WW domain YpSPTpSPS 1f8a 1.84 pS2 → S 0.69 [142] 3.92 
SCFCDC4 ubiquitin ligase GLLpTPPQSG 1nex 2.70 pT → pS 1.06 [143] 2.50 
GGA3 VHS domain pSDEDLLHI 1lf8 2.30 pS → S 0.69 [144] 0.77 
GGA1 VHS domain ADDIpSLLK 1py1 2.60 pS → S 1.39 [145] -0.10 
c-src SH2 domain pYEEIE 1shd 2.00 pY → Y 5.60 [146] 7.40 
Protein tyrosine phosphatase 1B ETDpYpYR 1g1f 2.00 pY2 → Y 2.32 [153] 3.05 
GCN5 QTARKpSTGGKAPRKQLASK 1pua 2.30 pS → S 1.21 [147] 0.28 
GGA2 VHS domain DDIpSLLK 1ujk 1.90 pS → S 0.65 [145] -0.10 
Pin1 full length YpSPTpSPS 1f8a 1.84 pS1, pS2 → S NB [142] >3 
Pin1 WW domain YpSPTpSPS 1f8a 1.84 pS1, pS2 → S NB [142] >3 
SCFCDC4 ubiquitin ligase GLLpTPPQSG 1nex 2.70 pT → T NB [143] >3 
EAT-2 SH2 domain SLTIpYAQVQK 1i3z 2.15 pY → Y NB [148] >3 
DOK1 PTB domain TWIENKLpYGM 1uef 2.50 pY → Y NB [149] >3 
Protein tyrosine phosphatase 1B DADEpYL 1ptu 2.60 pY → Y NB [150] >3 
BRCA1 BRCT repeats ISRSTpSPTFNKQ 1t29 2.30 pS → S NB [151] >3 
GADS SH2 domain DDpYVNV 1r1p 1.80 pY → Y NB [152] >3 
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Supplementary table 2 – Experimental and calculated changes in free energy for protein-phosphopeptide complex formation for 
mutations in the environment of the phosphate group in protein-phosphopeptide complexes. 
Protein Peptide Structure Resolution (Å) Mutation 
Contacts with the 
phosphorylated residue 
Gdephosphorylation (kcal/mol) 
Experimental Calculated 
14-3-3 Z RLYHpSLPA 1qja 2.00 E180K Ion pair 0.92 [154] 2.55 
P56-LCK SH2/SH3 domain EGQpYQPQPA 1lck 2.50 R134K H-bond, cation-π interaction 0.43 [72] 0.25 
PLK-1 Polo-Box domain PMQSpTPL 1umw 1.90 H538A/K540M H-bond/H-bond 3.44 [155] 2.45 
SAP SH2 domain TIpYAQVQK 1d4w 1.80 R32Q Two H-bonds 1.14 [156] 2.23 
SAP SH2 domain TIpYAQVQK 1d4w 1.80 C42W H-bond 1.44 [156] 0.17 
SAP SH2 domain TIpYAQVQK 1d4w 1.80 T53I Hydrophobic contact -0.02 [156] 0.63 
Src SH2 domain PQpYEpYIPA 1nzl 1.90 R311A H-bond 0.53 [157] 0.59 
Src SH2 domain PQpYEpYIPA 1nzl 1.90 R311F H-bond 0.00 [157] 0.89 
Src SH2 domain PQpYIpYVPA 1nzv 2.10 R311A H-bond 0.90 [157] 0.37 
Src SH2 domain PQpYIpYVPA 1nzv 2.10 R311F H-bond 0.00 [157] 0.74 
Src SH2 domain PQpYEEIP 1sps 2.70 R12A H-bond 1.06 [146] 1.69 
Src SH2 domain PQpYEEIP 1sps 2.70 R32A Two H-bonds 3.20 [146] 2.87 
Src SH2 domain PQpYEEIP 1sps 2.70 S34A H-bond 0.89 [146] 1.96 
Src SH2 domain PQpYEEIP 1sps 2.70 E35A Ion pair 0.43 [146] -1.40 
Src SH2 domain PQpYEEIP 1sps 2.70 T36A H-bond 1.02 [146] 0.68 
Src SH2 domain PQpYEEIP 1sps 2.70 T37A H-bond network -0.19 [146] -0.06 
Src SH2 domain PQpYEEIP 1sps 2.70 C42A Hydrophobic contact -1.13 [146] -0.04 
Src SH2 domain PQpYEEIP 1sps 2.70 C42S Hydrophobic contact -0.79 [146] 0.22 
Src SH2 domain PQpYEEIP 1sps 2.70 S44A H-bond network 0.19 [146] 0.09 
Src SH2 domain PQpYEEIP 1sps 2.70 H58A H-bond network 0.32 [146] 1.08 
Src SH2 domain PQpYEEIP 1sps 2.70 K60A 
H-bond, hydrophobic 
contact 
1.37 [146] 1.11 
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Supplementary table 3 – Known SH2-mediated protein-protein interactions and binding 
sites in human. Experimentally determined interactions for p85 (ENSP00000274335), SYK 
(ENSP00000326032), STAT1 (ENSP00000354394), LCK (ENSP00000328213), SRC 
(ENSP00000353950) and GRB (ENSP00000339007) were taken from the Human Protein 
Reference Database (16/06/2006) and were manually curated  in order to identify only 
interactions that were mediated by an SH2 domain and whenever possible the exact binding site 
within the target protein. We kept only binding site information that we could confidently match 
to the protein sequences used. The 85 interactions found are listed below, annotated with their 
Ensembl protein IDs, experimental evidence type and pubmed ID were the evidence was found 
(as annotated in HPRD).  In the field for the evidence type, vv stands for in vivo, vt for in vitro 
and 2H for yeast-two-hybrid assays.  
Ensembl Id for SH2 
containing protein 
Ensembl ID for 
target protein 
Experimental 
Evidence 
Binding 
Site 
Pubmed 
ID 
ENSP00000274335 ENSP00000222139 vv 
 
7559499 
ENSP00000274335 ENSP00000288032 vt|2H|vv 
 
7982920 
ENSP00000274335 ENSP00000324890 vt|vv Y191 8621607 
ENSP00000274335 ENSP00000230882 vv 
 
9632636 
ENSP00000274335 ENSP00000294423 vv 
 
9774657 
ENSP00000274335 ENSP00000338934 vt|vv Y354 10377409 
ENSP00000274335 ENSP00000264818 vt|vv 
 
10995743 
ENSP00000274335 ENSP00000346578 vt|2H|vv 
Y1039, 
Y1102, 
Y1108 
10521483 
ENSP00000274335 ENSP00000262908 vt|vv Y1117 11865050 
ENSP00000274335 ENSP00000344798 vt|vv Y1062 10652352 
ENSP00000274335 ENSP00000342681 vv Y487 9079809 
ENSP00000274335 ENSP00000290277 vv 
 
11812000 
ENSP00000274335 ENSP00000303939 vt|vv Y201 7807015 
ENSP00000326032 ENSP00000354566 vt|vv Y188, Y199 7761456 
ENSP00000326032 ENSP00000278888 vt|vv 
 
8071371 
ENSP00000326032 ENSP00000222139 vt|vv 
 
9852052 
ENSP00000326032 ENSP00000221972 vt|vv 
 
7500027 
ENSP00000326032 ENSP00000085219 vt 
 
8627166 
ENSP00000326032 ENSP00000220597 vt 
 
10790433 
ENSP00000354394 ENSP00000288135 vt|vv 
 
9355737 
ENSP00000354394 ENSP00000275493 vt|vv Y978 12070153 
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ENSP00000354394 ENSP00000354394 vt Y701 9630226 
ENSP00000328213 ENSP00000301178 vv Y821 9178760 
ENSP00000328213 ENSP00000338171 vt 
 
9195899 
ENSP00000328213 ENSP00000220597 vt 
 
10790433 
ENSP00000328213 ENSP00000274335 vv 
 
7504174 
ENSP00000328213 ENSP00000263798 2H|vv 
 
10627473 
ENSP00000328213 ENSP00000342681 vt|vv 
 
7513045 
ENSP00000328213 ENSP00000271610 vt|vv 
 
8576115 
ENSP00000328213 ENSP00000292588 vt|vv 
 
8650207 
ENSP00000328213 ENSP00000265010 vt 
 
8879209 
ENSP00000328213 ENSP00000313829 vv 
 
9045636 
ENSP00000328213 ENSP00000332816 vt|vv 
 
9091579 
ENSP00000328213 ENSP00000228307 vv 
 
9488700 
ENSP00000328213 ENSP00000264972 vv Y319 10318843 
ENSP00000328213 ENSP00000305426 vt|vv 
 
10455176 
ENSP00000328213 ENSP00000226279 vt|vv 
 
10636863 
ENSP00000328213 ENSP00000276420 vt|vv 
 
10799545 
ENSP00000328213 ENSP00000345492 vv 
 
10799879 
ENSP00000328213 ENSP00000326032 vv 
 
7539035 
ENSP00000353950 ENSP00000264033 vv 
 
8635998 
ENSP00000353950 ENSP00000251849 vt 
 
7517401 
ENSP00000353950 ENSP00000332816 vt|vv Y402 8849729 
ENSP00000353950 ENSP00000351245 vt 
Y94, Y451, 
Y453 
9655255 
ENSP00000353950 ENSP00000317272 vv 
 
9837958 
ENSP00000353950 ENSP00000305426 vt|vv 
 
10455176 
ENSP00000353950 ENSP00000330608 vt|vv 
 
11483589 
ENSP00000353950 ENSP00000301178 vv Y821 9178760 
ENSP00000353950 ENSP00000344798 vv 
 
10070972 
ENSP00000353950 ENSP00000306124 vt 
 
11834516 
ENSP00000353950 ENSP00000338171 vt 
 
9195899 
ENSP00000339007 ENSP00000275493 vt|vv 
 
1322798 
ENSP00000339007 ENSP00000212292 vv 
 
7500025 
ENSP00000339007 ENSP00000346032 vt 
 
7510700 
ENSP00000339007 ENSP00000330608 vv 
 
7664271 
ENSP00000339007 ENSP00000261799 vt|vv Y716 7935391 
ENSP00000339007 ENSP00000261937 vt|vv 
 
7970715 
ENSP00000339007 ENSP00000341189 vt|vv Y925 7997267 
ENSP00000339007 ENSP00000305426 vt 
 
10455176 
ENSP00000339007 ENSP00000304895 vv 
 
7488107 
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ENSP00000339007 ENSP00000326032 vt|vv 
 
11964172 
ENSP00000339007 ENSP00000353950 vt|vv 
 
11964172 
ENSP00000339007 ENSP00000258385 vt|vv 
 
9668219 
ENSP00000339007 ENSP00000085219 vt|vv Y807 11551923 
ENSP00000339007 ENSP00000298467 vt 
 
9516488 
ENSP00000339007 ENSP00000296474 vv Y1360 
8918464,  
7488076 
ENSP00000339007 ENSP00000355406 vv 
 
9824671 
ENSP00000339007 ENSP00000302452 vt 
 
11882361 
ENSP00000339007 ENSP00000220597 vt 
 
10790433 
ENSP00000339007 ENSP00000340944 vv Y542 8041791 
ENSP00000339007 ENSP00000303507 vt|vv Y177 8112292 
ENSP00000339007 ENSP00000313829 vt|vv 
 
8576157 
ENSP00000339007 ENSP00000324890 vt|vv 
 
8576157 
ENSP00000339007 ENSP00000345492 vv 
 
8649391 
ENSP00000339007 ENSP00000317272 vt|vv Y1374 8662889 
ENSP00000339007 ENSP00000264731 vt 
 
8695800 
ENSP00000339007 ENSP00000244007 vt|vv 
 
9281317 
ENSP00000339007 ENSP00000286301 vt|2H|vv Y699, Y923 9380408 
ENSP00000339007 ENSP00000288135 vt|vv Y703 10377264 
ENSP00000339007 ENSP00000216373 vv 
 
10940929 
ENSP00000339007 ENSP00000351285 vt|vv 
 
11964172 
ENSP00000339007 ENSP00000254667 vt|vv 
 
7518772, 
10490839 
ENSP00000339007 ENSP00000299293 vt|vv 
Y196, 
Y306, 
Y349, Y392 
8780727, 
12402043, 
9182757 
ENSP00000339007 ENSP00000327688 vt 
 
8798570 
ENSP00000339007 ENSP00000336919 vt|vv 
 
11707405 
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Supplementary table 4 – High-confidence predictions of SH2-mediated protein-protein interactions. For 7 human SH2 
domains with available complex structure we used FoldX to predict the 10 most likely targets in the human proteome that were 
conserved in at least 3 of the 9 genome studied. We considered only tyrosines that have been predicted or shown experimentally to 
be phosphorylated (see methods). To further characterize the predicted interactions we compiled information on correlated 
expression, shared gene ontology terms, shared interaction partners and conservations of physical and genetic interactions. We 
used a naïve bayes approach to weight each evidence type in order to calculate the odds that a protein pair interacts in vivo, given 
this new information (see Methods).  A posterior odd greater than 1 is equal to a probability higher than 50% that the interaction is 
a true in vivo interaction. For these interactions we could not find any conserved physical or genetic interactions. We found 16 
interactions that were already known and documented in the Human Protein Reference Database (last checked on April 2007). 
SwissProt Id for SH2 
containing protein 
SwissProt Id  for 
predicted Target 
Ensembl Id for SH2 
containing protein 
Ensembl Id  for 
predicted Target 
Posterior 
Odds 
Combined 
Likelihood 
ratio 
GO LR 
Conserved Int 
LR 
Shared Int. 
LR 
Correlated 
expression LR 
Number of 
shared GO 
biological 
functions 
Number of 
common 
interacting 
partners 
Correlated 
expressed 
pair 
Known int. 
KSYK_HUMAN LPHN1_HUMAN ENSP00000326032 ENSP00000340688 0.0011 1 1 1 1 1 0 0 
  
KSYK_HUMAN CLK3_HUMAN ENSP00000326032 ENSP00000344112 0.6028 548 548 1 1 1 GO_BP >2 0 
  
KSYK_HUMAN B3AT_HUMAN ENSP00000326032 ENSP00000262418 0.0011 1 1 1 1 1 0 0 
 
Yes 
KSYK_HUMAN NP_001558.2 ENSP00000326032 ENSP00000298229 7.567824 6879.84 13.2 1 521.2 1 GO_BP 1 >0 
  
KSYK_HUMAN SRGP1_HUMAN ENSP00000326032 ENSP00000347198 0.0011 1 1 1 1 1 0 0 
  
KSYK_HUMAN ERBB3_HUMAN ENSP00000326032 ENSP00000267101 7.567824 6879.84 13.2 1 521.2 1 GO_BP 1 >0 
  
KSYK_HUMAN PTN11_HUMAN ENSP00000326032 ENSP00000340944 254.85214 231683.8 13.2 1 17551.8 1 GO_BP 1 >7 
  
KSYK_HUMAN PHLB1_HUMAN ENSP00000326032 ENSP00000354611 0.0011 1 1 1 1 1 0 0 
  
KSYK_HUMAN RON_HUMAN ENSP00000326032 ENSP00000296474 51.085716 46441.56 13.2 1 3518.3 1 GO_BP 1 >2 
  
KSYK_HUMAN MERTK_HUMAN ENSP00000326032 ENSP00000295408 7.567824 6879.84 13.2 1 521.2 1 GO_BP 1 >0 
  
GRB2_HUMAN UFO_HUMAN ENSP00000339007 ENSP00000301178 2.23817 2034.7 1 1 2034.7 1 0 >1 
 
Yes 
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GRB2_HUMAN FAK2_HUMAN ENSP00000339007 ENSP00000332816 19.30698 17551.8 1 1 17551.8 1 0 >7 
 
Yes 
GRB2_HUMAN PGFRA_HUMAN ENSP00000339007 ENSP00000257290 12.89948 11726.8 1 1 11726.8 1 0 >6 
 
Yes 
GRB2_HUMAN BCR_HUMAN ENSP00000339007 ENSP00000303507 126.76541 115241.3 13.2 1 8730.4 1 GO_BP 1 >5 
 
Yes 
GRB2_HUMAN FRS2_HUMAN ENSP00000339007 ENSP00000299293 9.60344 8730.4 1 1 8730.4 1 0 >5 
 
Yes 
GRB2_HUMAN ANC1_HUMAN ENSP00000339007 ENSP00000339109 0.0011 1 1 1 1 1 0 0 
  
GRB2_HUMAN VGFR2_HUMAN ENSP00000339007 ENSP00000263923 2.23817 2034.7 1 1 2034.7 1 0 >1 
 
Yes 
GRB2_HUMAN CSF1R_HUMAN ENSP00000339007 ENSP00000286301 5.53102 5028.2 1 1 5028.2 1 0 >3 
 
Yes 
GRB2_HUMAN IRS1_HUMAN ENSP00000339007 ENSP00000304895 19.30698 17551.8 1 1 17551.8 1 0 >7 
 
Yes 
GRB2_HUMAN CASL_HUMAN ENSP00000339007 ENSP00000265010 19.30698 17551.8 1 1 17551.8 1 0 >7 
  
SH21A_HUMAN NCOA5_HUMAN ENSP00000331181 ENSP00000290231 0.0011 1 1 1 1 1 0 0 
  
SH21A_HUMAN 4EBP1_HUMAN ENSP00000331181 ENSP00000340691 0.0011 1 1 1 1 1 0 0 
  
SH21A_HUMAN BMX_HUMAN ENSP00000331181 ENSP00000340082 0.0011 1 1 1 1 1 0 0 
  
SH21A_HUMAN PTPRF_HUMAN ENSP00000331181 ENSP00000353030 0.0011 1 1 1 1 1 0 0 
  
SH21A_HUMAN IRS1_HUMAN ENSP00000331181 ENSP00000304895 0.0011 1 1 1 1 1 0 0 
  
SH21A_HUMAN KIT_HUMAN ENSP00000331181 ENSP00000288135 0.0011 1 1 1 1 1 0 0 
  
SH21A_HUMAN BTK_HUMAN ENSP00000331181 ENSP00000308176 0.01452 13.2 13.2 1 1 1 GO_BP 1 0 
  
SH21A_HUMAN FUBP3_HUMAN ENSP00000331181 ENSP00000318177 0.0011 1 1 1 1 1 0 0 
  
SH21A_HUMAN BCAR1_HUMAN ENSP00000331181 ENSP00000162330 0.0011 1 1 1 1 1 0 0 
  
SH21A_HUMAN ALK_HUMAN ENSP00000331181 ENSP00000306717 0.0011 1 1 1 1 1 0 0 
  
P85A_HUMAN TIE2_HUMAN ENSP00000274335 ENSP00000346578 73.009464 66372.24 13.2 1 5028.2 1 GO_BP 1 >3 
 
Yes 
P85A_HUMAN V1AR_HUMAN ENSP00000274335 ENSP00000299178 0.0011 1 1 1 1 1 0 0 
  
P85A_HUMAN PAK2_HUMAN ENSP00000274335 ENSP00000314067 51.085716 46441.56 13.2 1 3518.3 1 GO_BP 1 >2 
  
P85A_HUMAN U5S1_HUMAN ENSP00000274335 ENSP00000262414 0.00528 4.8 1 1 1 4.8 0 0 co-exp. 
 
P85A_HUMAN RBM19_HUMAN ENSP00000274335 ENSP00000261741 0.0011 1 1 1 1 1 0 0 
  
P85A_HUMAN RET_HUMAN ENSP00000274335 ENSP00000344798 73.009464 66372.24 13.2 1 5028.2 1 GO_BP 1 >3 
 
Yes 
P85A_HUMAN RON_HUMAN ENSP00000274335 ENSP00000296474 51.085716 46441.56 13.2 1 3518.3 1 GO_BP 1 >2 
 
Yes 
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P85A_HUMAN NP_003595.1 ENSP00000274335 ENSP00000247066 7.7077 7007 1 1 7007 1 0 >4 
 
Yes 
P85A_HUMAN WAPL_HUMAN ENSP00000274335 ENSP00000345162 0.0011 1 1 1 1 1 0 0 
  
P85A_HUMAN PHF10_HUMAN ENSP00000274335 ENSP00000341805 0.00528 4.8 1 1 1 4.8 0 0 co-exp. 
 
LCK_HUMAN VAV2_HUMAN ENSP00000328213 ENSP00000317258 2.23817 2034.7 1 1 2034.7 1 0 >1 
  
LCK_HUMAN FAK1_HUMAN ENSP00000328213 ENSP00000341189 19.30698 17551.8 1 1 17551.8 1 0 >7 
 
Yes 
LCK_HUMAN BAP1_HUMAN ENSP00000328213 ENSP00000296288 0.0011 1 1 1 1 1 0 0 
  
LCK_HUMAN CSK21_HUMAN ENSP00000328213 ENSP00000217244 0.0011 1 1 1 1 1 0 0 
  
LCK_HUMAN SMCA2_HUMAN ENSP00000328213 ENSP00000265773 0.0011 1 1 1 1 1 0 0 
  
LCK_HUMAN PHF14_HUMAN ENSP00000328213 ENSP00000306296 0.0011 1 1 1 1 1 0 0 
  
LCK_HUMAN LSD1_HUMAN ENSP00000328213 ENSP00000246149 0.0011 1 1 1 1 1 0 0 
  
LCK_HUMAN TBA1_HUMAN ENSP00000328213 ENSP00000248437 2.751936 2501.76 1 1 521.2 4.8 0 >0 co-exp. 
 
LCK_HUMAN CD79A_HUMAN ENSP00000328213 ENSP00000221972 10.743216 9766.56 1 1 2034.7 4.8 0 >1 co-exp. Yes 
LCK_HUMAN ETS1_HUMAN ENSP00000328213 ENSP00000324578 0.00528 4.8 1 1 1 4.8 0 0 co-exp. 
 
SRC_HUMAN SFR11_HUMAN ENSP00000353950 ENSP00000235399 0.0011 1 1 1 1 1 0 0 
  
SRC_HUMAN WDR43_HUMAN ENSP00000353950 ENSP00000296126 0.0011 1 1 1 1 1 0 0 
  
SRC_HUMAN SMCA2_HUMAN ENSP00000353950 ENSP00000265773 0.0011 1 1 1 1 1 0 0 
  
SRC_HUMAN TOP2A_HUMAN ENSP00000353950 ENSP00000269577 0.57332 521.2 1 1 521.2 1 0 >0 
  
SRC_HUMAN MYPT1_HUMAN ENSP00000353950 ENSP00000261207 0.0011 1 1 1 1 1 0 0 
  
SRC_HUMAN ALK_HUMAN ENSP00000353950 ENSP00000306717 51.085716 46441.56 13.2 1 3518.3 1 GO_BP 1 >2 
  
SRC_HUMAN EHD2_HUMAN ENSP00000353950 ENSP00000263277 0.0011 1 1 1 1 1 0 0 
  
SRC_HUMAN EHD1_HUMAN ENSP00000353950 ENSP00000320516 0.0011 1 1 1 1 1 0 0 
  
SRC_HUMAN VAV_HUMAN ENSP00000353950 ENSP00000302269 19.30698 17551.8 1 1 17551.8 1 0 >7 
  
SRC_HUMAN TM1L1_HUMAN ENSP00000353950 ENSP00000343901 2.23817 2034.7 1 1 2034.7 1 0 >1 
  
STAT1_HUMAN INAR1_HUMAN ENSP00000354394 ENSP00000270139 29.543844 26858.04 13.2 1 2034.7 1 GO_BP 1 >1 
  
STAT1_HUMAN BCR_HUMAN ENSP00000354394 ENSP00000303507 0.12507 113.7 113.7 1 1 1 GO_BP >1 0 
  
STAT1_HUMAN SYNE1_HUMAN ENSP00000354394 ENSP00000265368 0.0011 1 1 1 1 1 0 0 
  
  
 
 
 98 
STAT1_HUMAN TRA2B_HUMAN ENSP00000354394 ENSP00000259043 0.00528 4.8 1 1 1 4.8 0 0 co-exp. 
 
STAT1_HUMAN STA5B_HUMAN ENSP00000354394 ENSP00000293328 628.87697 571706.3 113.7 1 5028.2 1 GO_BP >1 >3 
 
Yes 
STAT1_HUMAN Q9Y4I1-3 ENSP00000354394 ENSP00000350945 0.0011 1 1 1 1 1 0 0 
  
STAT1_HUMAN V1AR_HUMAN ENSP00000354394 ENSP00000299178 0.0011 1 1 1 1 1 0 0 
  
STAT1_HUMAN TRA2A_HUMAN ENSP00000354394 ENSP00000297071 0.0011 1 1 1 1 1 0 0 
  
STAT1_HUMAN ADRB2_HUMAN ENSP00000354394 ENSP00000305372 0.0011 1 1 1 1 1 0 0 
  
STAT1_HUMAN Q13480-2 ENSP00000354394 ENSP00000262995 0.57332 521.2 1 1 521.2 1 0 >0 
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Supplementary table 5 – Estimation of Likelihood Ratio for interactions transfer 
across species. We considered that protein interaction information is to some extent 
conserved across species[2, 78]. We have calculated the overlap of predicted human 
interactions with the positive and negative datasets and used this information to 
calculate a likelihood ratio for this evidence type. The genetic and physical 
interactions were compiled for S. cerevisiae, D. melanogaster and C. elegans from 
BIND[171],BioGRID[172], Flybase[173] and Wormbase (http://www.wormbase.org). 
We have used four types of homology/orthology detection using BLAST: RBH – 
reciprocal best blast hit; IRBH – indirect reciprocal best blast hit; best homolog with 
an E value smaller than 1E-10 and simple the best blast hit with no E value cut off.  
We defined a human protein as an indirect reciprocal best hit of a protein A in another 
species when the human protein’s best blast hit (A’) likely originated by duplication 
from A. When A’ is the best blast hit of A in that genome with an E value <1E-30. 
Interaction 
type 
Homology type N(pos) N(neg) p(pos) p(neg) 
LR 
p(pos)/p(neg) 
D
.m
el
a
n
o
g
a
st
er
 P
h
y
si
ca
l 
in
te
ra
ct
io
n
s RBH 59 38 0.007165 1.43E-05 502.1499 
IRBH 52 52 0.006315 1.95E-05 323.4186 
best homolog 
<1E-10 
53 73 0.006436 2.74E-05 234.8107 
best blast hit 57 166 0.006922 6.23E-05 111.0534 
D
.m
el
a
n
o
g
a
st
er
 G
en
et
ic
 
in
te
ra
ct
io
n
s RBH 79 74 0.009593 2.78E-05 345.2712 
IRBH 83 74 0.010079 2.78E-05 362.7533 
best homolog 
<1E-10 
89 82 0.010808 3.08E-05 351.0275 
best blast hit 90 101 0.010929 3.79E-05 288.1948 
S
. 
ce
re
vi
si
a
e 
P
h
y
si
ca
l 
in
te
ra
ct
io
n
s RBH 121 10 0.014693 3.75E-06 3913.365 
IRBH 133 16 0.016151 6.01E-06 2688.417 
best homolog 
<1E-10 
150 33 0.018215 1.24E-05 1470.084 
best blast hit 181 111 0.021979 4.17E-05 527.3762 
S
. 
ce
re
vi
si
a
e 
C
o
m
p
le
x
es
 RBH 213 38 0.025865 1.43E-05 1812.846 
IRBH 233 43 0.028294 1.61E-05 1752.477 
best homolog 
<1E-10 
255 79 0.030965 2.97E-05 1043.946 
best blast hit 310 165 0.037644 6.2E-05 607.6349 
S
. 
ce
re
vi
si
a
e 
G
en
et
ic
 
in
te
ra
ct
io
n
s RBH 93 11 0.011293 4.13E-06 2734.357 
IRBH 104 76 0.012629 2.85E-05 442.5728 
best homolog 
<1E-10 
109 82 0.013236 3.08E-05 429.9101 
best blast hit 141 182 0.017122 6.83E-05 250.5605 
C
. 
el
e
g
a
n
s 
P
h
y
si
ca
l 
in
t
er
a
ct
i
o
n
s RBH 18 9 0.002186 3.38E-06 646.8372 
IRBH 18 12 0.002186 4.51E-06 485.1279 
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best homolog 
<1E-10 
19 20 0.002307 7.51E-06 307.2477 
best blast hit 20 57 0.002429 2.14E-05 113.4802 
C
. 
el
eg
a
n
s 
G
en
et
ic
 
in
te
ra
ct
io
n
s RBH 73 37 0.008865 1.39E-05 638.0961 
IRBH 80 38 0.009715 1.43E-05 680.8812 
best homolog 
<1E-10 
91 47 0.01105 1.76E-05 626.1934 
best blast hit 99 55 0.012022 2.07E-05 582.1534 
 
 
Supplementary table 6 – Estimation of Likelihood Ratio for protein pairs sharing 
interaction partners. Protein pairs sharing binding partners are more probably 
interacting than random proteins given that they more likely belong to the same 
pathway or complex. We created a human interaction network combining the 
interactions in the Human Protein Reference Database[163] with two recent yeast-
two-hybrid studies[5, 6]. We then binned human protein pairs with increasing number 
of shared partners and for each bin calculated the likelihood of detecting an in vivo 
interaction.  
Minimal N of shared 
Interactions 
N(pos) N(neg) p(pos) p(neg) LR=p(pos)/p(neg) 
1 4114 5445 1.065527 0.002044 521.1889 
2 2286 775 0.592075 0.000291 2034.714 
3 1372 269 0.355348 0.000101 3518.282 
4 882 121 0.228438 4.54E-05 5028.193 
5 579 57 0.149961 2.14E-05 7007.006 
6 405 32 0.104895 1.2E-05 8730.393 
7 289 17 0.074851 6.38E-06 11726.75 
8 229 9 0.059311 3.38E-06 17551.8 
 
Supplementary table 7 – Estimation of Likelihood Ratio for protein pairs sharing 
biological processes. Proteins pairs that participate in the same biological processes 
or have similar molecular functions are more likely to interact. We have binned 
protein pairs with increasing number of shared GO annotations[174] on biological 
processes or molecular functions and we tested the predictive power of each bin. 
Minimal number of 
shared GO process 
N(pos) N(neg) p(pos) p(neg) LR=p(pos)/p(neg) 
1 3032 74242 0.368185 0.027875 13.20823 
2 1141 3244 0.138555 0.001218 113.7548 
3 361 213 0.043837 8E-05 548.1413 
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4 100 18 0.012143 6.76E-06 1796.77 
5 36 1 0.004372 3.75E-07 11643.07 
 
Supplementary table 8 – Estimation of Likelihood Ratio for protein pairs sharing 
molecular functions. We binned human protein pairs with increasing number of 
shared molecular functions as determined by GO annotations and for each bin 
calculated the overlap with the positive and negative sets.  
Minimal number of 
shared GO functions 
N(pos) N(neg) p(pos) p(neg) LR=p(pos)/p(neg) 
1 3945 321961 0.479053 0.120886 3.96286 
2 1244 40577 0.151063 0.015235 9.91529 
3 545 6131 0.066181 0.002302 28.74949 
4 302 1641 0.036673 0.000616 59.52006 
5 157 716 0.019065 0.000269 70.9172 
6 61 145 0.007407 5.44E-05 136.0589 
7 15 20 0.001821 7.51E-06 242.5639 
8 6 4 0.000729 1.5E-06 485.1279 
 
Supplementary table 9 – Estimation of Likelihood Ratio for co-expressed protein 
pairs. Gene expression information has been used to increase the confidence in 
predicting protein interactions[58]. Co-expressed human gene pairs were taken from 
the literature[175, 176] and stratified into two bins according to the level of 
confidence of co-expression. The smaller bin of high confidence co-expressed genes 
was taken from[175] that can be found online 
(www.bcgsc.ca/project/bomge/coexpression/). For both bins we calculated the overlap 
with the positive and negative datasets to calculate likelihood ratio scores. 
Co-expression N(pos) N(neg) p(pos) p(neg) LR=p(pos)/p(neg) 
Co-expressed genes 825 55359 0.100182 0.020785 4.819818 
High-confidence co-
expressed genes 
79 408 0.009593 0.000153 62.62272 
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5.1 – Abstract 
Progress in uncovering the protein interaction networks of several species has 
led to questions of what underlying principles might govern their organization. Few 
studies have tried to determine the impact of protein interaction network evolution in 
the observed physiological differences between species. Using comparative genomics 
and structural information we show here that eukaryotic species have re-wired their 
interactomes at a fast rate of approximately 10
-5
 interactions changed per protein pair, 
per million years of divergence. For H. sapiens this corresponds to 10
3
 interactions 
changed per million years. Additionally we find that the specificity of binding 
strongly determines the interaction turnover and that different biological processes 
show significantly different link dynamics. In particular, human proteins involved in 
immune response, transport and establishment of localization, show signs of positive 
selection for change of interactions. Our analysis suggests that a small degree of 
molecular divergence can give rise to important changes at network level. We propose 
that the power law distribution observed in protein interaction networks could be 
partly explained by the cell’s requirement for different degrees of protein binding 
specificity. 
 
5.2 – Non technical summary 
In order to understand how the cell performs the required biological functions and reacts to 
changes in the environment scientists have been studying how cellular components interact. In recent 
Chapter 5 
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years, new experimental methods have increased immensely our ability to map out these connections. 
However, it is important to keep in mind that biological systems are constantly evolving to cope with 
environmental changes. What then is the impact of the genomic variability brought by point mutations, 
segmental duplications, etc, on these interaction networks? The authors have tried here to quantify the 
rate by which protein interactions change during the evolution of eukaryotic cells.  According to the 
authors, about 0.5% to 3% of the interactions can change every million years. Also protein properties 
such as binding specificity (defined as the number of binding surfaces or binding partners) and protein 
function help determine the rate of interaction turnover. 
This work suggests that protein interactions are evolutionary plastic and the fact that a group of 
proteins is conserved in different genomes does not mean that their interaction repertoire and function 
is necessarily conserved. This work emphasizes the importance of studying biological systems in the 
context of evolutionary change. 
 
5.3 – Introduction  
Many partial protein interaction maps for several eukaryotic species have now 
been published [2-7, 13, 15, 163] and several studies have tried to analyse the 
structure and evolution of such networks on a topological level [35, 37, 177-181]. The 
massive data produced by sequencing efforts has allowed for comparison of different 
genomes, giving us much more information about their organization and evolution 
than what would be possible by the analysis of individual genomes [99, 182-185]. By 
analogy, to obtain a similar insight into the structure and evolution of interactomes, 
different protein networks would need to be compared, a procedure one could call 
“comparative interactomics”. This could be achieved by studying the conserved 
interactions between groups of orthologs proteins in different species, defined as 
interologs [2, 78, 85]. Recent attempts to compare protein interaction networks of 
different species [76, 77] suggested that, at the moment, the current data are poorly 
suited for direct comparison; the overlap between datasets is small and this is most 
likely due to insufficient data quantity and quality. An alternative approach has been 
to look for conservation of network modules between species [40, 186]. This has lead 
to the development of several network alignment tools and has been largely more 
successful at finding conserved interactions [79, 186].   
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These studies have not, however, taken into account the large evolutionary 
distance separating the species under study. In fact, the four eukaryotic species for 
which we currently have the most interaction data (S. cerevisiae, D. melanogaster, C. 
elegans and H. sapiens) shared a common ancestor more than 900 million years ago 
[110]. This raises the intriguing hypothesis that this evolutionary distance is too large 
for these species to have retained many of the similarities in their interaction network. 
In fact, the relative success of the network alignment approaches hints that 
evolutionary pressures do not constrain the exact cellular interactions but rather the 
required functional complexes that emerge. Hence, the lack of overlap would 
correspond in part to divergence and not merely to poor coverage.  
Even without the ability to compare interactomes directly, one could try to 
obtain estimates for the rate of change in interactomes, by mining existing data with 
comparative genomics. Previously, Wagner [37, 187] used paralogous protein pairs 
from S. cerevisiae to estimate that 2 x 10
-6
 new interactions are added to the yeast 
interactome per protein pair per million years (My), suggesting that, on average, 
around 50 to 100 new interactions have arisen every 1 My. The method relied on very 
few numbers of interactions between paralogous protein pairs, making it impossible to 
dissect the different contributions to the average value. Also, in the last three years, 
we have more data available for a greater number of species, allowing us to compare 
how interactomes have changed in more recent evolutionary time and to draw more 
general conclusions about these processes.  
We have attempted to evaluate the rate of change of interactions in the 
interactomes of several eukaryotic species (S. cerevisiae, D. melanogaster, H. sapiens 
and C. elegans). We have determined that, in all species tested, interactions change at 
a rate on the order of 1×10
-5
 interactions per protein pair, per million years. The 
approach used allowed us to explore different protein properties influencing 
interaction turnover. We have observed that specificity in protein binding and protein 
function can determine link dynamics during the evolution of cellular networks.  
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5.4 – Results  
 
5.4.1 – Recently duplicated proteins of eukaryotic species have a fast rate of 
interaction change  
To calculate the rate of interaction change we have established for each 
protein, in all species studied here, an approximate age of origin, according to the 
presence or absence of an identifiable orthologs in several other reference species (see 
Methods). We assumed that any interaction observed today with a recently-duplicated 
protein was either inherited in the process of duplication or created after the process 
of gene duplication. It has been estimated that for S. cerevisiae the fraction of gene 
duplicates with at least one shared interaction is below 20% after 50My [37]. We 
calculated for each species the fraction of interactions that are also observed with the 
closest homolog of the recently duplicated protein. Within the time frame studied (20 
to 100My) the fraction of observed conserved interactions after gene duplication is 
low (1% to 20%, see table 1 and supplementary table 1). Eliminating the interactions 
likely inherited by duplication, we are left with protein interactions that were either 
gained in the copy we are considering or they were inherited by duplication and 
subsequently lost in the homolog. Either of these cases represents an event of 
interaction change that occurred after gene duplication and we can thus calculate the 
rate at which interactions change (see methods). This rate is on all species 
approximately on the order of 1×10
-5
 interactions changed per protein pair for every 
million years (see table 1) and ranges from 5.36×10
-6
 in H. sapiens to 2.45×10
-5
 in S. 
cerevisiae. Considering the possible protein pairs in the different species (around 
1.8×10
7
 in S. cerevisiae and 2.3×10
8
 in H. sapiens, when excluding splicing 
alternatives) this estimate would correspond to a change of on the order of 100 to 
1000 interactions every million years. 
Due to the low coverage of the current interactomes it is quite possible that 
these values might change as new data is made available. To study the impact of 
coverage on the values mentioned above we have mimicked the effect of lowering the 
coverage of the current datasets by randomly sampling the interactomes in two ways: 
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randomly removing protein interactions or randomly removing proteins (and their 
interactions).  
The percentage of inherited interactions increases with increasing coverage, 
approximately linearly in the case of random node removal and non-linearly in the 
case of random protein removal (see supplementary figure 1). Therefore the 
percentage of inherited interactions is a measure that depends on the size of the 
network and is therefore likely to change as more data is added.  
The rate of change of interactions, on the other hand, appears to be 
independent of network size. There is no significant change in the rate in the case of 
random removal of proteins. In the case of random removal of interactions only for 
removal of more than 80% of the interactions there is a significant increase of the rate 
(see supplementary figure 1). It is important to note that, the trend points to a 
stabilization of the value, indicating that further increases in coverage will not likely 
change it. We deduce from this result that the rate of change of interactions is a 
measure that is mostly independent of network size and can be used to study the 
evolution of protein interaction networks.   
To test the robustness of out method for variations in accuracy of the data, the 
human interactome was separated into three sub sets, as defined in the Human Protein 
Reference Database: yeast two-hybrid (including the two recent high-throughput 
studies [5, 6]), in vitro studies such as GST pull-down and in vivo studies such as co-
immunoprecipitation . The in vivo and in vitro sub-sets contain only literature derived 
interactions and should therefore be of higher accuracy. The rate of change of 
interactions for these three datasets is respectively 1.09×10
-5
, 7.23×10
-6
 and 7.12×10
-6 
(see supplementary table 1). The calculated rate using the high accuracy datasets is of 
very similar value than either from the human yeast-two-hybrid data and the data 
from the other species. We conclude that the order of magnitude reported is a good 
approximation for the rate of change of eukaryotic protein interactions networks. 
 
 
5.4.2 – The rate of change of interactions correlates with the number of binding 
partners of a protein in all eukaryotic species studied.  
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Topological analysis of protein interaction networks have shown previously 
that the distribution of the number of interactions follows a power law, such that the 
frequency of proteins with n interactions falls off as n
-α
 [35]. It has been proposed that 
the observed power law distribution could arise by network growth and preferential 
attachment, where newly created nodes would preferentially link to already highly 
connected nodes [188]. Two independent studies have shown, for S. cerevisiae, 
preferential attachment in the protein interaction network [178, 187], supporting the 
model proposed for the emergence of the power law distribution (at least in the case 
of protein interaction networks).  
We asked if there is also a correlation between the number of partners of a protein 
and the rate of change of its interactions. Using the data for different species, we 
observed a linear correlation between the number of binding partners and the link 
turnover for all species studied (figure 1). The correlation in all cases is strong with R
2
 
of 0.94 for S. cerevisiae, 0.97 for D. melanogaster, 0.96 for C. elegans and 0.93 for H. 
sapiens.  
From these results we can conclude that there is preferential turnover of 
interactions in eukaryotic interactomes with highly connected proteins having a faster 
rate of change in their interactions.  
 
5.4.3 – Domain binding characteristics influence the rate of change of 
interactions. 
The initial observations about the robustness of power law networks to random 
node removal [189] and the correlation between protein essentiality and the number of 
interactions [35] have led to the idea that the overall structure of interactomes could 
be the outcome of selection for robustness to gene deletion. Wagner suggested 
however that there is no need to invoke natural selection to explain the network 
topology, since the local preferential attachment and network growth observed in the 
S. cerevisiae interactome suffice to create power law networks [187]. We showed 
above that preferential turnover is a property of the protein interaction networks of all 
species studied, but what might determine this behavior at a molecular level?  
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It is known that interfaces of transient protein-protein interactions are less 
restricted in evolution than the binding surfaces of permanent complexes. Also, 
interacting residues of transient complexes are less likely to co-evolve than interaction 
residues of permanent complexes [190]. It is plausible that different types of 
interactions have different likelihoods of changing their interactions over a given 
evolutionary period. To test this in an unbiased fashion, we first aimed to determine 
the protein domains that contribute more to the fast rate of change. We considered 
only domains that conferred a rate of change to a group of proteins, larger than 
average in at least 3 of the 4 species studied (see Methods). All of the domains 
selected by this criteria (see table 2) are currently known to mediate protein-protein 
interactions. Interestingly, five of the eight domains are known to form domain-
peptide interactions, as opposed to domain-domain interactions, suggesting that 
proteins containing peptide-binding domains are more likely to change their 
interactions faster over the same evolutionary time than other types of domains [191].  
Many domain-peptide interactions involved a globular domain binding to a 
peptide that does not adopt a regular secondary structure and that is not part of the 
globular region of the target protein [61]. Since the interaction area is small, changes 
in the critical residues can easily abolish binding. Also, random point mutations in the 
proteome can more easily create new binding sites for these domains. This could 
explain their fast link turnover.  
To test this hypothesis further we analyzed a database containing structures of 
interacting protein domains [192] in search for domains with different degrees of 
specificity. Here, we define as a specific protein one that has few ligands and few 
interaction surfaces.  An unspecific protein is one that has many potential ligands 
and/or many different interaction surfaces. Therefore promiscuous protein binding 
domains are those that have been observed in a structure at close physical contact with 
a high number of other types of domains. We have binned proteins containing 
domains with increasing number of known structural interactions with other domains 
and calculated for each bin the rate of change (see methods and figure 2). Using the 
human dataset of literature derive protein interactions we observed that groups of 
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proteins having domains capable of interacting with a higher number of other domains 
tend to have higher rates of change of their interactions. 
For promiscuous proteins (containing domains capable of interacting with 15 or 
more other domains), we calculated the rate of change of interactions and compared 
this value to the obtained for proteins containing peptide binding domains, proteins 
containing more specific domains (less than 5 structural interactions in iPfam) and the 
average for all proteins. We observe that peptide binding domains and promiscuous 
domains, have a higher rate of change of interactions (p-value <0.01 for both groups 
with a Mann Whitney U test) than the average for the proteome (see table 3). The 
difference between these two groups is not statistically significant (p =0.06 with a 
Mann Whitney U test). Proteins having more specific binding domains have a rate of 
change of interactions not significantly different from the average value (p=0.86 with 
a Mann Whitney U test).  
We have studied also domains with different binding specificities as defined by 
their number of observed physical interactions. Using the iPFAM [192] database, we 
were able to assign plausible binding interfaces to roughly 20% of human interactome 
(see Methods). We then searched for proteins that had multiple interactions occurring 
through the same domain and we compared this group to another having proteins with 
similar number of interactions through more than one domain (see supplementary 
figure 1). Given the same number of interactions, proteins that preferentially bind 
through one domain (more promiscuous) have on average a higher rate of change of 
interactions than proteins interacting through multiple domains. For protein hubs 
having between 10 to 50 interactions the rate is 2.2 times higher for the promiscuous 
domains (p-value = 0.0089 with a Mann Whitney U test) than the more selective 
domains, having the same average number of interactions.  
We conclude from these results that the specificity, as defined by the number of 
binding surfaces or physical interactions, of a binding domain is a strong determinant 
of the rate of change of interactions, with more promiscuous binding correlating with 
higher rates of change of interactions.   
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5.4.4 – Human proteins related to Immune response, transport and localization 
have likely been under positive selection for change of their interactions in the 
recent evolutionary past.  
The results above suggest that specificity, as defined here, determines link 
dynamics, affecting the rate at which proteins might explore possible beneficiary 
interactions and remove deleterious ones. Innovation explored in this way, is grounds 
for natural selection to act upon during evolution. It is then plausible that proteins 
belonging to different functional classes might have different rates of change of 
interactions due to differential selection pressures. To study this we have binned 
human proteins according to Gene Ontology biological processes [174] (see Methods) 
and have, for each biological process, calculated the average number of interactions 
and the rate of change (see figure 3). To reduce the number of functions and increase 
the reliability of the calculated rates, we have considered only GO processes with at 
least 150 proteins present in the current human interactome (excluding yeast-two-
hybrid interactions). We compared the values obtained with the expected rates for 
proteins with increasing average connectivity (black line in figure 3).  
Most groups of proteins have average rates that are not much different than 
groups of proteins with a similar connectivity. Within these we could distinguish 
between processes that have proteins with rates similar or lower than average (like 
metabolism) and biological processes that have above average rates (like intracellular 
signaling, phosphorylation, regulation of cellular processes and regulation of 
apoptosis).  These results confirm what was suggested by Kunin et al. [193] that the 
functional role of proteins poses constraints on the evolution of new interactions. We 
suggest this is due to differential usage of proteins binding specificity in the different 
cellular processes.  
More interestingly, we found some biological processes (immune response, 
transport and localization, cell adhesion and response to stress/stimulus) that showed 
higher link dynamics than one would expect from their average number of 
interactions. On table 4 we list the biological processes that have a rate significantly 
higher (p-value <0.05 with a with a Mann Whitney U test) than expected from their 
average connectivity.  
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We redid this analysis removing GO annotations inferred electronically. 
Although roughly 50% of the annotations are lost most of the results remain 
qualitatively the same (results not shown). Importantly we still see GO functions that 
have a rate significantly higher than expected from their average connectivity 
(organismal physiological process, defense response, immune response and response 
to biotic stimulus) 
We hypothesize that the groups of proteins deviating from the linear 
preferential turnover, have been under particular strong positive selection for the 
change of their interactions. 
 
5.5 – Discussion 
 
In the seminal work of Mary-Claire King and Allan Wilson – “Evolution at 
Two Levels in Humans and Chimpanzees” – it was proposed that, given the small 
differences observed between the proteins in both species, the most likely mechanism 
that could account for the differences between humans and chimpanzees would be 
changes in gene expression [194]. In fact, in the 30 years following, a considerable 
amount of evidence has surfaced to support this view (for a review see [195]).  
However, as we have shown above it is quite possible that in the time since the 
divergence of these two species a significant change in protein interactions could have 
taken place and therefore, changes in protein interaction networks can have a similar 
important role in species evolution.  
 
5.5.1 – Calculation of the rate of change and potential caveats  
Extending on the work of Wagner [37, 187] for S. cerevisiae, we have shown 
here that the interactomes of several eukaryotic species have high rates of change of 
their interactions. According to our calculations, 100 to 1000 interactions might 
change every million years in eukaryotic interactomes. Estimating that, in the current 
interactomes, proteins have on average 4 to 10 interactions then the link turnover 
would change 0.5% to 3% of the interactions every My. This estimate clearly points 
to an important effect of link dynamics in the evolution of cellular interactions.  
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Some caveats to our estimated rate should be noted. Namely, we have focused 
our attention on the evolution of protein interactions of single gene duplicates. The 
effects of single gene duplication could be considerably different from large segment 
or whole-genome duplication events [196]. If a protein that is part of a complex 
duplicates the changes in gene dosage might unbalance the complex stoichiometry 
and cause a reduction in fitness to the species [197]. On the contrary if the whole 
complex is duplicated, as would occur in a full genome duplication event, the balance 
between the complex components would be maintained. We can speculate that a 
single gene duplicate might have a stronger pressure to diverge in it’s interactions to 
avoid a gene imbalance effect, when compared to proteins originated from a full 
complex duplication. However, it is also known that living systems have mechanisms 
to guarantee the right expression level when dealing with important complexes.  A 
good example is the case of Tubulin where the stability of the mRNA depends on the 
existence of unpaired  or  subunits [198].  In fact it is almost impossible to keep the 
right stochiometry in a complex simply due to noise fluctuations, unless there are 
mechanisms that control possible imbalances.  Thus although it is intuitive that whole 
genome duplication could exert less pressure for divergence, this does not necessarily 
need to be true. 
Also, it has been proposed that duplicate genes pass trough a period of relaxed 
selection after gene duplication [185] possibly accompanied by a relaxation in the 
selection for maintenance of their interactions. As a result of this, the link dynamics is 
likely higher for recently duplicated genes then for proteins with established 
functions. However, experimental studies estimated that 69% to 84% of interactions 
between ancient proteins have diverged when comparing S. cerevisiae to C. elegans 
[78]. The authors tested 216 interactions that were known from S. cerevisiae among 
282 C. elegans proteins (that are conserved in S. cerevisiae). Of these, 35 interactions 
were experimentally observed in C. elegans. We can estimate that approximately 
5×10
-6
 interactions have changed per protein pair per My among these ancient 
proteins. This is roughly half of what we proposed as an estimate for the rate of 
change for eukaryotic interactomes but it considers only removal of interactions and 
not addition. Due to the reasons mentioned above we think that the rate that we have 
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calculated might be an overestimation of the rate for the whole interactome but 
currently available data suggests that even among ancient proteins there is 
considerable change of their interactions.  
Other studies also point to the importance of change of interactions after gene 
duplication. In studies of S. cerevisiae complexes it was observed that 7% to 20% of 
those complexes have arisen by duplication [199, 200]. However, in most of the 
instances (67% to 90%), only partial duplication was observed. Detailed studies of 
some of the duplicated complexes have shown, that even in the case where general 
function and localization is maintained it is possible that the specific activity of the 
complex has changed. These results suggest that, at least in the case of protein 
complexes, there is a very significant gain and loss of single interactions that can lead 
to the formation of new complexes with different specificities. 
 
5.5.2 – Binding properties and function determine the rate of change 
In a recent review [191], Neduva and Russell postulated that linear motifs 
might act as “evolutionary interactions switches”. The authors claimed that, due to 
binding to a linear peptide stretch and due to the small number of determinants for 
binding, a random mutation in the proteome can easily create or destroy such binding 
sites. We have shown that specificity of binding is a key factor determining the 
evolvability of the interaction networks. More promiscuous domains, like peptide 
binding domains and domains able to interact with common structural elements are 
more likely to change interactions faster over a given evolutionary period. This 
implies that some biological processes where these binding domains are involved 
(like signal transduction) will be more flexible in evolution than others (like 
metabolism). In fact proteins related to intracellular signaling cascades are two times 
more likely to interact with recently duplicated proteins than proteins involved in 
primary metabolism.  
If protein properties impact on how they add and lose interactions, then the 
power law distribution observed in protein interaction networks is in part determined 
by the cell’s use of different degrees of binding specificity.  
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We reported that proteins involved in the immune response, responses to external 
stimulus, transport, establishment of localization and organismal physiological 
processes show signs of such positive selection for new interactions. Interestingly, 
most of these biological processes are known to have an excess of proteins under 
positive selection as shown by sequence studies [201, 202]. Our results suggest that 
positive selection for sequence change in proteins is propagated to faster rates of 
change at the network level. Alternatively it is possible that the preferential fixation of 
duplicated proteins involved in these biological functions might partly explain this 
observation.  
 
5.5.3 – Link dynamics and cellular evolution 
This study opens up interesting questions regarding the evolution of cellular 
functions. Some challenges faced by the cells require the interaction of several 
components to integrate information and provide a solution. One example would be 
the decision to divide or differentiate given a set of external conditions. It could be 
said that these challenges require a network solution as oppose for example to some 
metabolic problems like adapting an enzyme to do a required metabolic step.  
In network challenges as defined above, selection forces would not restrain the 
exact binary interactions but the functional complexes arising from them. It is 
plausible that the fast link dynamics is then advantageous to the cell, given that it 
allows for exploration of different network conformations from where innovation 
might arise. 
If there is indeed a fast turnover of interactions that are material for selection 
to act upon then we expect to see convergent network motifs that are optimal for 
solving particular cellular problems. An example of what might be an optimal 
network solution is the coupling of slow and fast positive feedbacks in cell decision 
processes [203].  
If fast link dynamics is important for the cell to search for optimal solutions to 
network problems, then is it also likely that the rate of change itself might be under 
constraint and therefore under natural selection. Hence, during cellular evolution, the 
selection of different degrees of specificity is not only important for the functional 
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role of the proteins but it has direct consequences in regards to the evolvability of the 
whole cellular network.   
Further work on protein interaction maps will help us understand to what 
extent evolvability constrains the differential usage of protein domains in cellular 
networks. As it was the case for comparative genomics the availability of more and 
complete interactomes for different species will vastly increase our understanding of 
how the cells complexity arises from the interactions of its components and evolves to 
cope with the changing environments.  
 
5.6 – Materials and Methods 
 
5.6.1 – Estimating protein time of origin 
For each protein of S. cerevisiae, D. melanogaster, C elegans and H. sapiens 
we have established a likely time of origin by looking for putative orthologs in several 
other fully sequenced genomes (that we refer to here as reference species) using the 
orthologs defined in the Inparanoid database [170]. For the species not covered in the 
Inparanoid database we have used the reciprocal BLAST best-hit method. Succinctly, 
we considered that if two proteins were the reciprocal best blast hit between two 
species that these proteins are likely orthologs.  
We established putative orthologs between S. cerevisiae and the following 
species: S. bayanus, C .glabrata, K. lactis, A. gossypii, C. albicans, D. hansenii, Y. 
lipolytica, N. crassa, S. pombe. For D. melanogaster we used as reference species D. 
pseudoobscura, A. gambiae, C. elegans and S. cerevisiae. For H. sapiens proteins we 
have looked for putative orthologs in M. musculus, F. rubripes, D. melanogaster and 
S. cerevisiae. For C. elegans proteins we have searched for putative orthologs in C. 
briggsae, D. melanogaster and S. cerevisiae.  
We considered that proteins with no apparent ortholog in any of the reference 
species likely originated after the divergence of the most recently diverged reference 
species. S. cerevisiae proteins with no putative ortholog in any of the reference 
species, most likely originated after the divergence of S. cerevisiae and S. bayanus, 
~20 million years ago [101]. D. melanogaster proteins with no apparent ortholog are 
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younger than the split with D. pseudoobscura (~40 My ago) [204]. C. elegans 
proteins with no apparent ortholog are younger than the split with C. briggsae (~100 
My ago) [205]. H. sapiens proteins with no apparent ortholog are younger than the 
split with M. musculus (~70 My ago) [206]. 
 
5.6.2 – Calculating the rate of change of interactions 
The interactomes used for C. elegans, S. cerevisiae and D. melanogaster were 
extracted from BIND [171], including only direct protein-protein interactions. To 
create the human interactome used here, we added protein interactions from two 
recent studies yeast-two-hybrid studies [5, 6] to the literature derived interactions 
compiled in the human protein reference database (taking only direct protein-protein 
interactions) [163].   
We considered that an interaction was inherited in the process of duplication when an 
interaction to a recently duplicated protein was also observed with its closest 
homolog. Removing these interactions we are left with protein interactions that were 
either gained in the copy we are considering or they were inherited by duplication and 
subsequently lost in the homolog. Either of these cases represents an event of 
interaction change that occurred after the gene duplication event. 
The rate of change of interactions can be calculated by: 
Rate = Changed interactions / (possible protein pairs * divergence time) 
Designating the recently duplicated proteins as Pnew and proteins originated before the 
split with the most recently diverged reference species as Pold then: 
Changed interactions = Changed interactions among Pnew + Changed interactions 
between Pnew and Pold 
Possible protein pairs = Pnew * Pold + (Pnew * (Pnew -1)/2) 
Divergence time = divergence time of the most recently diverged reference species 
(see above) 
 
5.6.3 – Preferential interaction change, protein domains and biological processes 
To determine if the number of interaction partners of a protein correlates with 
the rate of change of interactions, we have binned all proteins in Pold according to the 
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number of interactions to other proteins in Pold. We considered bins of proteins with i 
to i +5 interactions with i ranging from 1 to 20. For each of these bins Pold(bin), the rate 
of change of interactions was considered to be: 
Rate of change (bin) = Changed interactions between Pnew and Pold(bin)/( Pold(bin) × Pnew× 
divergence time) 
We observed a very strong preferential turnover in all species such that 
proteins with higher degree of connectivity have on a higher rate of change. For 
proteins with k interactions the rate of change r can be calculated by: 
r(H. sapiens) = 9E-07k - 9E-07 
r(D. melanogaster) = 4E-06k - 2E-06 
r(C. elegans) = 4E-06k - 7E-07 
r(S. cerevisiae) = 3E-06k - 2E-06 
 
To determine which domains correlate with higher rates of change of 
interactions, we binned proteins in Pold according to the protein domains defined by 
Interpro [207]. For each protein domain we retrieved all proteins in Pold where this 
domain is observed and calculated the rate of change of interactions as above. To 
select protein domains that conferred an above-average rate in most species, we 
selected bins with at least 20 proteins (to increase the reliability of the calculated rate) 
and with a rate greater than average in at least 3 of the 4 species. There are 96 protein 
domains that are represented by 20 or more proteins in at least 3 species. Of these, 8 
have an above rate of change in at least 3 of the 4 species studied. The effect of both 
constrains (number of proteins and average rate) is detailed in supplementary table 2. 
 
To study protein domain with different binding specificity we have binned 
proteins containing domains with increasing number of interactions with other 
domains (extracted from the iPFAM database) and calculated for each bin the rate of 
change. We considered bins of proteins in Pold having proteins domains with i to i +10 
iPFAM interactions with i ranging from 1 to 15. We calculated the Rate of change (bin) 
as above. 
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We have used the iPFAM database to search for plausible binding interfaces in 
all human interaction derived from the human protein reference database. We could 
assign a possible binding interface to ~20% of the human interactome. We then built 
to groups of proteins according to the number of binding interactions per domain. We 
selected a group of proteins that had 3 or more interactions trough one domain (likely 
more promiscuous domains), and a second group of proteins that interacted with 3 or 
more partners via multiple domains (likely more selective domains). We then further 
subdivided the two groups into bins protein with i to i +5 interactions with i ranging 
from 5 to 15 and calculated the rate (bin) as above (see supplementary figure 1). 
 
In order to study the different biological processes we have binned proteins in 
Pold according to the biological processes defined in Gene Ontology [174] 
(downloaded in 29/03/2006). For each Gene Ontology biological process we have 
selected all proteins defined as participating in that biological process or any of its GO 
term children processes. For all such bins of proteins we have calculated the rate of 
change of interactions as above. 
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5.8 – Figures and Tables 
 
Table 1 – Eukaryotic species had in the recent evolutionary past fast rate of 
change of interactions. Using estimated times of origin for all the proteins and the 
currently available protein interaction data we have calculated the rate of change of 
interactions and the percentage of these interactions conserved after the process of 
gene duplication (see Methods).  
 D. 
melanogaster 
C. 
elegans 
S. 
cerevisiae 
H. sapiens 
Approximate divergence from 
reference species (My) 
40 100 20 70 
Older proteins with interactions 5761 1774 4190 6111 
Recently duplicated  proteins 
with interactions 
788 412 514 266 
Interactions to a new protein 3721 892 1207 729 
Interactions gained or lost  3615 854 1120 623 
Percentage of interactions 
conserved after duplication (%) 
3 4 7 15 
Rate for change of interactions  
(per protein pair per My) 
1.86E-05 1.05E-05 2.45E-05 5.36E-06 
 
 
Table 2 – Domains found to contribute to the fast rate of change of interactions in 
at least three of the four species studied. We have binned proteins according to the 
protein domains defined by Interpro [207]. To find protein domains that conferred an 
above average rate in most species we selected bins and with an average rate greater 
than average in at least 3 of the 4 species. 
 
Domain 
Name 
Description 
BTB/POZ The BTB (for BR-C, ttk and bab) or POZ (for Pox virus and Zinc finger) domain mediates 
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homodimerisation and in some instances heterodimerisation. 
Band 4.1 
(contains Pleckstrin homology-type and FERM domains)  It is a conserved domain of about 150 
residues, involved in the linkage of cytoplasmic proteins to the membrane. The PH domain is 
described to also mediate protein-protein interactions [208]. 
UBA 
Ubiquitin associated (UBA) domains are a commonly occurring sequence motif of approximately 45 
amino acid residues. Comparison of UBA structures reveals that a similar folds and a conserved 
large hydrophobic surface patch which may be a common protein-interacting surface present in 
diverse UBA domains.  
Protein 
kinase 
Eukaryotic protein kinases are enzymes that belong to a very extensive family of proteins which 
share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. 
SH2 
The Src homology 2 (SH2) domains function as regulatory modules of intracellular signalling 
cascades by interacting with high affinity to phosphotyrosine-containing target peptides in a 
sequence-specific, SH2 domains recognize between 3-6 residues C-terminal to the phosphorylated 
tyrosine in a fashion that differs from one SH2 domain to another, and strictly phosphorylation-
dependent manner. 
PDZ 
PDZ domains are found in diverse signalling proteins in bacteria, yeasts, plants, insects and 
vertebrates. They bind either the carboxyl-terminal sequences of proteins or internal peptide 
sequences. Peptide binding of the ligand takes place in an elongated surface groove as an 
antiparallel beta-strand interacts with the betaB strand and the B helix. 
SH3 
SH3 (src Homology-3) domains are small protein modules containing approximately 50 amino acid 
residues. The surface of the SH3-domain bears a flat, hydrophobic peptide ligand-binding pocket 
which consists of three shallow grooves defined by conservative aromatic residues in which the 
ligand adopts an extended left-handed helical arrangement. 
SH3 
variant 
This is a structural variant of the SH3 (src Homology-3) domain. 
 
 
Table 3 – Specificity of protein binding is an important factor determining the 
rate of change of interactions. We separated human proteins that likely originated 
before the split with M. musculus into three groups: proteins having domains with 5 or 
less physical contacts with other domains in the iPfam structural database - likely to 
be more selective domains; Proteins having domains with 15 or more structural 
contacts with other domains in the iPfam structural database - likely to be more 
promiscuous domains - and proteins containing well known peptide binding domains 
(SH3, SH2, Protein kinase, WW and PDZ). We counted the average number of 
interactions of these proteins (with other proteins originating before the split) with the 
reference species and we calculated the rate of change of interactions. We compared 
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these values with the values obtained with all proteins originating before the split with 
the reference species. 
 
Average for 
proteome 
Selective 
domains 
Peptide binding 
domains 
Promiscuous 
domains 
Number of 
Interactions 
5.17 5.92 11.26 11.48 
Rate  6.21×10
-06
 6.35×10
-06
 1.23×10
-05
 1.81×10
-05
 
Ratio to 
average rate 
 1.02 1.98 2.92 
p-value Mann 
U test 
 0.866 0.015 5.767×10
-08
 
 
Table 4 – Biological processes with above average rate of change of interactions. 
We have binned proteins according to the biological processes defined in Gene 
Ontology and selected bins with an average rate that was significantly higher than the 
expected rate of group of proteins with the same average number of interactions. 
 
Biological Process 
Number of 
proteins 
Rate of change of 
interactions 
p-value 
Mann U 
test 
Protein transport 272 1.12E-05 0.000627 
Establishment of localization 705 8.78E-06 0.000731 
Intracellular transport 284 1.01E-05 0.000755 
Response to external stimulus 171 1.34E-05 0.001371 
Organismal physiological process 619 8.62E-06 0.001461 
Response to other organism 211 1.31E-05 0.004489 
Response to pest, pathogen or 
parasite 
206 1.29E-05 0.005542 
Response to biotic stimulus 375 1.30E-05 0.011637 
Defence response 350 1.28E-05 0.016926 
Immune response 327 1.25E-05 0.027447 
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Figure 1 – Preferential interaction turnover is observed in all eukaryotic 
interactomes.  We have binned proteins according to their average number of 
interactions and calculated for each bin the rate of change of interactions. There is a 
very strong correlation between the degree of connectivity and the interaction 
turnover. 
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Figure 2 – Protein binding domains with many structural interactions observed 
have a higher link turnover. We have grouped proteins containing domains with 
increasing observed structural interactions with other domain types and calculated for 
each bin the rate of change of interactions. Proteins containing domains known to 
interact with many other different domains have a higher rate of change of 
interactions than proteins containing domains with few know interactions.  
 
 
Figure 3 – Biological process can determine link dynamics independently of the 
number of interaction partners. We have binned proteins according to the 
biological processes defined in Gene Ontology and calculated for each bin the average 
number of interactions and average rate of change of interactions (see Methods). 
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5.9 – Supplementary Results 
 
Supplementary figure 1 – Dependence of the calculated rate of change and 
percentage of gene duplication on network size.  
A,C,E,G – Sampling was done by randomly removing interactions. Any protein with 
no interaction is no longer considered as part of interactome. B,D,F,H – Sampling was 
done by randomly removing proteins and their interactions. Any protein with no 
interaction is no longer considered as part of interactome. A,B – Sampling of S. 
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cerevisiae interactome; C,D – Sampling of D. melanogaster interactome; E,F – 
Sampling of H. sapiens interactome; G,H – Sampling of C. elegans interactome. 
 
 
 
Supplementary figure 2 - Specificity of binding can determine the rate change of 
interactions in groups of proteins with the same connectivity. A) We binned all 
proteins according to the number of interactions with proteins originated before the 
split with the reference species and calculated the rates of change of interactions with 
recently duplicated proteins.  B) We mapped the most likely interacting domains in 
the human interactome using the database of interacting motifs. We selected two 
groups of proteins: ● – proteins having 3 or more interactions trough at least 2 or 
more domains; ● – proteins having 3 or more interactions trough the same domain. 
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We binned both groups according to the number of interactions occurring in the full 
interactome with proteins originated before the split with the reference species and 
calculated the rates of change of interactions with recently duplicated proteins.  
 
Supplementary table 1 – The estimated rate calculated is robust to variation in 
accuracy of the datasets used. To test for a possible bias of the experimental method 
used in determining protein interactions, we divided the interactions of the human 
dataset into three subsets, as defined in the Human Protein Reference Database: yeast 
two-hybrid, in vitro studies such as GST pull-down and in vivo studies such as co-
immunoprecipitation. The estimated rate of change of interactions calculated with the 
yeast two-hybrid method (including human high-throughput studies) was only 
marginally higher than those observed with the other two datasets (obtained 
exclusively from literature derived protein interactions).  
 H.sapiens H.sapiens H.sapiens 
Approximate divergence from 
reference species (My) 
70 70 70 
Experimental method Yeast two-hybrid in vivo  in vitro  
Old proteins with interactions 2693 3806 4021 
Recently duplicated  proteins with 
interactions 
138 109 119 
Interactions between the two 
groups of proteins 
293 262 305 
Interactions gained or lost 291 213 242 
Percentage of interactions 
conserved after duplication (%) 
1 19 21 
Rate of change of interactions (per 
protein pair per My) 
1.09E-05 7.23E-06 7.12E-06 
 
Supplementary table 2 – Impact of constraining the list of domains by 
representation in the difference species and by the average rate of change. To 
increase the reliability of the rate of change for each domain we have selected only 
domains that were represented in most species by at least 20 domains. Of all Interpro 
domains, 96 observe this condition. Of these 96 domains, 8 have an above average 
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rate of change for at least 3 species studied. We can say that these 8 domains 
consistently contribute to the fast rate of change in most species.   
 In >=1 
species 
In >=2 
species 
In >=3 
species 
In 4 
species 
Domains represented in at least 20 
proteins 
628 189 96 12 
Domains represented by at least 20 
proteins and rate of change above the 
average for the proteome 
271 57 8 1 
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6 - Concluding remarks and future prospects 
I have shown that it is possible to determine the binding specificities of SH3 
and SH2 domains using structural information. Having the binding specificity, one 
can accurately predict biologically relevant protein targets using protein secondary 
structure information and comparative genomics. It is also possible to see above that 
conservation of the predicted binding site correlates with the relevance of the 
predicted interactions. Unfortunately only a fraction of the known SH3 and SH2 
interactions are mediated by highly conserved putative binding sites. This analysis of 
the conservation of the target binding sites then prompted me to investigate the 
evolution of protein interactions. Above it was shown that protein-interactions are 
actually quite plastic in evolution and that specificity of binding helps determine the 
rate of change of a protein’s interactions partners.  
These results underscore the importance of using computational tools to 
extend our current knowledge by looking for patterns and establishing predictive 
models. In the last years, we have witnessed an increase in our capacity to probe the 
cell in a genome wide fashion. We can now measure the expression level of most 
transcripts at the same time [209, 210], test the interactions of many of the cellular 
components [5, 14, 211], follow protein concentrations at different states over time 
and space [164, 212], etc. The analysis and integration of all these rich data sources is 
still lagging. Computational biology faces the challenge in the years to come of 
integrating this information and to produce useful biological models with predictive 
capabilities.  
How might the work presented here be carried further? I have stressed the 
value of studying protein structure to predict protein interactions. The many recent 
works on graph theory popularized a view of overly simplified cellular interactions, 
were components are denoted by nodes and interactions by edges [34]. Even though 
many interesting observations can be made, by studying these nodes and edges, only 
by incorporating the rich structural details can we hope to model the binding 
specificities of cellular components. I briefly describe below how one could continue 
to develop structure based prediction of protein interactions. These interaction 
Chapter 6 
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networks might then be further annotated in an attempt to move from cellular 
interaction maps to cellular models. I would also argue that understanding biological 
systems should be done in the light of the process that originates them – biological 
evolution. In this respect, further research should be devoted into understanding how 
cellular diversity originates and how cellular functions might be robust to genetic 
change.  
 
6.1 – Future directions in computation methods to predict protein 
interactions 
Aloy and Russell have found that it is possible to accurately model the 
interaction between two proteins, having a structure of interacting homologs, when 
the sequence identity is above 30% [45, 49]. For this reason, a structure of protein 
complex can be thought of as a template for an interaction type that can be used to 
model homologous interactions.  In 2004 the same authors estimated that it would be 
possible to cover around 2000 interaction types using this strategy. They also 
predicted a maximum of 10,000 interaction types that will eventually be covered by 
the increasing number of deposited structures in the PDB database [50].  
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Figure 1 – Framework for automatic structure based prediction of protein 
interactions. Any interaction type available in the PDB database [213] could be 
studied in an automatic fashion by pooling homologous sequences from a sequence 
database, creating homology models and predicting the binding energies with FoldX. 
These high-confidence predictions should be further characterized by experimental 
testing and by further annotation that might indicate the biological relevance of the 
interactions.  
 
It should be possible to take any interaction type for which a known structure 
is available, and to study it using current tools to predict particular instances of this 
type of interaction in the different species. The framework is represented in figure 1 
above.  
After having selected an interaction type one would have to study the possible 
protein conformation variability that might impact on binding. This could be achieved 
either with the use of different models of the same interaction (when available in the 
database) as was done in the SH3 example in manuscript 2, or using a molecular 
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dynamics simulations as was employed in the work of Hou and colleagues [54]. The 
third step would be to search for homologs of the template’s protein that could be 
modeled by this interaction type.  
To model the selected proteins it is necessary to correctly align all positions of 
the new protein sequences with the template. This is a crucial step that is still not 
possible to do automatically in a very accurate way. Although domain family 
databases exist [214, 215] and also sequence analysis tools are available to 
automatically group similar sequence families together (http://hmmer.janelia.org), 
these are still not accurate enough to guarantee that the important binding residues are 
correctly aligned in all cases. Homology modeling approaches should be used to 
improve the sequence alignments [216, 217]. Once these critical steps have been 
taken, it is possible to use FoldX derived position scoring matrices to predict the 
binding specificity of the binding domains (as described in manuscripts 2 & 3) and 
therefore to predict the binding of putative protein partners.  
When using the matrices, it is assumed that the positions in the target protein 
that are important for binding are independent. This might be, in many cases, not 
strictly correct and it is important to have a second step where all targets are properly 
modeled and new binding energies are calculated. In the case of the SH3 domain, the 
binding energies calculated with the PSSMs are in good agreement with the energies 
calculated with the full reconstructions, suggesting that, at least for SH3 domains the 
binding positions in the target peptide are mostly independent. This is probably 
because the peptide is bound in an extended conformation.  Interactions in which the 
bound peptide adopts other conformations, bringing peptide residues to close 
proximity, could require other approximations (ie two-residue matrices). 
The binding energies calculated from the structural information relate to the 
likelihood that the two proteins will bind if they meet in the cell. Even if the predicted 
interactions are of very high accuracy we are ultimately interested in knowing which 
are biologically relevant. There are many factors that might determine the relevance 
of an interaction. It is important to know for example if the two proteins are expressed 
at the same time or in the same tissue, if they are localized to the same cellular 
compartments, if they are functionally related (i.e genetically interact), etc. All this 
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information can be group generically into a term that could be referred to as the 
biological context information. As was shown in manuscripts 2 and 3, it is possible to 
mine this type of biological context information to increase the reliability of the 
predicted interactions.  
Importantly the developed methods are able to predict new interactions that 
can be experimentally tested. As depicted in the figure 1 above, the information 
discovered in this way will help us to further improve the described framework in a 
cycling iteration between experimental work and computational predictions. 
An important challenge for the continuation of the work presented in this thesis would 
be to try to set up an automatic pipeline that would implement the framework 
proposed above. This pipeline would constantly search for new interaction types and 
conformational variants, improve the scoring schemas as new binding information is 
made available and integrate any relevant biological information into filters that 
increase the biological relevance of a predicted interaction. Some of these efforts are 
under way in the form of the ADAM database (http://adan.embl.de/). 
I should note that it would not have been possible to establish the 
computational methods detailed if not for the availability of experimental data on 
which to train our approaches and evaluate the results. This underscores the 
importance of having reference databases that store information in a reliable and 
standardized way. Hopefully the success of computational biology will also spur the 
development of better standards for the communication and storage of biological 
information [218]. 
 
6.2 – From cellular interactions to cellular models  
Predicting the interaction of cellular components is only the first step in 
understanding how function arises from these interactions. The interaction networks 
constructed with available methods should constitute a starting point, a skeleton to be 
decorated with details required for a working model of the cell (see Figure 2 below). 
Some of these details include knowing the concentration of the components, the 
changes in concentration and molecular state over time and space and the 
characteristics of the interactions with other molecules (i.e. binding affinity, on and 
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off rates). Most commonly these models are created by consolidating information 
found in the scientific literature. Usually this information is obtained from small scale, 
detailed analyses that provide high confidence information on a single or a few 
molecular components. The recent technological advances in the different high-
throughput methods created large datasets that have to be similarly integrated. There 
is currently some mistrust of some of these high-throughput methods. The data 
produced is perceived as being inaccurate, mostly because the approaches are still 
under development and the initial evaluations have shown that these are still not up to 
par with small scale experiments [55]. However, there is no reason why standardized 
high-throughput methods should not even be of higher quality than many small scale 
experiments done with different protocols in different labs. The same way genome 
mapping is currently considered accurate and standardized, many of the other high-
throughput methods will likely be considered in the same light in the future. The large 
amounts of data being produced will ultimately allow for larger and richer models of 
the cell but better computational approaches are still required to get the most of these 
datasets.  
It is already possible, for example, to computationally identify biological 
modules within an interaction network [41, 219] but we are far from being able to 
predict what each component is doing in these modules.  In this respect computational 
biology can also serve to highlight the experimental methods that are more 
informative and complementary by quantifying the amount and quality of information 
they provide and the degree of overlap between the different approaches [59]. 
An interesting challenge for computational biology will be to set up methods 
that can integrate different high-throughput information into predictive models of 
cellular pathways that are at least as accurate as models obtained from more detailed 
experimental analysis of single components. 
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Figure 2 – Annotating interaction networks with different data sources. Cellular 
interactions networks should serve as a starting point for further characterization. 
Integration of information like: a) component state and concentration, b) structural 
data, c) localization data, should allow us to build useful models of cellular pathways. 
Image analysis software can be used to extract localization information over time into 
3D-spacial (d) models of the cells. 
 
6.3 – Evolutionary studies of cellular networks 
Understanding biological evolution can serve us to better comprehend or 
design other evolving systems. One example of this was the development of genetic 
algorithms that are heavily inspired on biology, but evolution theory is generally 
applied to the study of many other fields like economics, linguistics, sociology, etc.  
Apart from an inspirational role, understanding biological evolution might help us to 
better understand biological systems per se. In our attempt to comprehend how 
cellular networks operate it is important to keep in mind that these functions arose by 
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an evolutionary process. It is possible that some properties of the observed biological 
functions can only be explained when taking into account how they originated. For 
example, when we are observing current species we are, in fact, looking at a snapshot 
of the evolutionary process and therefore many components existing today might not 
be biologically relevant (i.e. pseudogenes). In the same way, it is very likely that a 
fraction of the observed interactions between cellular components are not serving any 
biological function but are just part of the variability explored by species during 
evolution.  
Also, the capacity of species to generate phenotypic variability (evolvability) 
may have to be considered when trying to understand function. It is difficult to argue 
that evolvability can be selected, in evolution, given that it apparently does not confer 
an immediate advantage to the individual but a future advantage to the group. 
However some authors have used simulations to show that, in theory, evolvability is a 
selectable trait under changing environmental conditions [220]. The authors argue that 
mechanisms that generate diversity are themselves subject to change and therefore the 
rates at which diversity is generated can be selected for. The issue is far from resolved 
but it would serve as an example that in some cases function can only be fully 
understood in light of evolution.  
Marc Kirschner and John Gerhart provided a list of mechanisms they think are 
linked to increased evolvability in metazoa [221]. They suggested for example that 
flexible versatile proteins like calmodulin and protein kinases, that have broad 
specificities, increase the evolvability of species because only a few mutations are 
required to create a potential target for regulation by these proteins. It was shown 
above, in manuscript 4, that lower specificity of binding indeed determines a faster 
rate of change of interactions. It is interesting to think that lower specificity was 
selected for in some functions, like signaling transduction, partly because they impart 
a higher evolutionary plasticity but at this point it remains mostly speculative. It 
would be interesting in the future to try to experimentally demonstrate that the 
recruitment of different binding specificities would depend for example on the rate of 
change of environmental conditions. This would suggest that evolvability at the level 
of different rates of change of interactions can be selected for. 
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Kirschner and Gerhart also suggested that compartmentalization of molecular species, 
either in space or in time (in the form of gene expression programs) is another 
mechanism of increasing evolvability [221]. They argue that compartimentalization 
reduces the pleiotropic damage from mutation and allow for the accumulation of non-
lethal genetic and phenotypic variation.  I would add that compartimentalization, in 
time and space, provides with an extra mechanism to determine specificity of 
interactions. This in turn should relax the lower bounds of acceptable binding 
specificity and allow the presence of more promiscuous binding domains. In fact, a 
theoretical study has recently suggested that the average binding specificity increases 
with cellular complexity from single cell organism to human cells [222]. If this idea is 
correct than one would also expect that, in general, more specific domains are less 
compartmentalized than promiscuous domains. I hope to be able to address this 
question in the future.  
  
6.4 – Mutational robustness at the cellular level  
In biological systems the phenotypic properties that are important for species 
fitness are, in many cases, robust to genetic change. It is very interesting to note that 
this mutational robustness can be established at different levels of biological 
organization (i.e. molecular, cellular and developmental). For example a mutation at a 
coding region may or may not change the coding amino-acid. In fact, many of the 
possible mutations at the DNA level will, even if changing the coding amino-acid, 
have little impact on the overall function of a produced protein [223]. We can then say 
that protein function is robust to mutations of its coding DNA. Even if a mutation 
affects the functional properties of a protein, the selectable trait might still remain 
unchanged if the changes are somehow compensated. For example, it has been 
experimentally shown that elimination of the enzyme glucose-6-phosphate 
dehydrogenase impairs minimally in growth [224]. Using theoretical models of 
metabolic networks Edwards and Palsson have shown that, although this enzyme is 
important for the generation of NADPH, in in silico knock out strains growth is 
reduced only 1% when compared to wild-type [225]. This is not achieved trough gene 
redundancy since there is no gene doing the same exact reaction in the cell. The 
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analysis revealed that the there is a large reorganization of the metabolic fluxes that 
compensates for the loss of the enzyme. This serves as an example of redundancy at 
the level of the cellular networks. There are many other cases where it was shown that 
perturbation of cellular networks either by component removal or duplication leads to 
a viable cell [226, 227]. Although the exact mechanisms are not known at this time, 
these results argue that the cellular networks are indeed particularly robust to genomic 
variability. This in fact could work to increase the cells evolvability, given that it 
allows the cell to accumulate non lethal variability that can be explored under 
changing environmental conditions.   
The work I have developed might also have application for the study of 
cellular robustness. Having the structural information about a given interaction also 
allows us to more readily design mutations that might disrupt it or redefine the 
specificity of binding of a protein [228]. The ability to target an interaction instead of 
removing the whole protein will be important in establishing how networks or 
pathways are robust to variability and to understand what is the contribution of each 
interaction for the function of the module under study.  
 
 
6.5 – Towards realistic in silico evolutionary studies 
Much of what was discussed above on the evolution of cellular networks, 
robustness and evolvability could be potentially better studied if one could perform in 
silico evolution of a realistic cell model. In silico evolution models have been used for 
a long time to study many subjects like protein-interaction network evolution [187] or 
the origin of sexual reproduction [229]. In all of these cases most cellular details are 
ignored or overly simplified mostly to save computational time or, in same cases, due 
to the lack of more realistic models. Recently, a group of scientists interested in 
artificial evolution have proposed the creation of a new research agenda – 
computational evolution [230]. They argued that although biological evolution has 
inspired computational algorithms many of the mechanisms of biological evolution 
have yet to be incorporated into computational models.  The authors postulate that 
increasing the level of detail will lead to better algorithms, more capable of addressing 
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future challenges of the field of in silico evolution. I propose that some of the 
methodologies presented in this thesis could in theory be applied to further this 
research agenda. The structural details and the capability to evaluate the impact of 
mutation on the proteins binding specificity using tools like FoldX [52] should be 
incorporated into evolutionary simulations (see Figure 3). Currently the FoldX 
algorithm cannot evaluate the impact of point mutations on the backbone of the 
protein and can only calculate the impact of mutations on the binding to other proteins 
(see manuscripts 2 and 3 as well as other works in the group [51, 228]) or to 
DNA/RNA [231]. Nevertheless this would serve as proof-of-principle for the 
integration of more realistic evaluation of mutations into in silico evolution studies.  
 
Figure 3 – Adding details to in silico evolutionary models. The ability of FoldX to 
evaluate the impact of point mutations on proteins properties (stability, binding 
specificity to other proteins or DNA/RNA) should be incorporated into computational 
evolutionary studies. Although potentially slower, these studies would be able to 
address more open ended questions than current models. Random mutations (1) in the 
genome, that affect coding regions, would be evaluated with FoldX (2) to determine 
changes in binding specificity. If these changes affect the proposed cellular model, the 
simulation would be updated with new parameters (3) and re-run (4) on the cellular 
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simulator. The impact on fitness would then be evaluated (5) and the process would 
continue.  
 
 
7 – Manuscripts not included in the thesis 
I additionally contributed to the manuscripts listed below during the period of my 
PhD. These have not been included in the thesis given that my contribution to them 
was relatively small.  
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